Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRP,Agouti-related protein,42296,0.206522120129345,0.00490960648594144,0.1968992914169,0.21614494884179,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN1,CCN family member 1,42047,0.291476178954644,0.00680046292634401,0.27814727161901,0.304805086290278,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0835604611289003,0.00205536723725927,0.0795319413438722,0.0875889809139285,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLR,Low-density lipoprotein receptor,42170,0.342739336529846,0.00424686144967061,0.334415488088492,0.351063184971201,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPY,Pro-neuropeptide Y,42262,0.263165756089784,0.00601130542008177,0.251383597466424,0.274947914713145,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.201277307628461,0.00275600094973734,0.195875545766976,0.206679069489946,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI,Tissue factor pathway inhibitor,42152,0.116946669037123,0.00298773458448092,0.11109070925154,0.122802628822705,1.11253692993846e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOM,Apolipoprotein M,42199,0.101219689719673,0.00273545893160985,0.0958581902137172,0.106581189225628,1.16855716815932e-285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APCS,Serum amyloid P-component,39870,0.115770305564285,0.00312700579529015,0.109641374205516,0.121899236923054,2.96732654082524e-283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROC,Vitamin K-dependent protein C,42199,0.0906466060365621,0.00247760513808508,0.0857904999659153,0.0955027121072089,1.3308418402378e-279
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.115601878648759,0.00320793178938243,0.10931433234157,0.121889424955949,1.1333240721274e-271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFGE8,Lactadherin,42137,0.157153342778814,0.0043821588897565,0.148564311354891,0.165742374202737,3.78040003463976e-269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F7,Coagulation factor VII,42194,0.102428200203616,0.00301191244236598,0.0965248518165789,0.108331548590654,2.31729215076656e-243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.188076875590887,0.00566216421143107,-0.199174717445292,-0.176979033736482,1.42856513132863e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHR,Growth hormone receptor,39736,0.0914198700881684,0.00274132655514305,0.086046870040088,0.0967928701362488,1.63227763094844e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOC1,Apolipoprotein C-I,39959,0.12455791674451,0.00374297935708987,0.117221677204614,0.131894156284406,8.72338622499015e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL27,C-C motif chemokine 27,42145,0.194050507222251,0.00609052142510721,0.182113085229041,0.205987929215461,7.09742897089736e-215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.132280840858272,0.00418018421141589,0.124087679803897,0.140474001912647,3.90499051743495e-212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCHE,Cholinesterase,39806,0.0802823168848664,0.00262259640831354,0.0751420279245719,0.085422605845161,1.02367892388849e-197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.226533084819418,0.00752408663578773,0.211785875013274,0.241280294625562,1.20092501830275e-191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.0553573500098715,0.0018994975171736,0.0516343348762112,0.0590803651435317,3.95647315586926e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP1,Neuropilin-1,42230,-0.0775046062633391,0.00268286266339864,-0.0827630170836004,-0.0722461954430777,3.65169327150419e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,39835,0.0842866174956216,0.00296171916508233,0.0784816479320603,0.090091587059183,4.41879021014304e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTR,Transthyretin,39862,0.0680685055979332,0.0024439503048353,0.063278363000456,0.0728586481954104,3.73604703694091e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH,Parathyroid hormone,39649,0.226200476717899,0.00817089564156765,0.210185521260426,0.242215432175372,3.74040329658168e-163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLKB1,Plasma kallikrein,39759,0.0664570576763509,0.00241202514593557,0.0617294883903172,0.0711846269623846,9.92382446878334e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0872453729912033,0.00318052158851711,0.0810115506777098,0.0934791953046968,2.62675390253175e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA4,Kallistatin,39802,0.0628325613271233,0.00230874830730607,0.0583074146448034,0.0673577080094432,5.52991173769215e-158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0859579252483301,0.00317452400487871,0.0797358581987678,0.0921799922978924,2.56411208592806e-157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0675414220587578,0.00251509868416495,0.0626118286377945,0.0724710154797211,7.40581455685097e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROS1,Vitamin K-dependent protein S,39979,0.0672382761073048,0.00250358870176705,0.0623312422518414,0.0721453099627682,4.20948645277916e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.220864619301216,0.00826958905858063,0.204656224746397,0.237073013856034,4.15175030360852e-153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,42230,0.126563221991055,0.00476815463921946,0.117217638898185,0.135908805083925,2.08597621864019e-151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFP,Properdin,39979,0.0618087474757122,0.0023364729111709,0.0572292605698173,0.0663882343816072,1.04766978171586e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL23,C-C motif chemokine 23,42185,0.109647975037443,0.0041671348343631,0.101480390762092,0.117815559312795,7.17060577098961e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FURIN,Furin,42181,0.0839048516601344,0.0032608647149101,0.0775135568189106,0.0902961465013582,1.34098108660352e-142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0519519937335979,0.00204007030134853,0.0479534559429547,0.055950531524241,1.12375711563048e-139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAMR1,Inactive serine protease PAMR1,42137,0.0653460359789849,0.00261425539562906,0.0602220954035519,0.0704699765544178,7.53389612967338e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.148808354076548,0.0059823766579737,-0.160533812326177,-0.13708289582692,1.27734316620047e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPL,Lipoprotein lipase,42145,-0.118246752450862,0.004753798274237,-0.127564197068366,-0.108929307833357,1.37788551521869e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,39786,0.033108961535739,0.00132792387996772,0.0305062307310023,0.0357116923404757,1.39475867853961e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES1,Liver carboxylesterase 1,42163,0.208918941212725,0.00840212561478321,0.192450775007749,0.2253871074177,1.69846862894119e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.208110880834864,0.00844850036278315,0.191551820123809,0.224669941545919,4.36937204342883e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.194680274754484,0.00791563052786229,0.179165638919874,0.210194910589094,1.08283182115669e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.059150342717209,0.00241536420750973,0.0544162288704899,0.0638844565639281,1.22254617782611e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFH,Complement factor H,39418,0.0570138284671167,0.00232225737101399,0.0524622040199293,0.0615654529143041,1.42225858051143e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRN,"Attractin, Isoform 2",39979,0.040133782205365,0.00165160199960966,0.03689664228613,0.0433709221245999,3.31391599276339e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP6,Charged multivesicular body protein 6,39958,0.137677272337536,0.00566693795765223,0.126570073940538,0.148784470734535,3.77750770239067e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCA,Alpha-synuclein,39736,0.281628633111126,0.0116861472514913,0.258723784498203,0.304533481724049,3.92877963684942e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.0795654660246111,0.00330954961867374,0.0730787487720105,0.0860521832772116,4.02802697487375e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.348212562719827,0.0144909027180332,0.319810393392482,0.376614732047172,6.0845697698091e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.254082368763736,0.010576852138872,0.233351738571547,0.274812998955925,6.73439082313501e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN3,Contactin-3,42137,0.0673513529116525,0.00280720187275883,0.0618492372410452,0.0728534685822598,1.31138211654322e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,42181,0.0595006425279147,0.00248369116628911,0.054632607841988,0.0643686772138413,2.93660654793384e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A5,Zinc transporter ZIP5,42119,0.124182418444891,0.00525337564948157,0.113885802171907,0.134479034717875,4.35241264284148e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FN1,Fibronectin,39979,0.0640308773983845,0.00270488752921583,0.0587292978411214,0.0693324569556475,5.68046927125191e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFM,Afamin,39979,0.0472575670204245,0.00200763760968244,0.0433225973054469,0.0511925367354021,1.14924197637359e-119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F13B,Coagulation factor XIII B chain,39925,0.0591627488590569,0.0025444702730241,0.0541755871239297,0.0641499105941842,7.31221005828807e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,P4HB,Protein disulfide-isomerase,42073,0.0882846561068604,0.00382962544986989,0.0807785902251154,0.0957907219886054,2.30665222950105e-115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL6,C-X-C motif chemokine 6,42296,0.171788317120382,0.0074888833591665,0.157110105736416,0.186466528504348,2.66443941158678e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.280364985358133,0.0122984636544942,0.256259996595324,0.304469974120941,6.53558077018492e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F10,Coagulation factor X,39990,0.0656452365998209,0.00287579304851849,0.0600086822247247,0.0712817909749172,8.25129174160528e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,42145,-0.0882045698021929,0.00389911783786135,-0.0958468407644012,-0.0805622988399847,3.01578645335914e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBC,Inhibin beta C chain,42137,0.0890009742191065,0.00394703175622663,0.0812647919769023,0.0967371564613107,1.48052682998629e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYAP1,Synapse-associated protein 1,39736,0.131224578236482,0.00582290735661796,0.11981167981751,0.142637476655453,5.20759691477833e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAT,Tissue-type plasminogen activator,42272,0.114214926204857,0.00508215911352744,0.104253894342344,0.124175958067371,7.25343215899287e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB2,Carboxypeptidase B2,39959,0.0503223460115608,0.00223617950962176,0.0459394341727022,0.0547052578504195,9.37607502793285e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF9,Protein turtle homolog A,39958,0.191041014770041,0.00854438724178094,0.174294015776151,0.207788013763932,2.128547640056e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.0432980029937491,0.00195055178245267,0.0394749215001418,0.0471210844873563,2.80275804125575e-107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG2,Desmoglein-2,42137,-0.059112889194725,0.00268880227667933,-0.0643829416570165,-0.0538428367324335,2.76885499026884e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.178335636547847,0.00812345441607808,0.162413665892334,0.19425760720336,5.83983589629892e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD4,T-cell surface glycoprotein CD4,42100,0.063015009497003,0.0028821316847022,0.0573660313949866,0.0686639875990193,3.63329965676666e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,41843,0.23880108447974,0.0110886129120371,0.217067403172147,0.260534765787333,3.87901734516744e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFI,Complement factor I,39979,0.0415540129230516,0.00193556016418893,0.0377603150012413,0.0453477108448619,2.93175274587922e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.145823276924068,0.00683199409232791,0.132432568503106,0.159213985345031,1.94294625588774e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN2,Ficolin-2,42116,0.0856248976887081,0.00403276931188756,0.0777206698374085,0.0935291255400077,1.93246857574308e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORT1,Sortilin,42129,0.0804309474023211,0.00379274220703778,0.0729971726765271,0.0878647221281152,3.27101071265897e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0779370559248981,0.00367063690224489,0.0707426075964981,0.0851315042532981,3.84854848455774e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUSB,Beta-glucuronidase,42211,0.128323126374469,0.0060721702236141,0.116421672736185,0.140224580012753,1.45006654167407e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,39934,0.122876325470063,0.00580921342542306,0.111490267156233,0.134262383783892,1.99332304318164e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,42189,0.0723404615925587,0.00342701077634074,0.0656235204709309,0.0790574027141865,2.38903849376779e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCG,Pro-glucagon,41843,0.257028393670232,0.0123548150891346,0.232812956095528,0.281243831244935,1.29120105001714e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.146679684759444,0.00707134192687729,0.132819854582765,0.160539514936124,7.82119369891197e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOST,Sclerostin,42129,0.0795753023027815,0.00385605911268547,0.072017426441918,0.087133178163645,3.49778347152495e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.288637202275951,0.0139734743601967,0.261249192529965,0.316025212021936,4.4142624441663e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.079319604032795,0.0038485731487246,-0.0868628074042953,-0.0717764006612948,5.80331074050907e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.0408790279152765,0.00198553161225814,0.0369873859552505,0.0447706698753024,9.27400631561533e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUMB,Protein numb homolog,39657,0.171954735384658,0.00836922016247876,0.155551063866199,0.188358406903116,4.32475096239856e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,42070,0.25748387128505,0.0125708490371719,0.232845007172193,0.282122735397907,7.66822224752165e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR5,Cadherin-related family member 5,42145,0.0789175557271563,0.00385527547038172,0.0713612158052081,0.0864738956491045,9.68381024726875e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.224941439021577,0.0110186663863007,-0.246538025138726,-0.203344852904427,2.91494600939328e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH1,Somatotropin,42129,-0.36040143385745,0.0176938507202325,-0.395081381269105,-0.325721486445794,7.26130313716464e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.0448656028314377,0.00220170388642092,0.0405502632140527,0.0491809424488227,1.17464295922328e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO3,Beta-enolase,39638,0.127019816049366,0.00626916912704059,0.114732244560367,0.139307387538366,1.19895653893538e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPIND1,Heparin cofactor 2,39959,0.0587672190508787,0.00291429965587989,0.0530551917253541,0.0644792463764033,7.0561265631111e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTD,Biotinidase,39979,0.0412150808095335,0.00204976838738718,0.0371975347702546,0.0452326268488124,2.16933715548855e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLTP,Phospholipid transfer protein,42267,-0.0756509502372009,0.00377151714978738,-0.0830431238507842,-0.0682587766236177,3.15118447004749e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKB,Creatine kinase B-type,39966,-0.114997868397913,0.00572684820934405,-0.126222490888227,-0.103773245907599,3.66157234468421e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA3,Glutathione S-transferase A3,41843,0.152440162083792,0.00768235240019001,0.13738275137942,0.167497572788165,2.271280814654e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0662358518846904,0.0033397303103532,-0.0727817232929826,-0.0596899804763981,2.51242834790495e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,39657,0.172088925508921,0.00866493962164576,0.155105643850495,0.189072207167347,2.83420114118951e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.144084416959101,0.00729350606615447,0.129789145069438,0.158379688848763,1.18926393627779e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP10,Stromelysin-2,42124,-0.112815238401057,0.00574504401121344,-0.124075524663036,-0.101554952139079,1.12496032505595e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRP,Gastrin-releasing peptide,39638,0.104702440061713,0.0053306646223019,0.0942543374020015,0.115150542721425,1.87334456444907e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,39649,0.24100903133846,0.0122863591108906,0.216927767481114,0.265090295195805,3.03554985732475e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.046754032849901,0.00239651361040949,0.0420568661734984,0.0514511995263036,1.33666598541963e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.115934028188702,0.00597239826602741,0.104228127587289,0.127639928790116,8.66312387863726e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,42140,0.0761890801670927,0.00394453878912445,0.0684577841404088,0.0839203761937766,5.07161308828743e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR37,Prosaposin receptor GPR37,41900,0.124896232854066,0.0065082535393128,0.112140055917013,0.137652409791119,5.51196225695627e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.130498068791259,0.00680562659360451,0.117159040667794,0.143837096914724,7.43331637808295e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0994104373499362,0.00519438200080552,0.0892294486283573,0.109591426071515,1.37861107969816e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS1,Protein MTSS 1,39930,0.213295650353546,0.011135383896644,0.191470297916123,0.235121002790968,1.64375892214053e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EEF1D,Elongation factor 1-delta,39958,0.174096649397899,0.00910514389326644,0.156250567367097,0.191942731428701,3.07510806610316e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,42181,0.173843558645378,0.00913041377081553,0.155947947654579,0.191739169636176,8.67222777925864e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIP2,Cysteine-rich protein 2,42016,0.0689666893423146,0.00363496822676322,0.0618421516178587,0.0760912270667705,3.09141306655914e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YES1,Tyrosine-protein kinase Yes,42070,0.216160768111806,0.0113956487666625,0.193825296529148,0.238496239694465,3.32319675619056e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0845239069271961,0.00445359253426016,-0.093252948294346,-0.0757948655600462,4.27510085543548e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FYB1,FYN-binding protein 1,42115,0.174882500293607,0.00923805265404983,0.156775917091669,0.192989083495545,6.66829116651264e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0779878612953986,0.00412662918460335,0.069899668093576,0.0860760544972212,1.87108409664875e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.0561553523453068,0.00297216320421964,0.0503299124650363,0.0619807922255773,2.03390543928614e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJAP1,Tight junction-associated protein 1,42181,0.156058220509609,0.008293420126417,0.139803117061831,0.172313323957386,5.35394013409448e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SARG,Specifically androgen-regulated gene protein,39915,0.20698764231169,0.010994229339259,0.185438952806743,0.228536331816638,6.99833161847604e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0503416375570645,0.0026799686665947,0.0450888989705389,0.0555943761435902,9.87245209296127e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH9,Myosin-9,39966,0.212950444642069,0.0113550019885583,0.190694640744495,0.235206248539644,2.62749089795672e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,42047,0.0486293241141794,0.00259619781791578,0.0435407763910645,0.0537178718372943,2.65867867480922e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCS1,Neuronal calcium sensor 1,42262,0.052420193439222,0.0028232432273683,0.0468866367135801,0.0579537501648638,5.07437198464022e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,41913,0.158874321521526,0.00855534770215805,0.142105840025296,0.175642803017756,5.09695191301576e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,42137,-0.073592985518026,0.0039787149825259,-0.0813912668837767,-0.0657947041522752,1.86369608806739e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTYMK,Thymidylate kinase,39958,0.124408710908588,0.00672258163565704,0.1112324509027,0.137584970914476,2.35163329080556e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINC1,Antithrombin-III,39959,0.0267751017454193,0.00144944945693032,0.0239341808098359,0.0296160226810027,4.29633120824778e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.2100958586558,0.0114075126277461,0.187737133905418,0.232454583406183,1.2120677160667e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.146171946312124,0.00794223295373713,0.130605169722799,0.161738722901449,1.47484629989017e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADIPOQ,Adiponectin,39979,-0.126686615063089,0.00690187394886078,-0.140214288002856,-0.113158942123322,3.50001393787381e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYNU,Kynureninase,42296,0.0829794204512541,0.00453961303384023,0.0740817789049272,0.0918770619975809,9.15021118925486e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F9,Coagulation factor IX,42199,0.0333970359251629,0.00183271469051945,0.0298049151317448,0.0369891567185811,2.53550200969751e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.111279526484813,0.00612261969211439,0.0992791918882685,0.123279861081357,5.9867180698371e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.230417830640182,0.0126814421279277,-0.25527345721092,-0.205562204069444,6.44064441456769e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9,Complement component C9,39990,-0.104391830694315,0.00576183495340358,-0.115685027202986,-0.0930986341856444,2.38129804183686e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR3,Anterior gradient protein 3,41827,0.106447078749535,0.00591076951652319,0.0948619704971496,0.118032187001921,1.18526095005904e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZN,Kazrin,39930,0.188803812309707,0.0104935070275706,0.168236538535669,0.209371086083746,2.19051111358311e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLN,Promotilin,42119,0.160254959468492,0.00892179164992985,0.14276824783463,0.177741671102355,2.59316584498353e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOMO1,Nodal modulator 1,42137,0.0417745233128564,0.00232618066827837,0.0372152092030308,0.0463338374226821,2.76447940354137e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.190596338659265,0.0106230811825825,0.169775099541404,0.211417577777127,3.71733308023604e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2,Prothrombin,39979,0.0266462194651047,0.00149096455476216,0.0237239289377709,0.0295685099924385,1.79017828326119e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.178177439038957,0.00999212903964768,0.158592866121247,0.197762011956666,2.55331579524069e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.178287901017598,0.00998829553996186,0.158710841759272,0.197864960275923,2.6547687599661e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.129822649780764,0.00728684810662476,0.115540427491779,0.144104872069748,3.3155989953487e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS2,Protein MTSS 2,39919,0.178756462302936,0.0100515632162218,0.159055398399142,0.198457526206731,8.34824924624999e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON2,Spondin-2,42070,-0.0615718355249875,0.00348935911507687,-0.0684109793905382,-0.0547326916594368,6.54576087435565e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5E,5'-nucleotidase,42181,0.0947742560301782,0.00537601450191676,0.0842372676064213,0.105311244453935,8.58487156325526e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0726319319476789,0.00414093308907232,0.0645157030930971,0.0807481608022606,4.0482200659113e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL5,C-X-C motif chemokine 5,42101,0.197296639793084,0.0112519982256664,0.175242723270778,0.21935055631539,4.44213024744886e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.189053968109953,0.0107790235516946,0.167927081948631,0.210180854271274,5.65386487705781e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELN,Elastin,39958,0.0609280260642137,0.0034763657829759,0.054114349129581,0.0677417029988465,7.02827362127188e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRL,Appetite-regulating hormone,42145,0.145246390572891,0.00830789466350556,0.12896291703242,0.161529864113362,1.06861837487117e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXIN1,Axin-1,42119,0.168637236280207,0.00964572404826793,0.149731617145601,0.187542855414812,1.06892601282474e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFC,Platelet-derived growth factor C,41843,0.0485975287367251,0.00279087096667222,0.0431274216420475,0.0540676358314027,3.67267070820987e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHBP1,EH domain-binding protein 1,39958,0.130679028966925,0.00750167229771433,0.115975751263404,0.145382306670445,4.31982715496141e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0523866006538747,0.00300795691452501,0.0464910051014057,0.0582821962063437,4.64502872684222e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAP1,Proline-rich acidic protein 1,39966,0.0681744250530668,0.00391496406028064,0.0605010954949167,0.0758477546112168,4.79232006043045e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL13,C-X-C motif chemokine 13,42249,0.0995251536785887,0.00574438372399395,0.0882661615795606,0.110784145777617,1.54933573536759e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,39815,0.0457105031869467,0.00263522269305905,0.040545466708551,0.0508755396653425,1.55685391433527e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC5,Glypican-5,42016,0.0975180507483855,0.00563857892307056,0.0864664360591672,0.108569665437604,2.69119018748787e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR2,Cadherin-related family member 2,42070,0.113750016642063,0.00658815328806665,0.100837236197452,0.126662797086673,4.36880359349569e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11,Coagulation factor XI,39822,0.0545107090989592,0.00315733496461041,0.0483223325683228,0.0606990856295956,6.13777758950403e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,42070,0.11606387578333,0.00675170455532142,0.1028305348549,0.12929721671176,1.56742579081067e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFR,Epidermal growth factor receptor,42310,0.027378115919606,0.0015983629600861,0.0242453245178373,0.0305109073213748,4.29565809549297e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1S,Complement C1s subcomponent,39979,0.0363051503021792,0.00211788200635802,0.0321541015697175,0.0404561990346409,4.70065034964536e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAB2,Disabled homolog 2,42262,0.189817096075952,0.0110894805443798,0.168081714208968,0.211552477942937,5.28367145504165e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,42185,0.214342486438913,0.0125394317428145,0.189765200222996,0.238919772654829,7.89491332587549e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEFTY2,Left-right determination factor 2,42247,0.0879556133902242,0.00515576509655274,0.0778503138009809,0.0980609129794676,1.38254072920415e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.166621654548852,0.0097805487059382,0.147451779085213,0.185791530012491,2.09534360143805e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.186208249048948,0.0109209179125101,0.164803249940429,0.207613248157468,2.19234211681372e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,41997,0.0392650278404383,0.00230932775201707,0.0347387454464849,0.0437913102343918,3.68214847638883e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFC,Vascular endothelial growth factor C,42181,0.0941594139024406,0.00554087511689618,0.083299298673324,0.105019529131557,4.20551494101841e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.152884558572485,0.00901288685681982,0.135219300333118,0.170549816811852,7.16971498584531e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.103588977713454,0.00612630267345972,0.0915814244734726,0.115596530953435,1.79125079291097e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPD52L2,Tumor protein D54,39736,0.18404145654117,0.0109280682645252,0.162622442742701,0.20546047033964,7.28364760243113e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0619475007712913,0.00368462844856617,0.0547256290121017,0.069169372530481,8.63290790622389e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL3,C-X-C motif chemokine 3,42129,0.16034773432695,0.00953914330677532,0.141651013445671,0.17904445520823,9.00937463931046e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.132105138529701,0.00786845216077324,0.116682972294585,0.147527304764816,1.6677019282793e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPM,Carboxypeptidase M,42195,0.0568046644009693,0.00340204925046008,0.0501366478700676,0.0634726809318711,5.68497266381982e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNA4,Plexin-A4,42119,0.134132895546736,0.008048542829948,0.118357751600038,0.149908039493435,9.63808464214082e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,42119,0.0713810673811351,0.00428507830133228,0.0629823139105238,0.0797798208517463,1.08865124698628e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.120578148574904,0.00724314526728529,0.106381583851025,0.134774713298783,1.31683999403577e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAB2,Stabilin-2,39966,0.0468911641108599,0.00281765806722194,0.0413685542991049,0.0524137739226149,1.84468081529829e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,39736,0.127482505904395,0.00766096669786739,0.112467011176575,0.142498000632215,1.951465153673e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINK1,Misshapen-like kinase 1,39929,0.155365982307104,0.00934975381025461,0.137040464839005,0.173691499775203,2.77671507451204e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,41839,0.131112817855144,0.00790731271344756,0.115614484936787,0.146611150773502,3.93520834532849e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP20,Centrosomal protein 20,41843,0.124591553598409,0.00751986942227688,0.109852609530746,0.139330497666072,4.85360616025301e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.137957754514433,0.00832916368475319,0.121632593692317,0.154282915336549,6.85876910983888e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA1,Glutathione S-transferase A1,42119,0.140129848687977,0.00847663397297335,0.123515646100949,0.156744051275005,8.61662073046569e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.13479612490573,0.00815543550636069,0.118811471313263,0.150780778498197,8.91252114480759e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD63,CD63 antigen,41992,0.083270529312204,0.00505473527181298,0.0733632481794506,0.0931778104449575,2.22109566496367e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXLNA,Alpha-taxilin,42016,0.144856522901282,0.0088204525107679,0.127568435980176,0.162144609822387,5.05487985713922e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK1,Dickkopf-related protein 1,42249,0.0968474917152791,0.00589919863398137,0.0852850623926757,0.108409921037883,5.42176441453086e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0457062336373415,0.00278450919461198,0.040248595615902,0.051163871658781,5.72505514445101e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES3,Carboxylesterase 3,42070,0.116219461036138,0.00711765256236789,0.102268862013897,0.130170060058379,2.30403757217877e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0858348565638676,0.00526672718599003,0.0755120712793271,0.0961576418484081,3.79587572396375e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.119332674743874,0.00732714267642404,0.104971475098083,0.133693874389665,4.6184972570598e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.108105130378249,0.00664615901252677,0.0950786587136969,0.121131602042802,6.42181676379476e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFX1,Transcriptional repressor NF-X1,39575,0.110058787911959,0.00678318024023351,0.0967637546411008,0.123353821182816,1.60030718851627e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0416055520958837,0.00256625237276959,0.0365756974452553,0.0466354067465121,1.94054969129216e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,41843,0.105496238663698,0.00651468218539527,0.0927274615803235,0.118265015747073,2.03453508978615e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS6,Growth arrest-specific protein 6,42236,-0.040903955811152,0.00252737505005768,-0.0458576109092651,-0.035950300713039,2.27276046597386e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,39929,0.143326297806492,0.00887198267460229,0.125937211764272,0.160715383848713,4.65937216471544e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0499368170531582,0.00309486155736034,-0.0560027457055845,-0.043870888400732,6.51264396182137e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.053784190870998,0.00333984807915449,0.0472380886358552,0.0603302931061408,8.27307359126333e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOE,Apolipoprotein E,39979,0.113068307308113,0.00701840260083692,0.0993122382104727,0.126824376405753,9.39024236546255e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBIN,Erbin,42070,0.164912083708124,0.0102679837633691,0.144786835531921,0.185037331884328,1.64125667718776e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.18159229752932,0.0113157917761317,0.159413345648102,0.203771249410538,2.01073250611206e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL22,C-C motif chemokine 22,41991,0.0831065665488909,0.00518868991859934,0.0729367343084362,0.0932763987893457,3.30913252273423e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.136364137158954,0.00851162277860299,0.119681356512892,0.153046917805015,4.01286511110649e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0525642220932109,0.00328646381014965,0.0461227530253176,0.0590056911611042,4.70064497139841e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARF6,ADP-ribosylation factor 6,39930,0.174209536785586,0.0109063313401087,0.152833127358973,0.1955859462122,8.17242300412958e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,42249,0.152487875934201,0.00956279264828276,0.133744802343567,0.171230949524835,9.88130449453577e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF2,Growth/differentiation factor 2,42145,0.0564053774693201,0.0035409432011303,0.0494651287951047,0.0633456261435355,1.29149446945364e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCK2,Cytoplasmic protein NCK2,42185,0.170340854060607,0.0107033852103403,0.14936221904834,0.191319489072874,1.62369978037547e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMIP,C-Maf-inducing protein,39919,0.134014666925272,0.00841438629532766,0.117522469786429,0.150506864064114,1.69241455191683e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL10,C-X-C motif chemokine 10,42185,0.105043811054585,0.00660185681919565,0.0921041716889612,0.117983450420208,1.71312441884619e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HJV,Hemojuvelin,39934,0.0672753886135163,0.00422713442589234,0.0589902051387673,0.0755605720882653,2.02903265973311e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,42217,0.0735751223215996,0.00462884791100366,0.0645025804160324,0.0826476642271668,2.20724882661741e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.165511632519141,0.0104184622806057,0.145091446449154,0.185931818589128,2.54395022156861e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0598623746192401,0.00377040468580942,0.0524723814350536,0.0672523678034266,2.96276958827481e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCR,Breakpoint cluster region protein,42119,0.146764625090474,0.00924589104951777,0.128642678633419,0.164886571547529,3.11214942418345e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL17,C-C motif chemokine 17,42107,0.145378186247402,0.0091599342010132,0.127424715213416,0.163331657281388,3.23463298628077e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0442701204287218,0.00279372598424144,0.0387944174996086,0.049745823357835,4.69351718676985e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,39930,0.137242543837653,0.00865274961348227,0.120283154595228,0.154201933080079,4.71290129180773e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THPO,Thrombopoietin,41900,0.0619328199191345,0.00390860188618076,0.0542719602222202,0.0695936796160488,4.93098994690512e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0647064493497954,0.00408153197792232,0.0567066466730676,0.0727062520265231,5.31146651154594e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.150585713842702,0.00950893928821758,0.131948192837796,0.169223234847609,5.5429011767933e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM1,Isthmin-1,42119,0.0625784039060091,0.00395470540075518,0.054827181320529,0.0703296264914893,6.76581759819534e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC3B,Tetranectin,39726,0.0334290759439061,0.00211268085607967,0.0292882214659899,0.0375699304218222,8.73886907437732e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEG1,Protein HEG homolog 1,39736,0.043814605609947,0.00277230799369652,0.0383808819423018,0.0492483292775922,1.16653220765525e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH2,Neutral ceramidase,42016,0.0841212300675164,0.00533452676900844,0.0736655576002599,0.094576902534773,1.59660292272031e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS4,Galectin-4,42123,-0.0888742472250355,0.00565140485290971,-0.0999510007367385,-0.0777974937133324,3.09243588129551e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.10424820162041,0.00662360332668324,0.0912659391001108,0.117230464140709,3.13274284898476e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLA2,Src-like-adapter 2,39934,0.168569206511495,0.0107172285202171,0.14756343861187,0.189574974411121,3.67183337133302e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.080989128249145,0.00516161731808386,0.0708723583057007,0.0911058981925894,6.59302602486945e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKBKG,NF-kappa-B essential modulator,42119,0.143472133416785,0.00915236544957222,0.125533497135624,0.161410769697947,6.71716542337049e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOL1,Apolipoprotein L1,39990,0.0840411699939207,0.00536028978402154,0.0735350020172385,0.0945473379706029,7.9321704201814e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPC,C-type natriuretic peptide,42119,0.0825490644563607,0.00527018713887014,0.0722194976641752,0.0928786312485462,8.15584188802487e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,39929,0.0759050488919956,0.00484508748387472,0.0664086774236012,0.0854014203603901,9.62146197456659e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.161494396521522,0.0103227617188834,0.14126178355251,0.181727009490533,1.39441828285e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.16552863898157,0.0105906294239946,0.144771005310541,0.1862862726526,1.72497720686448e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R9B,Neurabin-2,42296,0.148147284832852,0.00949696925643317,0.129533225090243,0.166761344575461,2.15646779414957e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL5,C-C motif chemokine 5,42217,0.157689517600727,0.0101129623422641,0.13786811140989,0.177510923791565,2.40231427526752e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,42310,0.0631939248700829,0.00405324287884245,0.0552495688275517,0.0711382809126141,2.45408223160053e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL16,C-C motif chemokine 16,42310,0.0800698849738828,0.00514300065185351,0.0699896036962499,0.0901501662515157,3.45451205183585e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL16,Pro-interleukin-16,42296,0.0659781907859364,0.00423891385624044,0.0576699196277051,0.0742864619441676,3.66769224999605e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.131867273248327,0.00847114425093752,0.11526383051649,0.148470715980165,4.44596068094633e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCTN3,Tectonic-3,39958,0.0474663669177201,0.0030518585670552,0.0414847241262919,0.0534480097091483,5.44090725089154e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.177881591839574,0.0114535788825825,0.155432577229712,0.200330606449436,7.71963196598927e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEP,Leptin,42145,0.108152276704907,0.00697193114020697,0.0944872916701013,0.121817261739713,8.28016410845623e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.168339440416129,0.0108712699459884,0.147031751321992,0.189647129510266,1.55141917641772e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD6,T-cell differentiation antigen CD6,42284,0.0804072195491555,0.00522126242173275,0.0701735452025593,0.0906408938957517,4.56191796966523e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.157985649747162,0.0102667482861051,0.137862823106396,0.178108476387928,5.49264271543624e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0812673150820925,0.00528159636119171,0.0709153862141567,0.0916192439500282,5.75629492154788e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C4BPB,C4b-binding protein beta chain,42181,0.0588394231514532,0.00382898248641102,0.0513346174780876,0.0663442288248188,7.59895786210328e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,42070,0.211028928684081,0.013748134752939,0.18408258456832,0.237975272799841,9.94717497300842e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO1,Forkhead box protein O1,42119,0.133230555487962,0.00868176184595126,0.116214302269897,0.150246808706026,1.04682178810723e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.169495721810382,0.0110653473179514,0.147807641067197,0.191183802553567,1.95493466268503e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN1,Perilipin-1,41839,0.0518596853852683,0.0033973176383504,0.0452009428141015,0.0585184279564351,3.64197490672684e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,42145,0.13284551467545,0.00870876157120296,0.115776341995892,0.149914687355007,4.17957179937259e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC4,Syndecan-4,42145,0.072329001862188,0.00474775313884193,0.0630234057100578,0.0816345980143182,5.63679085648453e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD1,Sushi domain-containing protein 1,41900,0.0743557020287328,0.00488293483378398,0.0647851497545162,0.0839262543029494,6.34755415790053e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHBG,Sex hormone-binding globulin,39990,-0.0715999683742841,0.00470506414760748,-0.0808218941035948,-0.0623780426449735,8.71495860869684e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,42100,0.0304902250923378,0.00200594619020284,0.0265585705595403,0.0344218796251354,9.48840482005924e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.137246361156998,0.00902268371890929,0.119561901067936,0.15493082124606,9.6487424972708e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.114239120133114,0.00751699200942091,0.0995058157946488,0.128972424471579,1.23133594184713e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,39934,0.174293110173916,0.0114813452533035,0.151789673477441,0.196796546870391,1.52658213638309e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK2,Docking protein 2,42145,0.186660914077454,0.0123185775852566,0.162516502010351,0.210805326144556,1.916474675108e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A4,Protein S100-A4,42181,0.0849543124419345,0.00561660853914503,0.0739457597052103,0.0959628651786588,2.87286111595609e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FETUB,Fetuin-B,42199,0.0487909908369867,0.00322725655032441,0.0424655679983509,0.0551164136756225,3.19227043821296e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGL1,Fibrinogen-like protein 1,39990,-0.098473858263114,0.00651029261765422,-0.111234031793716,-0.0857136847325118,3.43154297869404e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.112720813114825,0.00745794562059146,0.0981032396984662,0.127338386531185,4.23247586777896e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL17,C-X-C motif chemokine 17,42296,0.0644660943452847,0.00427024426653221,0.0560964155828816,0.0728357731076878,4.39206645717527e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.104057100562353,0.00688687807702473,0.0905588195313848,0.117555381593322,4.5703333719602e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0653970448878693,0.00433429410102454,0.0569018284498612,0.0738922613258775,6.04477292161586e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY1,Aminoacylase-1,42145,0.0948791378686556,0.00630180436583126,0.0825276013116264,0.107230674425685,8.13798947401806e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEC31A,Protein transport protein Sec31A,39638,0.117167116162472,0.00778307857465354,0.101912282156151,0.132421950168793,1.03295548680102e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6A,Ras-related protein Rab-6A,42119,0.066881728983968,0.00444820993466132,0.0581632375120318,0.0756002204559042,1.10104130745262e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.105216953852828,0.00701826511132556,0.0914611542346303,0.118972753471027,2.13787999307178e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.0684437198272394,0.0045622057231167,0.0595017966099306,0.0773856430445481,2.16532978372866e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPHN1,Oligophrenin-1,39929,0.163133958481017,0.0109094765093103,0.141751384522769,0.184516532439265,4.43948208628996e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0612099895420435,0.00409980772417745,0.0531743664026557,0.0692456126814314,5.31436933551732e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN1,Dynactin subunit 1,42262,0.095545567975818,0.00640747581594467,0.0829869153765664,0.10810422057507,6.83737586007224e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK10,Kallikrein-10,42138,0.0611140280442641,0.00409897970962488,0.0530800278133993,0.0691480282751289,7.10036527529591e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS15,Enteropeptidase,42070,0.131384092633545,0.0088203009244887,0.114096302821547,0.148671882445543,8.7559540125608e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCXR,L-xylulose reductase,42181,0.0809319374558084,0.00543932201315443,0.0702708663100257,0.0915930086015911,1.10960531054194e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11R,Junctional adhesion molecule A,42137,0.0830992773220321,0.00559095927883922,0.0721409971355073,0.094057557508557,1.40571433633062e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,39736,0.124462824717007,0.0083669699410796,0.108063563632491,0.140862085801523,1.42080973593918e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0773164415436935,0.0052033502003717,0.067117875150965,0.0875150079364221,1.49705755426272e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELP,P-selectin,42217,0.0831335038483987,0.00559841006896686,0.0721606201132236,0.0941063875835737,1.70919427110363e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GASK1A,Golgi-associated kinase 1A,39575,0.0638852572442756,0.00429939928424869,0.0554584346471482,0.0723120798414031,1.83475370292877e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REN,Renin,42145,-0.120660087597632,0.00814333188463943,-0.136621018091525,-0.104699157103739,2.76318370754106e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BECN1,Beclin-1,39638,0.0886554627617506,0.00597816770091311,0.0769382540679609,0.10037267145554,2.79590646340668e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTBDN,Retbindin,42070,0.0445288848421919,0.0030077528000992,0.0386336893539975,0.0504240803303864,3.32648343640526e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,39934,0.176452414254659,0.0119327051434605,0.153064312173476,0.199840516335842,5.06007619319676e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,39657,0.144309996423737,0.00975932935556782,0.125181710886824,0.16343828196065,5.22494101862461e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORD,Sorbitol dehydrogenase,42204,0.101798843507357,0.00689190824866043,0.0882907033399825,0.115306983674731,5.41521491813937e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2B3,SH2B adapter protein 3,41843,0.14577111902379,0.00987732440805606,0.126411563184001,0.16513067486358,6.66516479665827e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.126018314897707,0.0085393931746671,0.10928110427536,0.142755525520055,6.74997406947285e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,42185,0.126636322386258,0.00859471631350208,0.109790678411794,0.143481966360722,9.24284958980401e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.165216391499443,0.0112259643719881,0.143213501330346,0.18721928166854,1.19571536430891e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.151899877480193,0.0103184999917459,0.131675617496371,0.172124137464015,1.32505689449157e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0828911306100499,0.00563812338555324,0.0718404087743656,0.0939418524457343,1.49498701112572e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLA,Alpha-galactosidase A,39713,0.0579799588723179,0.00394338920905016,0.0502509160225795,0.0657090017220562,1.7557950072859e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILPL2,RILP-like protein 2,39958,0.145890743363945,0.00993102766926376,0.126425929132188,0.165355557595702,2.06335001805108e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGCC,Regulator of cell cycle RGCC,39934,0.112987276351697,0.00770069163601737,0.0978939207451028,0.128080631958291,2.68482633166247e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,39930,0.142081904556366,0.00969482305498155,0.123080051368602,0.16108375774413,3.42976898460042e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP4,Dipeptidyl peptidase 4,41948,0.0409988880848209,0.00280075301498123,0.0355094121754577,0.0464883639941841,3.76489662784072e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,39934,0.107476507837801,0.00734257435918544,0.0930850620937979,0.121867953581805,4.44620765299401e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USO1,General vesicular transport factor p115,42070,0.130500368916824,0.00893584543188007,0.112986111870339,0.148014625963309,6.14193604938866e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.107055028532666,0.00733174961107079,0.0926847992949669,0.121425257770364,7.65747981281094e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.114891838309595,0.00787015792570828,0.0994663287752067,0.130317347843983,7.80352268933608e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN2,CCN family member 2,42146,0.0825890001182528,0.00566517161643898,0.0714852637500324,0.0936927364864732,8.86709222636471e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,39575,0.0890850619085409,0.00611432222052503,0.0771009903563119,0.10106913346077,1.21424199757094e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,39934,0.0924153717578525,0.00635762096988427,0.0799544346568793,0.104876308858826,1.90871656083299e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0432104873731282,0.00297858455369009,0.0373724616478956,0.0490485130983607,2.45012239481741e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D23,TBC1 domain family member 23,42070,0.130879662526642,0.00904249956809274,0.11315636337318,0.148602961680104,4.00103474815577e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.123771122084303,0.00856868526525013,0.106976498964413,0.140565745204193,7.2469980329355e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.0833911684685039,0.0057826286301778,0.0720572163533554,0.0947251205836523,1.01419604437773e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,42199,-0.0401239795732253,0.00278515090249712,-0.0455828753421197,-0.0346650838043309,1.0408774758804e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AAMDC,Mth938 domain-containing protein,39638,0.0765767581525259,0.00532863519819138,0.0661326331640708,0.087020883140981,2.06789146698749e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.167903855333124,0.0117320426393729,0.144909051759953,0.190898658906295,4.03563164685608e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0905956080761626,0.00633645518350759,0.0781761559164877,0.103015060235837,4.98834425185842e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.145895609378575,0.0102085292893838,0.125886891971383,0.165904326785768,5.34310363274188e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0286980088026634,0.00200956657130898,0.0247592583228978,0.032636759282429,6.24104689462697e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LG,CMRF35-like molecule 9,42137,-0.0534996316231008,0.00374640781631742,-0.0608425909430829,-0.0461566723031187,6.26196179938622e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.152652696192565,0.0107142508736562,0.131652764480199,0.173652627904931,1.14872277897192e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANG,Angiogenin,42152,0.0468334788408545,0.00329097754220615,0.0403831628581304,0.0532837948235785,1.25599852649605e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.100106432915273,0.00702964514278342,0.0863283284354179,0.113884537395129,1.26843335912908e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.148079107909959,0.0104355520888552,0.127625425815803,0.168532790004115,2.23237650263407e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.0980442078370054,0.00690501886980016,0.0845103708521971,0.111578044821814,2.32930663364082e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,39958,0.130319066176512,0.0091883788460416,0.11230984363827,0.148328288714753,2.83894730989088e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,42145,0.0441240621760735,0.00311346171801225,0.0380216772087695,0.0502264471433775,2.87423026359485e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,42119,0.0474845841527889,0.00335552944305947,0.0409077464443923,0.0540614218611855,3.85755292804978e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPOCK1,Testican-1,42016,0.0371272842543994,0.00262406886534213,0.0319841092783288,0.04227045923047,4.01197285850416e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINH1,Serpin H1,39757,0.182819335648248,0.0129619405423108,0.157413932185319,0.208224739111178,8.65690017145845e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0572474246651786,0.00406434260811324,0.0492813131532766,0.0652135361770805,9.79679659763042e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.134437004350245,0.00955347163686553,0.115712199941988,0.153161808758501,1.17891280874459e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.12810292145266,0.0090995014116181,0.110267898685888,0.145937944219431,1.23180707380375e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE4,Ribonuclease 4,39645,0.0392690730587801,0.00279030097415436,0.0338000831494375,0.0447380629681226,1.34236627448749e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRAP,BRCA1-associated protein,39813,0.155763013941066,0.0110696030890319,0.134066591886564,0.177459435995569,1.3656316458512e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF15,Growth/differentiation factor 15,42310,-0.0646442148373095,0.00459792433646225,-0.0736561465367755,-0.0556322831378434,1.37528899189175e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBNL,Drebrin-like protein,42185,0.130655124545093,0.00930391337923335,0.112419454321796,0.148890794768391,1.73935173000547e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2AP,CD2-associated protein,42145,0.0887580492133304,0.00633289415966391,0.0763455766603892,0.101170521766272,2.55890390212982e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPY30,Protein dpy-30 homolog,42216,0.0844608439135974,0.00603275644235558,0.0726366412865804,0.0962850465406143,3.14072389326805e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZI2,5-azacytidine-induced protein 2,39934,0.0783918580431719,0.00559774900117979,0.0674202700008595,0.0893634460854843,3.42934014232359e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.153512546109586,0.0109698297955238,0.13201167971036,0.175013412508813,3.43319606715434e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC1,Stanniocalcin-1,42249,0.0642500180621092,0.00459769763942724,0.0552385306888318,0.0732615054353866,4.49464879031371e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPK2,SRSF protein kinase 2,42119,0.119362427887192,0.00854127296895787,0.102621532868035,0.13610332290635,4.50015647199784e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.10885026038096,0.00778980077698744,0.0935822508580647,0.124118269903855,4.59665592894744e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOT,Angiomotin,39736,0.0540023079888877,0.00386173481628405,0.0464333077489709,0.0615713082288044,4.60342967399748e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.109945653733143,0.00787337818665294,0.0945138324873037,0.125377474978983,5.95536781933764e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSTN,Growth/differentiation factor 8,41900,0.0756251871784411,0.00542514153536352,0.0649919097691286,0.0862584645877535,7.3874525122413e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.132884221239148,0.00953373541344806,0.11419809982879,0.151570342649507,7.4908160329364e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.117167134689196,0.00842820226131661,0.100647858257015,0.133686411121376,1.40831874708606e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,42123,-0.0483533203511346,0.00348384498126091,-0.0551816565144059,-0.0415249841878632,1.68038884535343e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7,Interleukin-7,42119,0.0899337440661495,0.00648033317367349,0.0772322910457495,0.10263519708655,1.71214764486729e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BACH1,Transcription regulator protein BACH1,42119,0.104349395194447,0.00752565883737216,0.0895991038731977,0.119099686515697,2.02299780473572e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APPL2,DCC-interacting protein 13-beta,39736,0.157841122066022,0.0113811945224271,0.135533980802065,0.18014826332998,2.2508600451311e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTPBP2,GTP-binding protein 2,39649,0.114483972686517,0.0082598992206938,0.0982945702139568,0.130673375159077,2.54085090452626e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,42185,0.177429552936129,0.0128239162625839,0.152294677061465,0.202564428810794,3.0431944771878e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.092222846241031,0.00666086715868781,0.0791675466100029,0.105278145872059,3.04537344481635e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR5,Complement factor H-related protein 5,39864,0.0580982077640577,0.00419652451887466,0.0498730197070633,0.066323395821052,3.1073543681172e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.11294502869491,0.00816113313268197,0.096949207754853,0.128940849634966,3.31004117600126e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.135610492397185,0.00981513234763897,0.116372832995813,0.154848151798557,3.94661232487307e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREG1,Protein CREG1,41960,0.0559371600770352,0.00405555982083085,0.0479882628282067,0.0638860573258637,5.55405947834377e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0392247111609655,0.00284235118162161,0.0336537028449871,0.0447957194769438,5.66299479612571e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,42181,0.0311077452852354,0.0022580002464505,0.0266820648021924,0.0355334257682784,6.83913779375786e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MITD1,MIT domain-containing protein 1,42016,0.133732884710642,0.00970992419275076,0.114701433292851,0.152764336128434,7.26929924984664e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFP,Alpha-fetoprotein,41976,0.0900864830354632,0.00655126039769703,0.077246012655977,0.102926953414949,9.80469832652823e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0978778411089578,0.00712335102722369,0.0839160730955994,0.111839609122316,1.13627741436589e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL13,C-C motif chemokine 13,42275,0.0938968161681822,0.00683766677576782,0.0804949892876773,0.107298643048687,1.24724737157574e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.108292242820238,0.00788781892628678,-0.123752367915761,-0.0928321177247164,1.31028744794386e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.122515453648318,0.0089318419122286,0.10500904350035,0.140021863796286,1.76064731249149e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0678090477720742,0.00495127034575068,0.0581045578944028,0.0775135376497455,2.10643779349874e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,42016,0.0417446982169669,0.00304939367184269,0.0357678866201552,0.0477215098137786,2.25894938743373e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,42098,-0.0889489646692413,0.00650044310282195,-0.101689833150772,-0.0762080961877103,2.44041120679313e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1B,Meprin A subunit beta,42145,0.157510572545517,0.0115144772403867,0.134942197154359,0.180078947936675,2.57677117668286e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHK,Ketohexokinase,39638,0.0867274769365002,0.00634445646680641,0.0742923422615597,0.0991626116114408,3.39042821673767e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,39990,0.036690106142408,0.00268992223322303,0.0314178585652908,0.0419623537195251,4.96049699111113e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0729110257667942,0.00535102477824791,0.0624230172014283,0.0833990343321601,5.41180523236955e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLSCR3,Phospholipid scramblase 3,39911,0.079209166054896,0.0058116227257203,0.0678183855124842,0.0905999465973078,5.73727165357943e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK1,Docking protein 1,39929,0.188380918583161,0.0138254717006181,0.16128299404995,0.215478843116373,6.03149387003088e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPB1,Beta-ureidopropionase,39958,0.124224013129711,0.00911786612690707,0.106352995520973,0.142095030738449,6.13453977079735e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,42119,0.118408368026342,0.008711242400224,0.101334332921903,0.135482403130781,8.33915658745706e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0326915919293294,0.00241212806252965,0.0279638209267713,0.0374193629318875,1.41969714545626e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA11,Annexin A11,42087,0.0900805377474166,0.00664705896820422,0.0770523021697364,0.103108773325097,1.44356022815794e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR,GMP reductase 1,42296,0.0647404687929278,0.00478173408424828,0.0553682699878012,0.0741126675980544,1.69878831647507e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLG,Plasminogen,39742,0.0298145844898054,0.00220422022672354,0.0254943128454273,0.0341348561341835,2.32343515874381e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,39930,0.104853099344319,0.00775909185138858,0.0896452793155977,0.120060919373041,2.71477231430769e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA2,Apolipoprotein A-II,39990,-0.0671316721545906,0.00497136462998091,-0.0768755468293532,-0.057387797479828,3.0873619031834e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,39958,0.0987324615735105,0.00732052869090199,0.0843842253393426,0.113080697807678,3.86162816505279e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0899150278498514,0.00667552330815512,0.0768310021658674,0.102999053533835,4.32328331750841e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",41839,0.0682070245442557,0.00507614929385112,0.0582577719283075,0.0781562771602039,6.82217928912788e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB3,Plexin-B3,42099,0.0648619087786314,0.00482778941070249,0.0553994415336545,0.0743243760236083,6.89220598870996e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,39736,0.104352097383368,0.00776801745093879,0.0891267831795281,0.119577411587208,7.98904214831141e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",41900,0.12510205381398,0.00933125451832158,0.106812794958069,0.14339131266989,1.0141741703244e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM13A,Protein FAM13A,39930,0.0916168095745984,0.00684050693327478,0.0782094159853798,0.105024203163817,1.34694772097912e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,41900,0.0471923254373396,0.0035350557396823,0.0402636161875623,0.0541210346871169,2.16025865652001e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGLL,Monoglyceride lipase,42166,0.116936924848243,0.00876346406358929,0.0997605352836076,0.134113314412878,2.31570293649199e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.116508394095605,0.0087258833809576,0.0994056626689283,0.133611125522282,2.32771172854809e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IST1,IST1 homolog,39850,0.132382355695283,0.00991638749938297,0.112946236196493,0.151818475194074,2.40493072934562e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCC,Tubulin-specific chaperone C,42016,0.107823182006572,0.00808390934890486,0.091978719682719,0.123667644330426,2.51306484768483e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0763929010732573,0.00573025404710848,0.0651616031409246,0.0876241990055899,3.10792013145388e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.101694579169581,0.00764030138902021,0.0867195884471016,0.116669569892061,3.65317444492441e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF21,Fibroblast growth factor 21,42247,0.160308867223198,0.0120591187391839,0.136672994494398,0.183944739951999,4.47600079295084e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRKL,Crk-like protein,42143,0.140823327885709,0.0105931126657666,0.120060827060807,0.161585828710612,4.47920909531792e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0722338491849442,0.00543379842689346,0.061583604268233,0.0828840941016554,5.09025688208893e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.165204897540109,0.012442957273339,0.140816701284365,0.189593093795854,5.69757879888254e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0506282376717438,0.00381737249154895,0.0431461875883079,0.0581102877551797,6.85153412649275e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN2,Prorelaxin H2,39709,0.0686731157549001,0.00519211123382617,0.0584965777366008,0.0788496537731994,1.23029179197027e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0845080499720019,0.00639754619930341,0.0719688594213672,0.0970472405226365,1.37711220887717e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY4,Protein canopy homolog 4,42070,0.0996614919343284,0.00755423370193359,0.0848551938785386,0.114467789990118,1.69647419384082e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0731895331318698,0.0055531661570161,0.0623053274641182,0.0840737387996213,1.99323723258616e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK13,Kallikrein-13,41839,0.0593887316328678,0.00450770171912937,0.0505536362633742,0.0682238270023613,2.1639664264135e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",42107,0.144869313562921,0.0110019489386189,0.123305493643228,0.166433133482614,2.35548325219996e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP5,Retinol-binding protein 5,42070,0.0744260039043537,0.00565774028957258,0.0633368329367915,0.085515174871916,2.79158989580964e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNST,Consortin,42145,0.143828324760315,0.0109420894263944,0.122381829484582,0.165274820036048,3.18038393412915e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99L2,CD99 antigen-like protein 2,42137,0.0324932088297324,0.00247216224975434,0.0276477708202139,0.0373386468392509,3.21747459939387e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTBS,Di-N-acetylchitobiase,39860,0.0364570931286641,0.00277388192813548,0.0310202845495186,0.0418939017078097,3.62466832203555e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP43,Centrosomal protein 43,41797,0.0929644428004886,0.00707797680843023,0.0790916082559653,0.106837277345012,3.6848062255742e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM17,Splicing factor 45,39934,0.101652514863653,0.00774570280248388,0.0864709373707849,0.116834092356522,4.63673985189105e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0418071862619106,0.00319200641665312,0.0355508536852705,0.0480635188385508,5.84903658651736e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT,Linker for activation of T-cells family member 1,42296,0.0994952384587236,0.00761532398825183,0.08456920344175,0.114421273475697,8.8825404167662e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,41843,0.0798879079497735,0.00611754753919035,0.0678975147729604,0.0918783011265866,9.81777635907323e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.11988654688031,0.00919762501715293,0.10185920184669,0.137913891913929,1.3302797947531e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNMBP,Dynamin-binding protein,42016,0.0794750402345673,0.00609857490091732,0.0675218334287694,0.0914282470403653,1.38450950741552e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,41900,0.100763869231742,0.00773212045900792,0.085608913132086,0.115918825331397,1.38891374674073e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1R,Complement C1r subcomponent,39979,0.024718567411695,0.001897483149628,0.0209995004384242,0.0284376343849659,1.61891704837153e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS1BP3,HCLS1-binding protein 3,39638,0.11976898203792,0.00919797356435226,0.101740953851789,0.13779701022405,1.77869842896924e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.11924991126066,0.00915895874328877,0.101298352123814,0.137201470397506,1.80459096464839e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.1243675864829,0.00957235139463805,0.105605777749409,0.143129395216391,2.31342202918599e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0959128511497671,0.0073808896328576,0.0814463074693662,0.110379394830168,2.45304257860424e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMN,Protein amnionless,41913,0.0616269947036368,0.0047501617321868,0.0523166777085506,0.0709373116987229,2.94330367526912e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EREG,Proepiregulin,41997,0.104694835904924,0.00807109408782999,0.0888754914927767,0.12051418031707,3.01337228879609e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0936525425600325,0.00722032610704971,0.079500703390215,0.10780438172985,3.02683645987135e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEXIM1,Protein HEXIM1,42119,0.105120442103926,0.0081065319213034,0.0892316395381716,0.121009244669681,3.16604250820981e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,41900,0.0950247770332407,0.00733812668369305,0.0806420487332023,0.109407505333279,4.02152802265622e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLB,Beta-klotho,41839,-0.0971240847766433,0.00750286420678615,-0.111829698621944,-0.0824184709313424,4.27287326984893e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,42070,0.110439062349615,0.00853211816560287,0.0937161107450333,0.127162013954196,4.28993135568184e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.100417562312672,0.00776192574821621,0.0852041878461686,0.115630936779176,5.14903926800768e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPP,Lipoma-preferred partner,39575,0.0860581457874616,0.00665821722306325,0.0730080400302577,0.0991082515446656,6.14172165173345e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAP,Prolyl endopeptidase FAP,42310,0.0357329253779233,0.0027675871159114,0.030308454630737,0.0411573961251096,6.47090417573328e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,41843,0.117526829565256,0.00910387588820114,0.099683232824382,0.13537042630613,6.73068828522042e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMVK,Phosphomevalonate kinase,41832,0.140646623244261,0.010907751931823,0.119267429457888,0.162025817030634,8.19750559139832e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB27B,Ras-related protein Rab-27B,39958,0.107192441120762,0.00831013456124824,0.0909045773807154,0.123480304860808,8.39766387303248e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TWF2,Twinfilin-2,39966,0.11062507426082,0.00858161746068928,0.0938051040378695,0.127445044483771,9.30597830844199e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0415455165092023,0.00322612003855224,-0.0478687117847647,-0.0352223212336399,9.96219165091593e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,39736,0.0518082559177793,0.00403750518150048,0.0438947457620383,0.0597217660735202,2.00384045854591e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDHD2,Phospholipase DDHD2,39934,0.0857618572957584,0.00668605709736712,0.0726571853849189,0.098866529206598,2.1070935440428e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,39736,0.163449523901721,0.0127437194857922,0.138471833709569,0.188427214093874,2.15892182879492e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.0717434306556157,0.00560563977036905,0.0607563767056924,0.082730484605539,2.77554836242968e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,42310,0.0294750503530619,0.00230354837646467,0.0249600955351911,0.0339900051709326,2.83832445172943e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0929838757077781,0.00726813883198301,0.0787383235970914,0.107229427818465,3.23207782222462e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0852887426435074,0.00667249460910941,0.0722106532096529,0.0983668320773619,3.42241239441914e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR4,Complement factor H-related protein 4,39945,0.0943928777407457,0.00738220316687435,0.079923759533672,0.108861995947819,3.51887969161048e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP2,Methionine aminopeptidase 2,42247,0.0715082888516881,0.00560303742507343,0.0605263354985442,0.0824902422048321,4.33086007816053e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0461335439257339,0.00361344350728399,-0.0532158932000105,-0.0390511946514573,4.50010091686581e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLGA3,Golgin subfamily A member 3,39934,0.0999395821357478,0.00782826499087516,0.0845961827536325,0.115282981517863,4.53876817163062e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPL,N-acetylneuraminate lyase,39958,0.0594312762318288,0.00467682566016676,0.050264697937902,0.0685978545257557,9.54017688625053e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUCB2,Nucleobindin-2,42231,0.0477930065361116,0.00376672051564954,0.0404102343254385,0.0551757787467847,1.10784656033961e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.110214562645106,0.00868139942623103,0.0931990197696933,0.127230105520519,1.11369391056625e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD1,COMM domain-containing protein 1,39638,0.077942987635326,0.00614964682183322,0.0658896798645329,0.0899962954061192,1.47344704103239e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX15,Sorting nexin-15,39736,0.0688772040992504,0.00544574441955142,0.0582035450369296,0.0795508631615712,2.04451046684782e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F12,Coagulation factor XII,39979,0.0526360157765811,0.00416512870985219,0.0444723635052708,0.0607996680478914,2.30659810393592e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2L,Ataxin-2-like protein,39934,0.0611688755490616,0.00484933094719407,0.0516641868925612,0.0706735642055619,3.10028594757314e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAMBP,STAM-binding protein,41997,0.0799141881851602,0.00634060581559774,0.0674866007865886,0.0923417755837318,3.23920326964785e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA1,Ephrin type-A receptor 1,42162,0.0408341012166161,0.00324191336007444,0.0344799510308702,0.047188251402362,3.55493293886227e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BID,BH3-interacting domain death agonist,42119,0.0838050966577696,0.0066541905605957,0.070762883159002,0.0968473101565371,3.62068607579169e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0390385079821404,0.00309972507535653,0.0329630468344416,0.0451139691298392,4.05751580680472e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPB,Natriuretic peptides B,41900,-0.177575176603413,0.0141125589525777,-0.205235792150465,-0.149914561056361,4.21635509990804e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0324608101560821,0.00258185084961171,0.0274003824908431,0.0375212378213211,4.74311560910469e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBPL,FK506-binding protein-like,39930,0.0752372008550088,0.0059808423355355,0.0635147498773592,0.0869596518326584,4.75377774277203e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAX,Protein max,41839,0.133750001205382,0.0106596298297013,0.112857126739167,0.154642875671596,6.57912193690641e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHD3,EH domain-containing protein 3,39638,0.149401280620391,0.0119034174695879,0.126070582379998,0.172731978860783,6.88724841881467e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.140038697226527,0.0112003956156532,0.118085921819847,0.161991472633207,1.14278400516651e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,39959,0.0233754753582675,0.00186925075306306,0.0197117438822639,0.0270392068342711,1.19911087303359e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MME,Neprilysin,42070,0.0978587958158922,0.00783116645179875,0.0825097095703667,0.113207882061418,1.23605666959599e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPART,Spartin,39736,0.0980310231591168,0.00785265979898974,0.0826398099530969,0.113422236365137,1.5816536485192e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0836977852079521,0.00671415545907879,0.0705380405081577,0.0968575299077465,1.95625608936149e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0914666943032089,0.00734265819257893,0.0770750842457542,0.105858304360664,2.21605158729689e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAX1BP1,Tax1-binding protein 1,39929,0.0779431277090431,0.00626138241941315,0.0656708181669933,0.0902154372510929,2.43370065618626e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.10301849515673,0.00829457503429959,0.0867611280895031,0.119275862223957,3.16613001136401e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0903610310558379,0.00728588795309552,0.0760806906677707,0.104641371443905,4.33308135887175e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.110765586920623,0.00893434259553176,0.0932542754333808,0.128276898407865,4.53102557741853e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.129782265782319,0.0104788474537743,0.109243724772921,0.150320806791716,4.86991226915037e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDC,Nuclear migration protein nudC,42296,0.0790484244887635,0.00638364424486904,0.0665364817688201,0.0915603672087068,4.97601735544087e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSC2,Desmocollin-2,41984,-0.0438067942791568,0.00353792083091446,-0.0507411191077492,-0.0368724694505645,5.08130134626575e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAXX,Protein PAXX,39736,0.0576376191609193,0.00467267257192506,0.0484791809199462,0.0667960574018924,9.88412010131882e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT1,Deaminated glutathione amidase,39638,0.0552137997762479,0.00447723738709187,0.0464384144975479,0.063989185054948,1.02923054973573e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD5,Programmed cell death protein 5,42249,0.0709175126874686,0.00575571344343301,0.0596363143383399,0.0821987110365973,1.06438459447447e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.064701802575305,0.00524961135430762,0.0544125643208621,0.0749910408297479,1.10757358924304e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIFBP,KIF-binding protein,42070,0.102289943635433,0.0083058372465296,0.0860105026322351,0.118569384638631,1.14937631655339e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.107042463424615,0.00869260788550918,0.0900049519690166,0.124079974880213,1.27705088017768e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCLY,Selenocysteine lyase,42224,0.0601470966175818,0.00489148241312275,0.0505597910878612,0.0697344021473024,1.44602625311334e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0896708290833576,0.00730468088823987,0.0753536545424074,0.103988003624308,1.86384458243119e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,39657,0.109010845360738,0.00888235966917124,0.0916014204091626,0.126420270312314,2.12389726251908e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0909606359131063,0.00741251464240425,0.076432107213994,0.105489164612219,2.16523636528341e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EZR,Ezrin,42249,0.0299520849947027,0.00244314891555308,0.0251635131202187,0.0347406568691868,2.26204552150482e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEXN,Nexilin,39990,0.0861472356260379,0.00703098364434807,0.0723665076831156,0.0999279635689601,2.67685810408919e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN1,Pantetheinase,39990,0.0902500895054573,0.00737673053651017,0.0757916976538974,0.104708481357017,3.3355620896711e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0771766063108857,0.00630848378900653,0.0648119780844329,0.0895412345373385,3.36661673729211e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,39919,0.0697154004722238,0.00570123638363767,0.058540977160294,0.0808898237841537,3.61245015906789e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,39657,0.0991980010398602,0.00812092718776108,0.0832809837518485,0.115115018327872,4.2801091936432e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT2,Omega-amidase NIT2,39903,0.0897213454696271,0.00735406467973634,0.0753073786973439,0.10413531224191,5.07035278733265e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0925913273555702,0.00761031909941833,0.0776751019207103,0.10750755279043,7.05794874807204e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.0797517212265723,0.00655554546413293,0.0669028521168717,0.0926005903362729,7.1901204562523e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD27,CD27 antigen,42181,-0.0521977015838923,0.00429509315373326,-0.0606160841652095,-0.0437793190025751,8.29630655350502e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,39922,0.0246395748678455,0.00202709338306472,0.0206664718370386,0.0286126778986523,8.74489815951262e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.078428261105233,0.00645224310224294,0.0657818646248369,0.0910746575856292,8.808126771012e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.0625828679406806,0.00515731696224724,0.052474526694676,0.0726912091866852,1.13365018238054e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYDGF,Myeloid-derived growth factor,39958,0.121643040838823,0.0100295338128144,0.101985154565707,0.14130092711194,1.20422182515473e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD36,Platelet glycoprotein 4,39657,0.0569650007388497,0.00469900908141163,0.0477549429392829,0.0661750585384165,1.30682338348451e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.0977691734569777,0.00808626166020024,-0.11361824631097,-0.0819201006029853,1.76136311625498e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.178049967372035,0.014722786882195,0.149193305082933,0.206906629661137,1.83701506905561e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0939335015287576,0.00777116492512203,0.0787020182755185,0.109164984781997,1.84598531841213e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG2,Bone marrow proteoglycan,39966,-0.0624253423405669,0.00516930706220168,-0.0725571841824822,-0.0522935004986516,2.25913614768454e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.059462088228461,0.00493611976527668,0.0497872934885187,0.0691368829684033,3.01461098867741e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0401557296832101,0.00333377497533891,0.0336215307315458,0.0466899286348744,3.03670446293023e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0902058132777181,0.00748575632124003,0.0755337308880877,0.104877895667349,3.10597925636978e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXJ3,Forkhead box protein J3,39657,0.0550718107493427,0.0045706159077197,0.0461134035702121,0.0640302179284733,3.16538661536629e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0927727848063511,0.00770504874758521,0.0776708892610841,0.107874680351618,3.46745666650104e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAG1,Dystroglycan,42185,0.057413886365149,0.00477325365122997,0.0480583092087382,0.0667694635215597,3.72042361695248e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0759723249657489,0.00632651929792296,0.0635723471418199,0.0883723027896779,5.15790349453023e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD226,CD226 antigen,39657,0.0516191864870352,0.00429913146648836,0.0431928888127181,0.0600454841613524,5.24291342543226e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0775428370054873,0.00645904424480663,0.0648831102856663,0.0902025637253083,5.28272447450541e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.117643740341283,0.00982464713005413,0.0983874319663772,0.136900048716189,7.15703526776358e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGA,Protein O-GlcNAcase,39930,0.0862520811521618,0.00720021143746989,0.0721396667347208,0.100364495569603,7.22014780479922e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF2,TNF receptor-associated factor 2,42119,0.0834491085190152,0.00697417388218937,0.0697797277099241,0.0971184893281064,7.89573307477789e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,A1BG,Alpha-1B-glycoprotein,39979,0.0199779029252453,0.00167009063123134,0.0167045252880318,0.0232512805624587,8.81564429366081e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGF,Pro-epidermal growth factor,42081,0.125091136938777,0.0104627373347193,0.104584171762727,0.145598102114827,8.85964613709517e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.0657519525137485,0.00549925399444694,0.0549734146846325,0.0765304903428645,8.86678851969427e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4D,Semaphorin-4D,42249,0.0361531082956109,0.0030248783030544,0.0302243468216243,0.0420818697695975,9.24318413107409e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3F,Semaphorin-3F,42145,0.0320458837942004,0.00268142797703034,0.0267902849592209,0.0373014826291799,9.3662960293873e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS8,Galectin-8,42249,0.0730829201451368,0.00611900745602563,0.0610896655313266,0.0850761747589471,1.02069926205466e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICA1,Islet cell autoantigen 1,41913,0.0960440245358254,0.0080485568679508,0.0802688530746418,0.111819195997009,1.16762845723584e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.100467730741636,0.00842360826802679,0.0839574585363036,0.116978002946969,1.25063245311293e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN3,Centrin-3,39930,0.0946495150249571,0.00793250920103521,0.0791017969909281,0.110197233058986,1.26622182384157e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRAP2,GRB2-related adapter protein 2,42145,0.154861317889498,0.0129859063497874,0.129408941443915,0.180313694335081,1.27177714211347e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA5,Integrin alpha-5,42137,0.029820515772703,0.0025022974080895,0.0249160128528476,0.0347250186925584,1.40025541106079e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL32,Interleukin-32,42119,-0.0532063586709695,0.00446886423649138,-0.0619653325744926,-0.0444473847674464,1.60092425688063e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSB,Arylsulfatase B,42070,0.0664492562166742,0.00558876324556871,0.0554952802553596,0.0774032321779889,1.94295479984235e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.11869637098065,0.0099856751979667,0.0991244475926353,0.138268294368665,2.01368818865791e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLG4,Disks large homolog 4,39929,0.0864616883308411,0.00728029241402801,0.0721923151993462,0.100731061462336,2.44919023526575e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.118514862988053,0.00998698184643869,0.098940378569033,0.138089347407073,2.73003242696189e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FST,Follistatin,42166,0.0581194054424814,0.00490111258336659,0.0485132247790829,0.0677255861058799,2.80950204374902e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.125873325501307,0.0106166601094099,0.105064671686863,0.14668197931575,2.89221020638569e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0462976809056087,0.00390586978758067,0.0386421761219505,0.0539531856892668,2.97293387029599e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0731368775807832,0.00616634425317183,0.0610508428445664,0.085222912317,2.9740046050522e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0418361442353831,0.00353142106314035,-0.0487577295191382,-0.034914558951628,3.22011148694019e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM20A,Pseudokinase FAM20A,39958,0.0335720810582242,0.00283909371934017,0.0280074573683174,0.0391367047481309,4.47354391600603e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.067421277394829,0.00571711801020342,0.0562157260948303,0.0786268286948277,6.09830601427692e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0567602834378578,0.00481938144814721,0.0473142957994892,0.0662062710762263,7.81490341290439e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0617838567596481,0.00525054835561974,0.0514927819826334,0.0720749315366628,8.23102464163359e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.128802232400303,0.0109496780955373,0.10734086333305,0.150263601467557,9.43419545731866e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPY,Pancreatic prohormone,42089,0.121602847461029,0.0103483524135513,0.101320076730468,0.14188561819159,9.970990199538e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0240500581346661,0.00205015849737781,-0.0280683687895266,-0.0200317474798056,1.25859516018463e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18R1,Interleukin-18 receptor 1,42296,0.0389058600489911,0.00332243018178527,0.032393896892692,0.0454178232052903,1.59981496469455e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,42016,0.0934999025402463,0.00798940423540088,0.0778406702388606,0.109159134841632,1.74999049388807e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASC3,Protein CASC3,39649,0.0509517874282948,0.00435202045242251,0.0424218273415467,0.0594817475150429,1.78702979188914e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB9,Serpin B9,42016,0.0386651620426996,0.00330572208804654,0.0321859467501284,0.0451443773352708,1.8890177002579e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED8,Protein TMED8,39930,0.121927708904283,0.0104228313720714,0.101498959415023,0.142356458393543,1.97473591598763e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTF1,Cardiotrophin-1,41900,0.099410936092656,0.0085114307615866,0.0827285317999463,0.116093340385366,2.3028196134177e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.057572772107177,0.00493080848247542,0.0479083874815252,0.0672371567328288,2.5517379150437e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.116607408976468,0.00998756299250621,0.0970317855111557,0.13618303244178,2.60990365804258e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,42181,0.0290276784625465,0.00248878667363237,0.024149656582227,0.0339057003428659,2.76418923361768e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLM2,Protein GOLM2,42249,0.0266514022147488,0.00228747298666723,0.0221679551608811,0.0311348492686166,3.18599762774016e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLK1,Protein delta homolog 1,42310,0.0678022018221584,0.00582332080237862,0.0563884930494963,0.0792159105948205,3.48310313172566e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRY2,Protein sprouty homolog 2,41913,0.108689841053487,0.00934938691787235,0.0903650426944572,0.127014639412517,4.32884706429472e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0782993432644746,0.0067319642173818,0.0651046933984063,0.091493993130543,4.33340002594223e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,39657,0.0923243631589887,0.00794088875342356,0.0767602212022785,0.107888505115699,4.58346506552153e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP7,Caspase-7,39929,0.09917732169255,0.00853408913070636,0.0824505069963655,0.115904136388734,4.81632813232741e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.110601545079651,0.00952438105478257,0.0919337582122772,0.129269331947025,5.33425841631428e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX6,Peroxiredoxin-6,42262,-0.0701132521755675,0.00604250969992757,-0.0819565711874256,-0.0582699331637095,5.53738818107924e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0520979337196696,0.00449805199535695,0.04328175180877,0.0609141156305692,7.13355860741285e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0621696471268546,0.00536599222044858,0.0516523023747754,0.0726869918789338,7.2562471343923e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KITLG,Kit ligand,42145,-0.044482126571252,0.00384127220049499,-0.0520110200842222,-0.0369532330582819,7.26874614263231e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0439793825992719,0.00379925830780178,0.0365328363159805,0.0514259288825634,7.68043054608086e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIN2,Bridging integrator 2,42137,0.103682638070706,0.00898269471203081,0.0860765564351254,0.121288719706286,1.12120192904243e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRN,Agrin,42185,0.0415990998974909,0.00360665213450198,0.0345300617138671,0.0486681380811148,1.2349336000185e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C19orf12,Protein C19orf12,41839,0.0772959218736671,0.0067106354201659,0.064143076450142,0.0904487672971923,1.48968757967007e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YJU2,Splicing factor YJU2,39919,0.0384236154649121,0.00333474337935492,0.0318875184413765,0.0449597124884478,1.50908704906727e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.070333398888282,0.00612051159821448,0.0583371961557816,0.0823296016207823,2.01386928111106e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0300361614845891,0.00261459393477673,0.0249115573724267,0.0351607655967515,2.10180949194644e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0676689686092381,0.00589424280682817,0.0561162527078549,0.0792216845106213,2.45490624436427e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST13,Hsc70-interacting protein,39736,0.0630649592013427,0.00549362222373298,0.0522974596428261,0.0738324587598593,2.4720200422242e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0576237931307088,0.00502788191732374,0.0477691445727542,0.0674784416886633,3.06255005770052e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.100402942011437,0.0087659013301715,0.0832217754043013,0.117584108618574,3.10590841998729e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53,Cellular tumor antigen p53,41843,0.0511324736793026,0.00447229517387554,0.0423667751385065,0.0598981722200986,3.95307709965202e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0645236553239074,0.00564551333937523,0.0534584491787319,0.0755888614690828,4.09663121313914e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.0982709168590334,0.00859756783869582,0.0814196838951896,0.115122149822877,4.3229122325027e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PENK,Proenkephalin-A,39736,0.0358131825596485,0.0031334109772587,0.0296716970442215,0.0419546680750756,4.38313242901522e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,39657,0.0584263263612298,0.00511282849830561,0.0484051825045508,0.0684474702179088,4.49928477379177e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GLB2,Endophilin-B2,39929,0.0757346385830947,0.00664066782332433,0.062718929649379,0.0887503475168104,5.77242893162596e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,41992,0.0465872703950414,0.0040874934332294,0.0385757832659118,0.0545987575241711,5.91170276219203e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FIS1,Mitochondrial fission 1 protein,42125,0.0878898021712619,0.00771823894437701,0.072762053840283,0.103017550502241,6.62020001318029e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.109652255689541,0.00965444770568262,0.0907295381864028,0.128574973192679,9.2567096916815e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKA,Diacylglycerol kinase alpha,39657,0.0635518564700722,0.00559494235545226,0.0525857694533858,0.0745179434867586,9.79826146580808e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0830225257817352,0.00731888121566031,0.068677518599041,0.0973675329644294,1.08670662366535e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUOM,Fucose mutarotase,39736,0.0739165616179009,0.00651540209104652,0.0611463735194497,0.0866867497163521,1.14364393483414e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL1,Growth-regulated alpha protein,42117,0.106059488751898,0.00935947222857221,0.0877149231838967,0.1244040543199,1.24241026342068e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.086620439925523,0.00766026476857648,0.0716063209791131,0.101634558871933,1.62804402172405e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP1,Syntaxin-binding protein 1,39934,0.0890031574181512,0.00787176110442073,0.0735745056534866,0.104431809182816,1.74972974030216e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0540151653639711,0.00478099494593616,0.0446444152699362,0.0633859154580059,1.93116914694737e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,39934,0.0683491786215851,0.00605512427617511,0.0564811350402819,0.0802172222028883,2.1625014175868e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TADA3,Transcriptional adapter 3,39919,0.0460049302784913,0.004080083886817,0.0380079658603299,0.0540018946966526,2.4854389153205e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,39736,0.136458406074475,0.0121049783581137,0.112732648492572,0.160184163656377,2.57330628602466e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASHC3,WASH complex subunit 3,39929,0.086422721575977,0.0076710700184859,0.0713874243397446,0.101458018812209,2.76221414103568e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7,Complement component C7,39722,-0.0379566656908816,0.00337181735597942,-0.0445654277086013,-0.0313479036731619,3.07684349732192e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.0362806060538362,0.00323026790994627,-0.0426119311573309,-0.0299492809503415,3.82998557265043e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0908852595840574,0.0081081268562688,0.0749933309457706,0.106777188222344,4.93441382717726e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRAS,Ras-related protein R-Ras,39649,0.148768727736784,0.0132678178532761,0.122763804744363,0.174773650729206,5.06341573125951e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,39638,0.0648230856958304,0.0057818024279677,0.0534907529370137,0.0761554184546471,5.13242625732553e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRADD,Death domain-containing protein CRADD,41997,0.084237425659866,0.00752247566412996,0.0694933733581713,0.0989814779615608,5.60219435690427e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0529991296118405,0.00473105425461152,0.0437262632728019,0.0622719959508791,5.63358255757346e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0948651670206246,0.00847476961383735,0.0782546185775034,0.111475715463746,5.89586102708251e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID1,Nidogen-1,42189,0.0405279070156895,0.00362846609297204,0.0334161134734643,0.0476397005579147,7.68424272929121e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0652040392134854,0.00584711610708654,0.0537436916435958,0.076664386783375,9.467038514483e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXT,Oxytocin-neurophysin 1,42249,0.162435844954002,0.0145771481553071,0.133864634569601,0.191007055338404,1.02819795443977e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC22D1,TSC22 domain family protein 1,39934,0.0742505847010742,0.00666508651506271,0.0611870151315513,0.0873141542705971,1.12578320405983e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX2,Heme oxygenase 2,41839,0.0534901441135777,0.00480525414660743,0.0440718459862271,0.0629084422409283,1.17995000984399e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD207,C-type lectin domain family 4 member K,41832,0.0436825591213238,0.00392662012544371,0.0359863836754541,0.0513787345671935,1.27379459749841e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RWDD1,RWD domain-containing protein 1,42249,0.0696521525246284,0.0062660573563674,0.0573706801061483,0.0819336249431085,1.39430104743998e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0778850261565679,0.00700853390864654,0.0641482996956207,0.0916217526175151,1.54164101361065e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPSE,Heparanase,39866,0.106947345186463,0.00963953280942581,0.0880538608799885,0.125840829492938,1.86940508643409e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN2,Centrin-2,41839,0.0758760448552894,0.00684394585342232,0.0624619109825816,0.0892901787279971,1.94397496548878e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THOP1,Thimet oligopeptidase,42081,0.0349575248878786,0.00315362940009966,0.0287764112636833,0.041138638512074,1.97159488233532e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNLR1,Interferon lambda receptor 1,42119,0.0405801205175734,0.00366191218082525,0.0334027726431559,0.0477574683919909,2.04063543021704e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0974213153604665,0.00879224266889644,0.0801885197294294,0.114654110991503,2.19790932761997e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0885156560230621,0.00799870631776394,0.0728381916402448,0.104193120405879,2.43481334905615e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB1,Heat shock protein beta-1,41949,0.0780330293352277,0.00705331957712416,0.0642085229640644,0.0918575357063911,2.50926396026775e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MESD,LRP chaperone MESD,42137,0.135636065209419,0.0122707862593271,0.111585324141138,0.159686806277701,2.78310728122754e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGT1,Protein SGT1 homolog,41843,0.0884987327956217,0.00803329636893746,0.0727534719125043,0.104243993678739,4.21436636955522e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NSFL1C,NSFL1 cofactor p47,42249,0.069658476257368,0.00632574325905789,0.0572600194696145,0.0820569330451214,4.39589785254355e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D5,TBC1 domain family member 5,42119,0.0863127463306048,0.00784601754184621,0.0709345519485863,0.101690940712623,4.97784376404085e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK24,Serine/threonine-protein kinase 24,41839,0.0687573638266183,0.00625160654892893,0.0565042149907176,0.081010512662519,5.14511181489563e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO3,Forkhead box protein O3,41843,0.106203075813955,0.00966483435420729,0.0872600004797088,0.125146151148201,5.72572851277928e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF19,Fibroblast growth factor 19,42185,0.0859118908185122,0.00781978415629415,0.0705851138721757,0.101238667764849,5.82052021211387e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.141630907728751,0.0129027156316501,0.116341585090717,0.166920230366786,6.82454923442664e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.132929658251845,0.0121202737982425,0.109173921607289,0.1566853948964,7.16400567522437e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0726528829878005,0.00662597965120278,0.0596659628714431,0.085639803104158,7.86220919450171e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,42310,0.0792464749709657,0.00723678042904004,0.0650623853300472,0.0934305646118841,8.61205236663386e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,39919,0.061201745660246,0.00558851501073549,0.0502482562392044,0.0721552350812875,9.0224050687028e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.133875707579327,0.0122342712644721,0.109896535900962,0.157854879257693,9.41784901743971e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0414424710520481,0.00378611784370854,0.0340216800783794,0.0488632620257168,9.62513063824537e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,39586,0.0531272122586716,0.00486084701496933,0.0435999521093317,0.0626544724080114,1.15466071050644e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.103154797013594,0.00944677439734354,0.0846391191948003,0.121670474832387,1.21330350940558e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH9,Protocadherin-9,39930,0.0373287676397579,0.00341716362282773,0.0306311269390155,0.0440264083405002,1.21682063731219e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPI,Mannose-6-phosphate isomerase,42070,0.0936332418886131,0.00857560324748478,0.0768250595235429,0.110441424253683,1.22686220959112e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBP,Protein AMBP,42239,0.0221292496777149,0.00202801304122421,0.0181543441169155,0.0261041552385144,1.31660295630897e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COCH,Cochlin,39958,0.0505810321778055,0.00463361322527984,0.041499150256257,0.059662914099354,1.32363997521726e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0333968093815382,0.00306318392943739,-0.0394006498832355,-0.0273929688798409,1.45830813535434e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.118705698297169,0.0108863738389446,0.0973684055728378,0.140042991021501,1.51076373620711e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,42105,0.0701558827000353,0.00643709599716284,0.0575391745455961,0.0827725908544745,1.52267250445944e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD69,Early activation antigen CD69,42082,0.0960712802882559,0.00881604594838167,0.0787918302294278,0.113350730347084,1.54616354565032e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0842353911123586,0.00773630893204902,0.0690722256055425,0.0993985566191747,1.7035748454199e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1A,Lithostathine-1-alpha,42105,-0.0546811756685953,0.00502199337602891,-0.0645242826856119,-0.0448380686515786,1.70420263050976e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCB,Tubulin-folding cofactor B,42016,0.109731045095089,0.0100786363561465,0.0899769178370419,0.129485172353136,1.7230556554094e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSPN,Persephin,42119,0.0946651597570874,0.00869832220983468,0.0776164482258114,0.111713871288363,1.80270598580168e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.05381958556626,0.00494304159838696,0.0441312240334215,0.0635079470990984,1.81434412723172e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0735034038789486,0.0067577747395417,0.0602581653894469,0.0867486423684504,1.94075725648529e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0410372505324265,0.00377380232735539,0.0336405979708099,0.0484339030940431,2.09948197824766e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.10382546857304,0.00955293204040449,0.0851017217738467,0.122549215372232,2.22459672380538e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO9B,Unconventional myosin-IXb,41913,0.072068483482671,0.00664274704280811,0.0590486992787671,0.0850882676865749,2.61709135684097e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0387310713466213,0.00356919938177761,0.0317354405583372,0.0457267021349054,2.6736783374501e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH2,Cadherin-2,42145,0.0384947698345173,0.00355190827924898,0.0315330296071893,0.0454565100618453,2.94897883235157e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0668240622391004,0.00616902483129883,0.0547327735697547,0.0789153509084461,3.1342308961606e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP2,Caspase-2,42119,0.0744303528460077,0.00687589458886538,0.0609535994518315,0.0879071062401838,3.39444628656862e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2,Microtubule-associated protein 2,39929,0.0512063456312908,0.00473188502734025,0.0419318509777039,0.0604808402848777,3.69423445028107e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,41843,0.0659321642661434,0.00611363111218622,0.0539494472862584,0.0779148812460284,5.27773598085822e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM106A,Transmembrane protein 106A,39919,0.0779520211703109,0.00723208452602294,0.0637771354993059,0.0921269068413158,5.86891648850827e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARC,SPARC,42181,0.0758063566701563,0.00703645447092287,0.0620149059071475,0.0895978074331651,5.90918876974065e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.103786980019035,0.0096372114262321,0.0848980456236198,0.12267591441445,6.17469874488282e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACYBP,Calcyclin-binding protein,39713,0.113025667411548,0.0104902674046167,0.0924647432984991,0.133586591524597,6.18101432985697e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,42137,0.0540971846868821,0.005027849639809,0.0442425993928565,0.0639517699809078,6.86615564954026e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0761114571418519,0.00707376666281221,0.06224687448274,0.0899760398009639,7.24814783836073e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLUL1,Clusterin-like protein 1,42123,-0.0483573905042858,0.00449780234987294,-0.0571730831100368,-0.0395416978985348,7.49868668580263e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0637496974801567,0.00593610339427428,0.0521149348273791,0.0753844601329343,8.58020848312964e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE2,Glia-derived nexin,39958,0.0703176471897332,0.00654671637385669,0.0574860830969741,0.0831492112824923,8.79318427011407e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL4,C-C motif chemokine 4,42148,0.0672446774778599,0.00626343910313403,0.0549683368357172,0.0795210181200026,8.8319102496492e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PF4,Platelet factor 4,39914,0.105928613468363,0.00987103353980575,0.0865813877303441,0.125275839206383,9.76199065853336e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0398867293305768,0.00372014613518673,-0.0471782157555428,-0.0325952429056108,1.02924818563711e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.113582489618562,0.0105951760659574,0.0928159445292852,0.134349034707838,1.10398908336754e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTDH,Protein LYRIC,39657,0.10316012923508,0.00963662515295084,0.0842723439352965,0.122047914534864,1.30162851305627e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL8,C-C motif chemokine 8,42239,0.0651002739838456,0.0060989714697878,0.0531462899030615,0.0770542580646297,1.71412531583671e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0464988638160722,0.00435648717823391,-0.0550375786854107,-0.0379601489467337,1.72713732182927e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.0910269457052121,0.00853209937410223,0.0743040309319717,0.107749860478452,1.81454158761755e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT1,Angiopoietin-1,42085,0.0895316555680448,0.00841110235342775,0.0730458949553264,0.106017416180763,2.35444899718719e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPBP,Platelet basic protein,39908,0.0922758772429299,0.00866901579738594,0.0752846062800535,0.109267148205806,2.4688470855464e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,42119,0.0703600992976003,0.00661808238604894,0.0573886578209444,0.0833315407742562,2.70121620257152e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB6,Serpin B6,42216,0.0625727765479754,0.00589515276213443,0.0510182771341919,0.0741272759617588,3.23810034868927e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,42185,0.0941843573868839,0.00888217209699871,0.0767753000767664,0.111593414697001,3.6226609334236e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.0341703958589009,0.00322192113023771,0.027855430443635,0.0404853612741668,3.74963188096031e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0362283796840453,0.00342618035814985,0.0295130661820716,0.042943693186019,4.96614825390265e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,39927,0.0653805105166793,0.00618781729904285,0.0532523886105553,0.0775086324228033,5.65734655276923e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0515111106415179,0.00488160913265075,0.0419431567415224,0.0610790645415134,6.54783675751222e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.1207138822535,0.0114465047917802,0.0982787328616105,0.143149031645389,6.67834781203954e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMFG,Glia maturation factor gamma,39958,0.0766085200865605,0.00726916873066282,0.0623609493744614,0.0908560907986596,7.52858603632155e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.108342047976537,0.0102908000516627,0.0881720798752782,0.128512016077796,8.49962466304611e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0289898420302754,0.00275612732672135,0.0235878324699016,0.0343918515906493,8.94411716426936e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,41839,0.0898356755134322,0.00855467942284271,0.0730685038446605,0.106602847182204,1.0744470919212e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0284046412931659,0.00270729408731372,0.0230983448820311,0.0337109377043008,1.23274268723784e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP6,Bone morphogenetic protein 6,41886,0.0423321929391581,0.0040371098695696,0.0344194575948017,0.0502449282835145,1.26440867819574e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GET3,ATPase GET3,39958,0.0571209834234735,0.00545673200519698,0.0464257886932874,0.0678161781536596,1.58349071357569e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP2B1,AP-2 complex subunit beta,39649,0.0513789986236939,0.00491015096613697,0.0417551027300654,0.0610028945173224,1.66606842473124e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGFR,Opioid growth factor receptor,42070,0.0338291241021003,0.00323472629414581,0.0274890605655746,0.0401691876386261,1.68426407463226e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL3,Insulin-like 3,39929,0.0951131916407466,0.00909933683661714,0.077278491440977,0.112947891840516,1.85789612086892e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2,Complement C2,42199,0.02377088144793,0.00227709482307364,0.0193077755947057,0.0282339873011543,2.0498140561194e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMT,Catechol O-methyltransferase,41740,0.0876063236887729,0.00839510070093594,0.0711519263149385,0.104060721062607,2.14737153267152e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0644654766642273,0.00617715523136436,0.0523582524107532,0.0765727009177015,2.2253302205824e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA2,Integrin alpha-2,39736,0.0365165398095355,0.00350107926676389,0.0296544244466783,0.0433786551723927,2.36472652576646e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTD,Deoxycytidylate deaminase,39736,0.10102234364618,0.00969033936885181,0.0820292784832302,0.120015408809129,2.49180503094506e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0239759044090135,0.00230295637081437,0.0194621099222173,0.0284896988958097,2.75304476090315e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CERT,Ceramide transfer protein,41839,0.0642464018413059,0.0061750710156314,0.0521432626506684,0.0763495410319435,2.96977489593985e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBN1,Drebrin,39657,0.0535752906826535,0.00515954814542599,0.0434625763176186,0.0636880050476885,3.83711753698739e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L1,Bcl-2-like protein 1,39929,0.104488476382654,0.0100740204661351,0.0847433962690289,0.124233556496279,4.30240489969598e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIAE,Sialate O-acetylesterase,42147,0.0485027768696318,0.00467991186115604,0.039330149621766,0.0576754041174977,4.48391885775336e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLMH,Bleomycin hydrolase,42310,0.0322489762963982,0.00311448679700157,0.0261445821742752,0.0383533704185213,4.93715816579331e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0716339593826153,0.00692587247946358,0.0580592493228667,0.0852086694423639,5.57049981778095e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXN,Paxillin,41839,0.0533505573250673,0.00515884633635598,0.0432392185058096,0.063461896144325,5.68796282101964e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0749918361346885,0.0072524227383592,0.0607770875675045,0.0892065847018726,5.76630078934915e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0250928416157678,0.00242690298746828,0.02033611176033,0.0298495714712056,5.78625470613932e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA2,Adenosine deaminase 2,42096,-0.0455636480603871,0.00441975126949563,-0.0542263605485985,-0.0369009355721756,7.92405120104608e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RFC4,Replication factor C subunit 4,39919,0.0230638461431518,0.00223740630193221,0.0186785297913646,0.0274491624949389,8.3202963909838e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.025489207783092,0.00247887092178609,0.0206306207763913,0.0303477947897927,1.08269388886755e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AREG,Amphiregulin,42070,-0.0405585758441974,0.00394714466954736,-0.0482949793965102,-0.0328221722918845,1.12166148938075e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QDPR,Dihydropteridine reductase,42081,0.0435729846260218,0.00424337277786197,0.0352559739814123,0.0518899952706312,1.2044935450497e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0907042058436743,0.00884790875625448,0.0733623046814156,0.108046107005933,1.49799537710062e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C3,Complement C3,39445,0.0477069012979801,0.00465529587637616,0.0385825213802829,0.0568312812156774,1.56484761118668e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0302879940923303,0.00295827670226227,0.0244897717558962,0.0360862164287643,1.70828174720223e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF3,Trefoil factor 3,42143,-0.0371722878971229,0.00363675993202797,-0.0443003373638977,-0.0300442384303481,1.95340986435017e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.051653433116478,0.00505377342216412,0.0417480372090364,0.0615588290239197,2.05148901187069e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD276,CD276 antigen,42123,-0.0369061166669477,0.00361743349278499,-0.0439962863128063,-0.0298159470210891,2.37249884943037e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0811853031591279,0.00796042588808757,0.0655828684184763,0.0967877378997796,2.46737743347406e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP2,Retinol-binding protein 2,42070,-0.0800969926460064,0.00785471132150585,-0.0954922268361578,-0.0647017584558549,2.49818666545213e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD2,Polycystin-2,39575,0.0602976620032891,0.0059152980515073,0.0487036778223348,0.0718916461842434,2.719213602548e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,41843,0.0538759821673901,0.00528913236505431,0.0435092827318836,0.0642426816028965,2.80913134715994e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA9,Carbonic anhydrase 9,42262,-0.0479023384785,0.00470414045010528,-0.0571224537607064,-0.0386822231962937,2.88270665334687e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICALL2,MICAL-like protein 2,39649,0.0704516487258668,0.00691737030102481,0.0568936029358582,0.0840096945158755,2.96840328432385e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.114882385153448,0.0112844011333447,0.092764958932092,0.136999811374803,2.96952931766385e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES2,Cocaine esterase,42070,0.0571052013530179,0.00561072907152805,0.0461081723728229,0.0681022303332129,3.04703535428374e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0667743863179643,0.00656506921330524,0.0539068506598861,0.0796419219760426,3.27344737068653e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0300154502373804,0.00295398033006934,0.0242256487904445,0.0358052516843163,3.62987690464877e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6AP2,Renin receptor,41843,0.0402163258163013,0.00396054207317552,0.0324536633528773,0.0479789882797253,3.8885394350672e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0647439060215887,0.00637873920261724,-0.0772462348587185,-0.0522415771844589,4.03424521669712e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,41843,0.0462228380877527,0.00455419881467533,0.0372966084109891,0.0551490677645163,4.08092047127129e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POMC,Pro-opiomelanocortin,39638,0.0752109466792102,0.00741771229078096,0.0606722305892795,0.0897496627691409,4.70869039798586e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBXN1,UBX domain-containing protein 1,39736,0.0706194643560395,0.00696674090148925,0.0569646521891206,0.0842742765229584,4.82988702334544e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRGN,Neurogranin,39990,0.0945173326981044,0.00933259861339127,0.0762254394158575,0.112809225980351,5.26334853592567e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0296177136071231,0.00292757487014618,0.0238796668616366,0.0353557603526096,5.90559170885818e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,39930,0.101068967801182,0.00999234841533958,0.0814839649071166,0.120653970695248,6.01242956056442e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0605808637104221,0.00599755025440757,0.0488256652117832,0.0723360622090609,6.67187016723526e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0673384498072731,0.00667023424228059,0.0542647906924032,0.0804121089221431,7.33546494645376e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0362389134251807,0.00359262664964657,-0.043280461658488,-0.0291973651918734,7.65679846319105e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,39575,0.071712182531104,0.00711062889053821,0.0577753499056491,0.0856490151565589,8.15518130668151e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL18,C-C motif chemokine 18,42020,0.0713037726571646,0.007073326293469,0.0574400531219653,0.0851674921923638,8.17733753479618e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0655775060585035,0.00650579151331906,0.0528261546923981,0.0783288574246088,8.54314642984083e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN4,Cerebellin-4,42262,0.0322083055240136,0.00319767567612075,0.0259408611988169,0.0384757498492102,8.85684552179523e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA12,Serpin A12,41751,0.109867601079206,0.0109129882526264,0.0884781441040577,0.131257058054353,9.36636461143762e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.0822996799104325,0.00817445009471187,0.0662777577247973,0.0983216020960678,9.6913325472276e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA13,Carbonic anhydrase 13,41967,0.106780605513646,0.0106103924795523,0.0859842362537231,0.127576974773568,9.70381374205671e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF7,SLAM family member 7,42119,-0.0604782265769327,0.00601005753892146,-0.0722579393532188,-0.0486985138006466,9.77481162083458e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0385176307328063,0.00382777274089908,0.0310151961606441,0.0460200653049685,9.79080821469249e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0585696321613476,0.00582408970605335,0.0471544163374831,0.0699848479852122,1.08598961569511e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0586936119273855,0.00583924749603893,0.0472486868351492,0.0701385370196218,1.0993759511034e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0270796444827456,0.00269336261032602,-0.0323586351989846,-0.0218006537665066,1.10516108299289e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0417377939673839,0.00415318018957918,0.0335975607958088,0.0498780271389591,1.16340563667549e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATOX1,Copper transport protein ATOX1,42181,0.0718228746614845,0.0071575333779367,0.0577941092407286,0.0858516400822405,1.2980810452008e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0492999239931364,0.00491271648779101,0.039670999677066,0.0589288483092068,1.34521502999187e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTF2,Transcription termination factor 2,39649,0.050427105889951,0.00502699023652633,0.0405742050263594,0.0602800067535426,1.40114135739848e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0460726611548541,0.00459955645193873,-0.055087791800654,-0.0370575305090542,1.55025640966991e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL24,C-C motif chemokine 24,42166,0.083097981633364,0.00829610980053973,0.0668376064243061,0.0993583568424219,1.55710693303358e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0317357139953944,0.00317018702687246,-0.0379492805680644,-0.0255221474227244,1.65702881889229e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0942625295083795,0.00943648992051054,0.0757670092641789,0.11275804975258,2.0526222841602e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,39930,0.0584967545164008,0.00585747081752607,0.0470161117140497,0.0699773973187519,2.17751432866971e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR2,GMP reductase 2,39736,0.0671525884543968,0.00672442144949489,0.0539727224133868,0.0803324544954067,2.19287035772019e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFB,Complement factor B,39794,0.0331126283250034,0.00331793318601053,0.0266094792804228,0.0396157773695841,2.33678682580187e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUB1,NEDD8 ultimate buster 1,42119,0.084452199420936,0.00847153227726496,0.0678479961574967,0.101056402684375,2.50898479912305e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,42093,0.0898332755497318,0.00902642816247111,0.0721414763512884,0.107525074748175,2.9650389469099e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP5,Platelet glycoprotein V,39736,0.0368494667289833,0.0037019588040436,0.0295936274730579,0.0441053059849088,3.0277918998809e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0454313334074829,0.00457094789490328,0.0364722755334724,0.0543903912814933,3.37987449212308e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0828196222656398,0.0083332532467953,0.066486445901921,0.0991527986293586,3.40124455995325e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB4,Ephrin type-B receptor 4,42310,-0.0254090365608562,0.00255716663446695,-0.0304210831644114,-0.020396989957301,3.46255614979084e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0195828920237454,0.0019714082528976,-0.0234468521994247,-0.0157189318480661,3.57720060706076e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0836804733706014,0.00842735297992618,0.067162861529946,0.100198085211257,3.71058456105189e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGLAP,Osteocalcin,39966,0.0844205395526193,0.00850793576614825,0.0677449854509688,0.10109609365427,4.12304290258103e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP5,Fatty acid-binding protein 5,42218,0.0665084237816628,0.00670614684364966,0.0533643759681095,0.0796524715952162,4.18310477535273e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB1,Beta-crystallin B1,39958,0.0662797495971971,0.00668076091385494,0.0531854582060414,0.0793740409883528,4.18874598677724e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0381761677227831,0.00385375669542342,0.0306228045997532,0.045729530845813,4.70478454723624e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR2,Folate receptor beta,42249,-0.028988200772708,0.00292653764379745,-0.034724214554551,-0.023252186990865,4.72243664835697e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,39966,0.0613610186299599,0.00619262059225175,0.0492234822691465,0.0734985549907733,4.73000352455097e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.0861680933454878,0.00869946705373427,0.0691171379201686,0.103219048770807,4.74684525723473e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP3,Caspase-3,42310,0.0878413349607353,0.00887372314512413,0.070448837596292,0.105233832325179,5.02080565299132e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0757277301034176,0.00764767798159113,0.0607382812594989,0.0907171789473362,5.08598914357347e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP3,Syntaxin-binding protein 3,41843,0.0432920643546924,0.00437583809468195,0.0347154216891158,0.051868707020269,5.34119129986113e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0463776096885384,0.00469319714305085,-0.0555762760889181,-0.0371789432881587,5.9570742444451e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA3,Annexin A3,42224,0.0690118789098937,0.00699528357060107,0.0553011231115156,0.0827226347082718,7.00921936705978e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0279883968039052,0.00283868086750475,0.0224245823035959,0.0335522113042145,7.44078509621986e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0614368107996143,0.00624777527502084,0.0491911712605734,0.0736824503386551,9.96809452305917e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,42249,0.0673352622877258,0.00685365238440046,0.0539021036143009,0.0807684209611507,1.04792038812931e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN9,Septin-9,42070,0.0284858794609445,0.00289961537780552,0.0228026333204457,0.0341691256014433,1.05766646545221e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0457231346778175,0.00465672597592139,0.0365959517650116,0.0548503175906234,1.11757915450971e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT2,Angiopoietin-2,42262,-0.0369081522266967,0.00376264084554537,-0.0442829282839656,-0.0295333761694277,1.22194230627681e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0991830131951428,0.010116352438197,0.0793549624162766,0.119011063974009,1.3278356959495e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM3,Dynamin-3,39934,0.0545823730545728,0.00557114768249535,0.043662923596882,0.0655018225122637,1.42085437209521e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.118391674490692,0.0120905947942559,0.0946941086939504,0.142089240287433,1.44770398152903e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGA,Chromogranin-A,39966,-0.0841369952090046,0.00859041905521968,-0.100974216557235,-0.067299773860774,1.46313652990715e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,42181,0.0364267889356605,0.0037249767065232,0.029125834590875,0.0437277432804459,1.64318148054537e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0232914844903473,0.00238495868378695,0.0186169654701249,0.0279660035105697,1.86759073671017e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0682962345496352,0.00699056348576232,0.0545947301175411,0.0819977389817293,1.87377773533485e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0472211229789625,0.00484119004770813,0.0377323904854545,0.0567098554724704,2.17122463251566e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRD2,Protein ZNRD2,39930,0.0687383789982895,0.00705109393598111,0.0549182348837666,0.0825585231128125,2.28945892751305e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLU,Clusterin,39979,0.0296731966238153,0.00304715583498939,0.0237007711872361,0.0356456220603946,2.53722248494905e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0881090845904636,0.00904901181504208,0.0703730214329811,0.105845147747946,2.56614872308637e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0892087368278915,0.00917729902400044,0.0712212307408507,0.107196242914932,3.02502997579852e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,39638,0.075763363162962,0.00780893865895333,0.0604578433914135,0.0910688829345105,3.61996131267322e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,39930,0.0861423019235399,0.00888339987133953,0.0687308381757144,0.103553765671365,3.78544521871762e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THTPA,Thiamine-triphosphatase,39897,0.0859030156033403,0.00886337838118568,0.0685307939762164,0.103275237230464,3.97972407812267e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0501176932309602,0.00517407586567017,-0.0602588819276737,-0.0399765045342466,4.06593669329613e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YWHAQ,14-3-3 protein theta,39736,0.0727280409778577,0.00750602194678363,0.0580162379621618,0.0874398439935536,4.09360404354321e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0451711058837384,0.0046657968062732,0.0360261441434429,0.0543160676240338,4.26892458593286e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL16,C-X-C motif chemokine 16,42295,0.0227451965348591,0.00235106678313401,0.0181371056399165,0.0273532874298018,4.55671114842749e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0363121660640548,0.00375225391203568,0.0289577483964649,0.0436665837316448,4.57831270088474e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0657888429707883,0.0068043920210338,0.0524522346095621,0.0791254513320146,5.00409481287837e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMTN,Smoothelin,39897,0.0903454800970444,0.00937127992025187,0.0719777714533507,0.108713188740738,6.53701177703296e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0262267880953006,0.00272270401599389,0.0208902882239526,0.0315632879666487,6.84327879087027e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.11548942509477,0.0120325894942174,0.091905549686104,0.139073300503436,9.5514843845413e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4R,Reticulon-4 receptor,42262,0.0325931581695192,0.00339759373544231,0.0259338744480523,0.0392524418909861,1.00155100868156e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0310624206447716,0.0032388764276976,-0.0374106184430589,-0.0247142228464843,1.02763267771072e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0425004265816674,0.00443006866166639,0.0338174920048013,0.0511833611585335,1.0284862791527e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.06784066515221,0.00708004127389375,0.0539637842553783,0.0817175460490418,1.11525958570127e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAN,Neurocan core protein,42249,0.0361385047401747,0.00377539145946108,0.0287387374796309,0.0435382720007184,1.22466957023183e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.05162418367237,0.00541035226408468,0.041019893234764,0.062228474109976,1.64248698440479e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0359747659800933,0.00377041187957555,0.0285847586961252,0.0433647732640614,1.6979698415225e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSO,Cathepsin O,42296,0.0293934726636285,0.00308324851850889,0.023350305567351,0.0354366397599059,1.77654453294833e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB33A,Ras-related protein Rab-33A,39575,0.0641268702699592,0.00672451677203324,0.0509468173967741,0.0773069231431444,1.79289098152356e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX1,Peroxiredoxin-1,41742,-0.0882097734829413,0.00925351859147141,-0.106346669922225,-0.0700728770436573,1.80028839281497e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.050961093181943,0.00535363276391969,0.0404679729646604,0.0614542133992256,2.10263342136539e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0616420231719814,0.00648179862944737,0.0489376978582646,0.0743463484856983,2.23067526387253e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIAPIN1,Anamorsin,42181,0.0587113462977961,0.00617645510288684,0.0466054942961379,0.0708171982994543,2.31607647897412e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTX3,Pentraxin-related protein PTX3,42119,-0.0475956008918218,0.00500866907731596,-0.0574125922833611,-0.0377786095002825,2.38560175017234e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADD1,Alpha-adducin,39736,0.0670553071710567,0.00705976827987929,0.0532181613424933,0.0808924529996201,2.57064232183994e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LARP1,La-related protein 1,39919,0.059735714291584,0.00629000611749971,0.0474073023012845,0.0720641262818834,2.59505348413944e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP10,Caspase-10,41839,0.0680654118070993,0.00717758823312212,0.05399733887018,0.0821334847440187,2.88480929092202e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0618667776611687,0.00652507109415697,0.049077638316621,0.0746559170057164,2.91729827142785e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,39934,0.0596887374468834,0.00630791211161627,0.0473252297081155,0.0720522451856513,3.59837570825532e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.0629336476574065,0.0066551085160572,0.0498896349659343,0.0759776603488786,3.69632335511239e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.0521352830114179,0.00552659368513983,0.0413031593885438,0.062967406634292,4.61320369320728e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP6,Platelet glycoprotein VI,42115,0.0836837780648449,0.00888371533987476,0.0662716959986903,0.101095860130999,5.23644382870273e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0861881481745667,0.00914928989000884,0.0682555399901494,0.104120756358984,5.3960076403316e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RP2,Protein XRP2,42070,0.0404343021885531,0.00429527911660792,0.0320155551200015,0.0488530492571046,5.55788553710296e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,39952,0.0452213820529204,0.00480300368280415,0.0358074948346243,0.0546352692712165,5.62907892635672e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0642868210845887,0.00683113876858221,-0.0776758530710099,-0.0508977890981676,5.70608839498519e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0812769255653567,0.00863503713713992,0.0643522527765625,0.098201598354151,5.80538072730097e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1,Allograft inflammatory factor 1,41843,0.0494399790599768,0.00526312598604489,0.0391242521273289,0.0597557059926248,6.73097448231913e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0507866256061727,0.0054193286813852,0.0401647413906577,0.0614085098216877,8.5120039107325e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK7,Kallikrein-7,39475,0.0375600546768698,0.0040093551672055,0.029701718549147,0.0454183908045925,8.84210513471383e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUS,RNA-binding protein FUS,41831,0.0374369954970758,0.00399867839368123,0.0295995858454606,0.045274405148691,9.0412117520426e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSP1,Lymphocyte-specific protein 1,42119,0.0381417131236163,0.00407826353100237,0.0301483166028516,0.0461351096443809,9.89226333641873e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0225817644622354,0.00241766031869115,0.0178431502376008,0.0273203786868701,1.10720782718397e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0752158736015966,0.00806275310089061,-0.0910188696793422,-0.059412877523851,1.23451030326198e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS10,Regulator of G-protein signaling 10,39934,0.0561201511034568,0.0060188595750565,0.044323186336346,0.0679171158705675,1.32688317862622e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD22,B-cell receptor CD22,42296,0.0400618789748911,0.00429839417256693,0.03163702639666,0.0484867315531223,1.33615551119753e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM1,Dynamin-1,39930,0.108987991859225,0.011694441368641,0.0860668867766888,0.131909096941762,1.3828501640495e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,42296,0.062698255594579,0.00673194314469156,0.0495036470309836,0.0758928641581745,1.42201142189437e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0456750046344506,0.00491300540876321,0.0360455140332748,0.0553044952356265,1.67165661225612e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0623532545886106,0.00671811216899802,0.0491857547373745,0.0755207544398467,1.98731800051626e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.0497690930098113,0.00536480408051386,0.0392540770120042,0.0602841090076185,2.00591222766692e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACTB2,Endoribonuclease LACTB2,42145,0.0615954246669155,0.00664346970794694,0.0485742240393395,0.0746166252944915,2.10761485790046e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,42016,0.0433000466067832,0.00467414538759917,0.0341387216470888,0.0524613715664775,2.27026511797363e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB2B,Ras-related protein Rab-2B,39919,0.0583408526532419,0.00629740516363231,0.0459979385325226,0.0706837667739613,2.31802247458427e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESYT2,Extended synaptotagmin-2,39929,0.0781423890365674,0.00843589483022436,0.0616080351693276,0.0946767429038071,2.34339018841239e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.052773495150793,0.0057144979009392,0.0415730792649522,0.0639739110366339,2.96146295496124e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0818226615520825,0.00886466166289598,0.0644479246928064,0.0991973984113586,3.1802519225277e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C5,Complement C5,39979,0.014032533519402,0.0015218732412888,0.011049661966476,0.0170154050723281,3.47410324603201e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREH,Trehalase,39966,0.0701486319141413,0.00761151057229075,0.0552300711924514,0.0850671926358312,3.6205615373419e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.091712463770323,0.00995676886108874,0.0721971968025891,0.111227730738057,3.7944207389539e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0362389925312505,0.00393625795291927,0.0285239269435287,0.0439540581189722,3.856869611692e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,39736,0.0631854440906033,0.0068656424441672,0.0497287849000356,0.076642103281171,4.09608956197817e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARFIP1,Arfaptin-1,39934,0.0644011692642499,0.00700182323826211,0.0506775957172562,0.0781247428112437,4.29195655563928e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAN,Brevican core protein,42016,0.0319994139497482,0.00348302308346984,0.0251726887061473,0.0388261391933491,4.61398666073573e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPACT,Protein IMPACT,39929,0.0503703304220376,0.005485636790369,0.0396184823129143,0.0611221785311608,4.95453579391649e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0553624892310361,0.00602970905349583,0.0435442594861843,0.067180718975888,4.99587879810837e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS1,Galectin-1,42145,0.0322796206597895,0.0035291501673763,0.0253624863317319,0.039196754987847,6.70432338308126e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.0272079358791561,0.00299436194333666,0.0213389864702163,0.033076885288096,1.16590219535121e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APP,Amyloid-beta precursor protein,42112,0.0606038176061835,0.0066699881562788,0.0475306408198771,0.07367699439249,1.1680367951055e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0509232613003979,0.00561041750985072,0.0399268429810905,0.0619196796197053,1.31036803910044e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1B,Lithostathine-1-beta,42310,-0.0522139439103488,0.00575510200849242,-0.0634939438469939,-0.0409339439737037,1.31776276378654e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0517169635810081,0.00570373785145258,0.040537637392161,0.0628962897698551,1.39081466626633e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN3,Ataxin-3,39929,0.0558240639054983,0.00617802634111909,0.0437151322769049,0.0679329955340917,1.88967360716138e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0611690192259505,0.00677434569088939,0.0478913016718072,0.0744467367800937,2.01018020889541e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBI3_IL27,Interleukin-27,42247,-0.0278728646379192,0.00308815771517742,-0.033925653759667,-0.0218200755161715,2.02083929811815e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF2,Scavenger receptor class F member 2,42249,-0.0258745498988893,0.00286683161370399,-0.0314935398617492,-0.0202555599360295,2.02519826440482e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VGF,Neurosecretory protein VGF,39934,0.0275511446417581,0.00305193019122779,0.0215693614669517,0.0335329278165646,2.04026136491609e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLC,Galectin-10,42119,-0.0610912385556526,0.00677068146546815,-0.0743617742279702,-0.047820702883335,2.07561710746787e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,39649,0.0723538157081033,0.00802318801120493,0.0566283672061417,0.088079264210065,2.22946845994586e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTC,Probetacellulin,41843,0.0665380600170645,0.00738999686738436,0.0520536661569912,0.0810224538771379,2.47461583132224e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1A,Meprin A subunit alpha,39930,0.0692311783179999,0.00768823547654961,0.0541622367839627,0.0843001198520372,2.5046179253574e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.046763313350353,0.00520185759024967,0.0365676724734636,0.0569589542272423,2.87065058440116e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,41900,0.0465209954708014,0.00519088274742402,0.0363468652858503,0.0566951256557525,3.60658439170015e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0309831619869256,0.00345790893835982,0.0242056604677403,0.0377606635061108,3.66440299590658e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBP,Lipopolysaccharide-binding protein,42217,-0.0529739749740205,0.00591415199692881,-0.064565712888001,-0.04138223706004,3.7588051295812e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.06051019768888,0.0067712472659293,0.0472385530476586,0.0737818423301014,4.53619702162342e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40LG,CD40 ligand,42296,0.0713356937872783,0.00798907713729236,0.0556771025981853,0.0869942849763714,4.83275020102238e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,41968,0.0387311578431196,0.00434082333649045,0.0302231441035984,0.0472391715826409,5.14349989653816e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.0379458763829405,0.00425737201197434,0.0296014272394708,0.0462903255264102,5.59030927324307e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,39934,0.0779722767681722,0.00874711924046865,0.0608279230568536,0.0951166304794908,5.67129771446862e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TST,Thiosulfate sulfurtransferase,41809,0.0677264996220353,0.00760242272123953,0.0528257510884058,0.0826272481556648,5.8400503939218e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,39757,0.0662475073274563,0.00744574992666725,0.0516538374711885,0.0808411771837241,6.60017596731677e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0339915045047088,0.00382522272432667,0.0264940679650286,0.0414889410443891,7.27994091742393e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC1,MANSC domain-containing protein 1,42181,-0.0247999290114117,0.00280184941731694,-0.0302915538693529,-0.0193083041534705,9.71137197241431e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPN,Asporin,39958,0.0248813745963187,0.00281268713591233,0.0193685078099305,0.0303942413827068,1.03978200646186e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0978020375956069,0.0110677913270389,0.0761091665946107,0.119494908596603,1.10629245425683e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.051353124857046,0.00581260276237782,0.0399604234427855,0.0627458262713065,1.12427274688561e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0291987182790295,0.00330733094375397,0.0227163496292717,0.0356810869287872,1.19057321656953e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0449618021896322,0.00509313716650558,0.0349792533432812,0.0549443510359831,1.19596825733588e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.0647213479969424,0.00734281477327753,0.0503294310413184,0.0791132649525663,1.38001979641009e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0437896034916332,0.00496985755065321,0.0340486826923529,0.0535305242909135,1.42499259658493e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0410735195844429,0.00466905848344657,0.0319221649568876,0.0502248742119981,1.57246210785996e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.0813524230396822,0.00925325763426142,0.0632160380765298,0.0994888080028346,1.65137392218022e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.023493976169,0.00267586037106745,0.0182492898417078,0.0287386624962922,1.82737077182468e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0356358937511072,0.00406241741457382,0.0276735556185425,0.0435982318836719,2.00347318310469e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT2A1,Bile salt sulfotransferase,42119,0.05186938789857,0.00592570763042008,0.0402550009429467,0.0634837748541934,2.3155655526285e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG6,Large proline-rich protein BAG6,41900,0.0325988582422525,0.00372590289565292,0.0252960885667727,0.0399016279177322,2.40366695854353e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL26,C-C motif chemokine 26,42119,0.0791316121157777,0.00904916700274925,0.0613952447903892,0.0968679794411663,2.49898528723629e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0412320915126881,0.00471922065884253,0.0319824190213567,0.0504817640040194,2.73793629552e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIF,Macrophage migration inhibitory factor,42105,0.0589920694300405,0.0067553732251453,0.0457515379087557,0.0722326009513253,2.77801555944597e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0510247067055217,0.00585166282582149,0.0395554475669116,0.0624939658441319,3.11432578749254e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0572764224582245,0.00656919442011262,0.0444008013948038,0.0701520435216453,3.13762027188481e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.061888441447138,0.00709820877523289,0.0479759522476815,0.0758009306465945,3.20124743669309e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARA5,Scavenger receptor class A member 5,42249,0.0267268163684609,0.00307606625209581,0.0206977265143531,0.0327559062225687,4.08143118365358e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLNK,B-cell linker protein,39657,0.0368061821866838,0.00423635533358766,0.028502925732852,0.0451094386405156,4.20135580934409e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",42070,0.0743833262626932,0.00856662994450568,0.057592731571462,0.0911739209539243,4.29691405872116e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,42119,0.0523589580626337,0.00603111085431435,0.0405379807881776,0.0641799353370899,4.34957958181436e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEMIP2,Cell surface hyaluronidase,39657,0.028484062686824,0.00328101305522378,0.0220532770985854,0.0349148482750626,4.45416372262577e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BDNF,Brain-derived neurotrophic factor,39966,0.0736997330891753,0.00849262536923996,0.057054187365465,0.0903452788128856,4.5720755485265e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC79,Protein unc-79 homolog,39560,0.0489752062168934,0.00565023693621756,0.037900741821907,0.0600496706118799,5.02432326823145e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRG1,Scrapie-responsive protein 1,39958,0.0239339864420097,0.00276317729750592,0.0185181589388981,0.0293498139451213,5.27231662902371e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,41843,0.0406233823249914,0.00469312243726827,0.0314248623479456,0.0498219023020372,5.44832145877598e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0386596065237827,0.00446822998690036,0.029901875749458,0.0474173372981074,5.62315179145007e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,42070,0.0521744113576293,0.00603170742339817,0.0403522648077689,0.0639965579074898,5.72621719266501e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGF,Hepatocyte growth factor,42296,0.0300391783098839,0.00348008736226254,0.0232182070798493,0.0368601495399184,6.703072360223e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDS,Iduronate 2-sulfatase,42296,0.00799107227336753,0.000927636417088576,0.00617290489587392,0.00980923965086114,7.78944528482876e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MVK,Mevalonate kinase,41913,0.0718153640852587,0.00834609957570712,0.0554570089168728,0.0881737192536447,8.50433179011045e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB6,Integrin beta-6,41913,0.0266751844120259,0.00310068874621713,0.0205978344694403,0.0327525343546114,8.62871644854867e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0493130006749201,0.00573615184385011,-0.0605558582888663,-0.0380701430609738,9.08324322662246e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.03243311813648,0.0037747471934525,-0.0398316226356469,-0.0250346136373131,9.46458943252801e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0383667493571275,0.00446633892329636,0.0296127250674667,0.0471207736467884,9.84843876825304e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0685423689554389,0.00800289642941459,0.0528566919537863,0.0842280459570915,1.22759380257771e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,39930,0.0213018851669737,0.00248770632964392,0.0164259807608716,0.0261777895730757,1.2430184515794e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRZB,Secreted frizzled-related protein 3,41973,0.0213169411008754,0.00249297552515958,0.0164307090715626,0.0262031731301882,1.35400617067568e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRG,Histidine-rich glycoprotein,39925,0.0269427119821755,0.00315324830783606,0.0207623452988168,0.0331230786655342,1.45691438018476e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FADD,FAS-associated death domain protein,42145,0.0657322589912713,0.00769577091894122,0.0506485479901465,0.0808159699923961,1.46698384260877e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,41900,0.0470297516380948,0.0055078907461846,0.036234285775573,0.0578252175006166,1.50469318969273e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0613293201939691,0.00718194887660851,0.0472527003958164,0.0754059399921218,1.52119667290377e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TF,Serotransferrin,39979,0.0185267180541656,0.00217201687634993,0.0142695649765197,0.0227838711318115,1.65222006588054e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2R,Proteinase-activated receptor 1,42166,0.0491486460225625,0.00577843774183119,0.0378229080485734,0.0604743839965516,1.99538427361192e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,39958,0.0240606609555562,0.00282874468406426,0.0185163213747903,0.0296050005363222,2.02957274070138e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0555048137969828,0.00652982415185956,0.0427063584593381,0.0683032691346275,2.08731770828137e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0528391870118042,0.00622349090376259,0.0406411448404295,0.0650372291831789,2.31731910841209e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0634558352915839,0.00747956699538378,0.0487958839806317,0.0781157866025361,2.40722863931035e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.0321912787749495,0.00379856407766012,0.0247460931827357,0.0396364643671634,2.60529114824515e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFA,Vascular endothelial growth factor A,42253,0.0483246306793973,0.00570865963045726,0.0371356578037011,0.0595136035550936,2.81696556117014e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL2,Chordin-like protein 2,42145,0.0389938419276218,0.00461070459045453,0.0299568609303309,0.0480308229249126,3.01575693349659e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,39979,0.0132137953905456,0.00156212990109736,0.0101520207843948,0.0162755699966964,3.03019429200336e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.0343825938958428,0.00406649767591529,0.0264122584510488,0.0423529293406368,3.14162991491825e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TALDO1,Transaldolase,39948,0.037701237697007,0.00447223794797767,0.0289356513189708,0.0464668240750432,3.87165339575722e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0452590065741652,0.00537124150565273,0.0347313732230859,0.0557866399252445,3.93725943622561e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,42185,-0.0249080492906921,0.00295951949631726,-0.0307087075034739,-0.0191073910779102,4.27303169514346e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,42070,-0.0344902011942299,0.004101778920697,-0.042529687878796,-0.0264507145096637,4.56328958227147e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPI,Glucose-6-phosphate isomerase,39990,0.0406643857328329,0.00483745626741425,0.0311829714487009,0.0501458000169648,4.74003848699973e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAN,Aggrecan core protein,41994,0.02318827923376,0.00275956950732203,0.0177795229994089,0.0285970354681112,4.79317834447166e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,42125,-0.0791769751337893,0.0094373469771455,-0.0976741752089945,-0.0606797750585842,5.35111684594078e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM3,Junctional adhesion molecule C,39736,0.04318814713928,0.0051535173838558,0.0330872530669226,0.0532890412116374,5.91193493741449e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN2,Matrilin-2,42144,0.0250272929273869,0.00298893648199812,0.0191689774226706,0.0308856084321033,6.14811293342e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0496164269043717,0.00593428852028956,0.0379852214046042,0.0612476324041393,6.82395951146256e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0524559595875748,0.00627454344150277,0.0401578544422293,0.0647540647329202,6.86638185223737e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.0280150355343952,0.00335355116325639,0.0214420752544126,0.0345879958143777,7.23982482509724e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,42016,0.0340393350879936,0.00407547102141796,0.0260514118860144,0.0420272582899728,7.350101468204e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0949049935497769,0.0113782186801371,-0.117206302162846,-0.0726036849367082,8.08439187444738e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0233531008795049,0.0028022539791598,0.0178606830803517,0.0288455186786581,8.58526913331615e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,42185,0.0208874021021531,0.00250871925312132,0.0159703123660353,0.0258044918382709,9.16150356558839e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX8,Syntaxin-8,42119,0.0400581657807526,0.00482253147056884,0.0306060040984377,0.0495103274630675,1.07913510967501e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPA1,Inositol monophosphatase 1,42016,0.0512071493828701,0.0061717968200341,0.0391104276156032,0.0633038711501369,1.16932380789886e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS27,Serine protease 27,42107,0.0335692759410297,0.0040522681907181,0.0256268302872222,0.0415117215948371,1.30165690393418e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPP1,Osteopontin,42286,-0.03675717037071,0.00443964247038821,-0.0454588696126709,-0.0280554711287491,1.35292610417317e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0364919838824289,0.00441194500763804,0.0278445716674584,0.0451393960973995,1.47847095493489e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,42114,0.0284436826588045,0.00344258335064024,0.0216962192915497,0.0351911460260594,1.56092656591033e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0310198605457494,0.00375592129806262,0.0236582548015467,0.0383814662899521,1.60491372055423e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0426191723079898,0.005164741395863,-0.0527420654438813,-0.0324962791720984,1.7009937750683e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,39958,0.0164866908832175,0.00199896052006032,0.0125687282638993,0.0204046535025357,1.79344847192467e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.037220791345147,0.00452754176447721,-0.0460947732035223,-0.0283468094867717,2.19954830246468e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0234852670180999,0.0028570054273069,0.0178855363805783,0.0290849976556214,2.21300057374201e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.034960989732632,0.00426094000176964,-0.0433124321361005,-0.0266095473291635,2.51282663630344e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN6,Dynactin subunit 6,41839,0.059685134580789,0.00727693907926942,0.0454223339854209,0.0739479351761571,2.58181825914839e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0400592046146536,0.00489117285196565,0.030472505824801,0.0496459034045063,2.89009768536655e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGLN1,Egl nine homolog 1,42119,0.0461283381597839,0.0056345210585033,0.0350846768851174,0.0571719994344503,2.92291022690305e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0234960548564995,0.00287049501102161,-0.0291222250781018,-0.0178698846348971,2.9576513451208e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO1A,Coronin-1A,41883,0.0732684354176711,0.00895212690120072,0.0557222666913177,0.0908146041440245,2.98260028987713e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0297537313102616,0.00364028857222205,-0.0368886969118168,-0.0226187657087064,3.26138900711819e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.0677984973548679,0.00831228230793311,0.0515064240313191,0.0840905706784168,3.75991451306665e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGN,Secretagogin,41913,-0.036471207090727,0.00448432306837746,-0.0452604803047468,-0.0276819338767072,4.55480103235128e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WDR46,WD repeat-containing protein 46,39919,0.0301179923389857,0.00370269338139044,0.0228607133114604,0.037375271366511,4.58380408063611e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROK1,Prokineticin-1,42119,0.0407308404637327,0.00501248855971091,0.0309063628866993,0.0505553180407661,4.82491580235032e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNMT,Histamine N-methyltransferase,41961,0.0392780969684439,0.00483614231661202,0.0297992580278844,0.0487569359090035,4.99438020657533e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0339964253861028,0.00418715449439479,-0.0422032481951166,-0.0257896025770891,5.09112643922634e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEPR,Leptin receptor,42145,-0.0257125990540272,0.00317138760934156,-0.0319285187683367,-0.0194966793397178,5.59984815727001e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0388850505365991,0.00479751327321944,-0.0482881765521092,-0.029481924521089,5.71290200582802e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1F,Protein phosphatase 1F,39958,0.043712695368532,0.00539574080035916,0.033137043399828,0.0542883473372359,5.9915726260418e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB10,Ras-related protein Rab-10,39958,0.0437822272202467,0.00540675167129675,0.0331849939445051,0.0543794604959883,6.1723909050352e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLTA,Clathrin light chain A,41900,0.0382414887148753,0.00472416431763044,0.0289821266523196,0.047500850777431,6.22803193019112e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARD3,Partitioning defective 3 homolog,39757,0.0607701845794423,0.00750854524823228,0.046053435892907,0.0754869332659775,6.40027338574767e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCA2A,Guanylin,42083,-0.0287386064469023,0.00355290383641091,-0.0357022979662677,-0.0217749149275369,6.53918388801756e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.035103081323043,0.00434735714744245,0.0265822613140558,0.0436239013320302,7.4678036022868e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO2,Gamma-enolase,42249,0.0528694574973121,0.00656567458346895,0.040000735313713,0.0657381796809113,8.7868262228494e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,42070,0.0190239285500728,0.0023641292092129,0.0143902353000155,0.02365762180013,9.19801840636593e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARK7,Parkinson disease protein 7,42137,0.0411000263716194,0.00510888884451865,0.0310866042363628,0.0511134485068759,9.35266606364697e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0330653918610972,0.00411635878017443,-0.0411334550702391,-0.0249973286519553,1.03264559214773e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0321989760760583,0.00401371426852388,0.0243320961097515,0.0400658560423651,1.12214664430748e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME1,Proteasome activator complex subunit 1,42002,0.0293989681615635,0.00366534636476916,0.0222148892866159,0.036583047036511,1.13743685751074e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",39929,0.0870046659919777,0.0108456534771436,0.0657471851767762,0.108262146807179,1.14203192620963e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSNL1,Visinin-like protein 1,39929,0.0313850249263003,0.00392571952999854,0.0236906146475031,0.0390794352050974,1.42470610371239e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.042388734631037,0.00531120659125544,0.0319787697121763,0.0527986995498976,1.59391286976282e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.0716554759284443,0.00898112554299343,0.0540524698641772,0.0892584819927114,1.60248324028596e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0383610348781712,0.00481404635849595,-0.0477965657408233,-0.0289255040155191,1.73170388508758e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0352794520409685,0.0044282109768658,0.0266001585263116,0.0439587455556255,1.78155362936983e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0529663155353216,0.00665163139630979,-0.0660035130720888,-0.0399291179985544,1.81394509692801e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK6,Kallikrein-6,42158,0.0248011929149189,0.00311579482081421,0.018694235066123,0.0309081507637147,1.85900999040077e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSV,Cathepsin L2,42200,0.0321683797777034,0.0040418227642335,0.0242464071598057,0.0400903523956011,1.87282084370198e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0699440501686382,0.00881412291460973,0.0526683692560032,0.0872197310812733,2.29783243296076e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0219178850928298,0.00277228606749668,0.0164842044005364,0.0273515657851233,2.90885094180698e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP3,Stromelysin-1,42137,-0.039475629353981,0.00501584502947757,-0.049306685611757,-0.0296445730962049,3.80897378765495e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOA,Elongin-A,42070,0.0427092706959956,0.00542921901177508,0.0320680014329165,0.0533505399590748,3.92187369276003e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEPD,Xaa-Pro dipeptidase,39990,0.020977512601005,0.00266793578059976,0.0157483584710294,0.0262066667309805,4.09407286078712e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164,Sialomucin core protein 24,42137,0.0214147434480219,0.00272630911672258,0.0160711775792456,0.0267583093167981,4.30288064256791e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABHD14B,Protein ABHD14B,41976,0.0442915710699107,0.00564702249605098,0.0332234069776508,0.0553597351621707,4.71809588927886e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO2,Roundabout homolog 2,42249,0.017889490721865,0.00228296803855117,0.0134148733663047,0.0223641080774253,4.99124998396417e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DXO,Decapping and exoribonuclease protein,39929,0.0359462120436127,0.00458994515389394,0.0269499195419806,0.0449425045452448,5.25006563435074e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.042245080585153,0.00539744942104792,0.0316660797198991,0.052824081450407,5.45907782933059e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,42113,-0.0187755122607868,0.00240880621307588,-0.0234967724384155,-0.0140542520831581,6.93577974196856e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0282456975106474,0.00362336844250108,0.0211438953633452,0.0353474996579495,6.99081354048417e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",42123,-0.0747164321408809,0.00959144964862031,-0.0935156734521767,-0.0559171908295851,7.1931763084964e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0385037689375824,0.00495425421504174,0.0287934306761006,0.0482141071990642,8.40208839653099e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA6,Integrin alpha-6,42119,0.0396845015524476,0.00513519465042873,0.0296195200376073,0.0497494830672879,1.16981380740176e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0653781585306805,0.00847610113115733,0.0487650003136122,0.0819913167477489,1.31461907628481e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MILR1,Allergin-1,41913,-0.0398308032897985,0.00516469487008186,-0.0499536052351589,-0.029708001344438,1.3249953941688e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,39930,0.0651210237244916,0.00844723533838061,0.0485644424612656,0.0816776049877176,1.37240790921447e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAV,Integrin alpha-V,42262,0.0129038024459822,0.0016772221717683,0.00961644698931636,0.0161911579026481,1.52875553913517e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLB1,Beta-galactosidase,42016,0.0334829308992359,0.00435308914599598,0.0249508761730838,0.042014985625388,1.55211174282636e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX16,Syntaxin-16,41843,0.044205712172902,0.00575367472466315,0.0329285097125622,0.0554829146332417,1.66254267008336e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PER3,Period circadian protein homolog 3,39657,0.0956657154098278,0.0124519880425276,0.0712598188464736,0.120071611973182,1.68847793318894e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH7,Protocadherin-7,39930,0.0270888123536875,0.00353103064943697,0.020167992280791,0.0340096324265839,1.83715314365135e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRIB,Protein scribble homolog,39638,0.0680192512072338,0.00886654790437769,0.0506408173146535,0.0853976850998141,1.84379645095453e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,42230,-0.0173069314395138,0.00225735933350989,-0.0217313557331931,-0.0128825071458344,1.88109562880964e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,42137,0.0411998790995105,0.00537403782305291,0.0306667649663268,0.0517329932326942,1.88817427694851e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.0294455325070254,0.00384570720786473,-0.0369831186344403,-0.0219079463796105,2.06225918491567e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSHB,Thyrotropin subunit beta,42145,0.0526002070333496,0.00687165552072189,0.0391317622127346,0.0660686518539645,2.06904324854984e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF2,Fibroblast growth factor 2,42119,0.0531730481685906,0.00696802034872552,0.0395157282850886,0.0668303680520926,2.4847606709644e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0442303225834297,0.00580982373546571,0.0328430680619169,0.0556175771049425,2.85853356035636e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0179365644702712,0.00235704747027933,0.0133167514285237,0.0225563775120187,2.92483123554777e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGFAC,Hepatocyte growth factor activator,39897,0.0208341818440749,0.00273840872076937,0.0154669007513669,0.0262014629367829,3.00167362522073e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.0218692224399042,0.00287632430452128,-0.0275068180767659,-0.0162316268030425,3.07911224650092e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,39513,0.0409146297012156,0.00538630536899879,0.030357471177978,0.0514717882244532,3.30284969055435e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0319393056918526,0.00421606117921684,0.0236758257805875,0.0402027856031176,3.86084370614284e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM3,Myomesin-3,39736,-0.0743417172177775,0.00983279936069382,-0.0936140039647373,-0.0550694304708176,4.32791138287007e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILP,Rab-interacting lysosomal protein,42224,0.0446880954394966,0.00591215625212183,0.0331002691853378,0.0562759216936554,4.33142431639355e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.027936502368471,0.00369739009475123,0.0206896177827586,0.0351833869541834,4.43435146701993e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.021549068807732,0.00285285428639149,0.0159574744064047,0.0271406632090594,4.57345229418009e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0226846905031569,0.00300617162373896,0.0167925941206285,0.0285767868856853,4.82969132290633e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPLAH,5-oxoprolinase,39638,0.0530314711950812,0.00702889775957255,0.039254831586319,0.0668081108038434,4.88683043507805e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCG,Gamma-synuclein,42016,0.0507534906715035,0.00674667692959664,0.0375300038894941,0.0639769774535129,5.7048516097686e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,42181,0.0319549997295852,0.00425153195077735,0.0236219971060616,0.0402880023531088,5.99561567912234e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,41843,0.0428323501255557,0.00570160917953408,0.0316571961336689,0.0540075041174425,6.18049135401179e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD84,SLAM family member 5,42119,0.0240942980281674,0.00321371486134251,0.0177954168999361,0.0303931791563988,6.91780070225787e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0546217999127151,0.00728829712366972,0.0403367375503225,0.0689068622751078,7.07474874442363e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0436268715856091,0.00582946769127658,0.032201114910707,0.0550526282605112,7.66660031864646e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD244,Natural killer cell receptor 2B4,42296,0.0207651590927607,0.00277720707733071,0.0153218332211926,0.0262084849643289,8.065690796182e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX4,Syntaxin-4,42070,0.0444993970029769,0.00595641795329617,0.0328248178145164,0.0561739761914374,8.45924490365641e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0260974333990888,0.00349394628522452,-0.0329455681181289,-0.0192492986800488,8.5625345385992e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM1,Probable carboxypeptidase X1,42181,0.0517447007113842,0.00693984960686019,0.0381425954819383,0.0653468059408302,9.44649794795571e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0319900188078629,0.00429151596031233,0.0235786475256507,0.0404013900900751,9.71484669009204e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0571496529036765,0.00767074288062413,0.0421149968576532,0.0721843089496998,9.98682812925169e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,41913,0.0271433594572428,0.0036469920500898,0.0199952550390668,0.0342914638754188,1.04721386882285e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECE1,Endothelin-converting enzyme 1,41839,0.0264776456543433,0.0035625245679027,0.019495097501254,0.0334601938074326,1.13296563533272e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDHB,Succinate dehydrogenase,39930,0.049356802473342,0.00664369168117739,0.0363351667782343,0.0623784381684497,1.17177183040106e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0481157332312918,0.00649735344912792,0.035380920471001,0.0608505459915825,1.39994698957466e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOTL2,Angiomotin-like protein 2,39882,0.0365979921882084,0.00494297554305534,0.0269097601238199,0.0462862242525969,1.41507960816437e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0188241757538869,0.00254492649946615,0.0138361198149333,0.0238122316928406,1.47762683094607e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOB,Apolipoprotein B-100,39990,0.0170612384758264,0.00230753598347644,0.0125384679482126,0.0215840090034403,1.52804925053792e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDUA,Alpha-L-iduronidase,42262,0.0350865109886354,0.00475639933834583,0.0257639682854776,0.0444090536917932,1.7161447796261e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0251813875102302,0.00342377674348229,-0.0318919899274555,-0.0184707850930049,2.02216930664991e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,41913,0.0487259761329538,0.00662721389304579,0.035736636902584,0.0617153153633235,2.06032852858237e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBI,Acyl-CoA-binding protein,42085,0.0577825054616039,0.00786230396049902,0.0423723896990258,0.073192621224182,2.10692557034424e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0292894063348939,0.0039919064262844,0.0214652697393765,0.0371135429304113,2.33017648976863e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0268844616542301,0.00366795317283893,0.0196952734354658,0.0340736498729944,2.47055952491819e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGED1,Melanoma-associated antigen D1,41843,0.0356362672299487,0.00486585380429809,0.0260991937735245,0.045173340686373,2.55079300611759e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0245539431609642,0.00335673611949283,0.0179747403667582,0.0311331459551701,2.72054106794747e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0382105420305098,0.00522932078245763,0.0279610732968928,0.0484600107641267,2.88853421698366e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0334817696789448,0.00458340660281339,0.0244982927374305,0.042465246620459,2.92864534745355e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0652641864288413,0.00894653455745902,0.0477289786962217,0.082799394161461,3.18801548042523e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C8B,Complement component C8 beta chain,39979,0.0223478193408245,0.00306623657502497,0.0163379956537756,0.0283576430278735,3.34538163330465e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0652380966819244,0.00898302711697237,0.0476313635326585,0.0828448298311902,4.05923542844348e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPMT,Thiopurine S-methyltransferase,41843,0.0523048839982387,0.00721400706876342,0.0381654301434624,0.0664443378530151,4.38396495075861e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0655092981905042,0.00904875388377609,0.047773740578303,0.0832448558027053,4.79682061715748e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSNAX,Translin-associated protein X,39575,0.0288050353607251,0.00398289754829631,0.0209985561660644,0.0366115145553859,5.06954595339834e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZD2,PDZ domain-containing protein 2,39575,0.0431639266425933,0.00596909184224011,0.0314645066318027,0.0548633466533839,5.1046860803061e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH17,Cadherin-17,42145,-0.0497501904039832,0.00688695522179701,-0.0632486226387054,-0.0362517581692611,5.32434892056013e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0286947307900775,0.00397166377600949,0.0209102697890989,0.0364791917910561,5.33744363843911e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0358491165020369,0.00496229323537826,0.0261230217606955,0.0455752112433783,5.35995536811691e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0236563943067884,0.00327707790410433,0.0172333216147439,0.0300794669988329,5.58171004230557e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17D,Interleukin-17D,41913,0.0247928422778085,0.00344309368502843,0.0180443786551528,0.0315413059004642,6.30983248747667e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK4,Serine/threonine-protein kinase 4,42145,0.0634327324194482,0.00882189477103855,0.0461418186682126,0.0807236461706837,6.80011396343852e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA4,Annexin A4,42088,0.0525753134706975,0.00731414633926268,0.0382395866457427,0.0669110402956524,6.91197720433088e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.031222706986367,0.00434497497565892,0.0227065560340755,0.0397388579386585,7.02740723758891e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0347318917829307,0.00484166260265677,0.0252422330817234,0.044221550484138,7.76377537093543e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL,Podocalyxin,42070,0.0109526577713803,0.00152862349225624,0.00795655572655804,0.0139487598162025,8.18026729488925e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERMAP,Erythroid membrane-associated protein,39657,0.0323681946726006,0.00452113620724405,0.0235067677064022,0.0412296216387989,8.62311232037189e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAP3,Cytosol aminopeptidase,41913,0.0346949229360908,0.0048487252319358,0.0251914214814966,0.044198424390685,8.77482876598206e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GC,Vitamin D-binding protein,39979,0.0187352865788749,0.00261956305893098,0.0136009429833702,0.0238696301743797,9.07257220906685e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPAG1,Sperm-associated antigen 1,39934,0.0423048653426795,0.00591701501266629,0.0307075159178536,0.0539022147675055,9.23193928843153e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0545745513358388,0.00764571426716484,0.0395889513721957,0.0695601512994818,1.00540649938997e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRBP,Acrosin-binding protein,39919,0.0288257121635587,0.00403869238923703,0.0209098750806541,0.0367415492464632,1.00940110555799e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.0595161536638974,0.00834122466064894,0.0431673533290255,0.0758649539987694,1.01582124443387e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,39930,0.0356876868141646,0.00500309744270026,0.0258816158264721,0.0454937578018571,1.04101626911655e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0176449502237638,0.00247530543124852,-0.0224965488690109,-0.0127933515785167,1.06625980316994e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG4A,Cysteine protease ATG4A,41843,0.0417747802952093,0.00586820010792942,0.0302731080836677,0.053276452506751,1.14448074477786e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0315612850712332,0.00444251532981933,0.0228539550247873,0.0402686151176791,1.2701557348366e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCA,Calcitonin,41997,0.049674020084041,0.00701944232209366,0.0359159131327374,0.0634321270353446,1.550435246794e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC3,Membrane primary amine oxidase,42217,-0.0211977990447088,0.00299570301592086,-0.0270693769559136,-0.0153262211335039,1.55552745317927e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD93,Complement component C1q receptor,41654,-0.0225030053808128,0.00318031858248317,-0.0287364298024798,-0.0162695809591457,1.56276571195095e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.04016629872674,0.00568109810089976,0.0290313464489765,0.0513012510045036,1.62474597649623e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0329457838929522,0.0046686339026435,0.0237952614437709,0.0420963063421335,1.80454738061988e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0661852988756489,0.00938140379552142,0.047797747436427,0.0845728503148709,1.8273245799033e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0278748207684551,0.0039549800665486,-0.0356265816988904,-0.0201230598380199,1.90518964331211e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX9,Sorting nexin-9,42145,0.0482918089972385,0.00686015753045535,0.034845900237546,0.061737717756931,2.02276819088437e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN2,Transcobalamin-2,42286,-0.0214823721722685,0.00305536175387197,-0.0274708812098575,-0.0154938631346794,2.1471828441522e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS1,Nephrin,39657,0.0236467383475147,0.00337485526976199,0.0170320220187812,0.0302614546762481,2.58119441034365e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18,Interleukin-18,42069,0.0312728028113076,0.00447058906526522,0.0225104482433877,0.0400351573792274,2.77325893304521e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRN1,Secernin-1,42119,0.0390185496265728,0.00558413748361501,0.0280736401586874,0.0499634590944582,2.93159097812866e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGA,Fibrinogen alpha chain,39735,0.0220585445822656,0.00315696864912847,0.0158708860299738,0.0282462031345574,2.96322242716331e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAYN,Layilin,41997,-0.025244954484731,0.00361747577687428,-0.0323352070074046,-0.0181547019620574,3.12131903188408e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML1,Trem-like transcript 1 protein,39990,0.0374395876880486,0.00536498956498924,0.0269242081406697,0.0479549672354275,3.14905475022185e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA12,Carbonic anhydrase 12,42070,-0.0230401808992426,0.00330637217637806,-0.0295206703649436,-0.0165596914335416,3.35427667539214e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RB,Interleukin-17 receptor B,41934,-0.0379702403212549,0.00545273059811958,-0.0486575922935693,-0.0272828883489405,3.47400749631993e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0444198690293111,0.00637981847794921,0.0319154248125306,0.0569243132460915,3.52561613847224e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17C,Interleukin-17C,41913,-0.0497383937989881,0.00716092666508714,-0.0637738100625589,-0.0357029775354173,3.9378677995669e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0171072406254113,0.00246305438613053,0.0122796540285954,0.0219348272222271,3.94276594524444e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,39757,0.0248459055751487,0.00357770600436965,0.0178336018065842,0.0318582093437132,4.00501498384917e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,39966,0.018957145886936,0.00273462812563165,0.013597274760698,0.024317017013174,4.36609469584126e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL3,C-C motif chemokine 3,42119,0.0414689523502486,0.00598627375166625,0.0297358557969828,0.0532020489035145,4.48225350009891e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0460924191996831,0.00665977223039453,0.0330392656281098,0.0591455727712564,4.72599346863191e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,42310,-0.0164006005045686,0.00237157175994623,-0.0210488811540632,-0.011752319855074,4.8686924343565e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0330329833476029,0.00478205914598159,0.023660147421479,0.0424058192737268,5.15053558749402e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCA,Tubulin-specific chaperone A,39736,0.0587904527454894,0.00852345998723095,0.0420844711705167,0.075496434320462,5.57993317620068e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,42119,-0.0166913131631526,0.00242233986760326,-0.021439099303655,-0.0119435270226502,5.80281151022425e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELE,E-selectin,42310,0.0349697999719107,0.00509792228568615,0.0249778722919658,0.0449617276518556,7.20050440185313e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.0283485728162594,0.00413463756030546,-0.0364524624344581,-0.0202446831980607,7.42962982064778e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0214734752797035,0.00313342248091873,0.0153319672171028,0.0276149833423042,7.60375296049557e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",39949,0.0159154004973085,0.00232269914359381,0.0113629101758646,0.0204678908187524,7.65332068288719e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,39736,-0.0285036867890963,0.00416153750164208,-0.0366603002923147,-0.0203470732858778,7.81138522086829e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA4,Laminin subunit alpha-4,42185,0.0235834627139079,0.00345282606045277,0.0168159236354204,0.0303510017923953,8.84086936761901e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,39990,0.0182628561865271,0.00267575362619504,0.0130183790791848,0.0235073332938694,9.21882269326964e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIT,Vitrin,39958,0.0265528648966113,0.00389077006400421,0.0189269555711631,0.0341787742220596,9.26722399433611e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRDT,Bromodomain testis-specific protein,39575,0.0252925105103404,0.00370674353433966,0.0180272931830347,0.0325577278376462,9.36087921236976e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN2,Dynactin subunit 2,42070,0.0653338361519866,0.00958396200302394,0.0465492706260596,0.0841184016779135,9.69216144344902e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACYP1,Acylphosphatase-1,39701,0.0449514750966086,0.00659939887282222,0.0320166533058771,0.0578862968873402,1.01615232997259e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ING1,Inhibitor of growth protein 1,41820,0.0327018379300941,0.00480742855838417,0.0232792779556611,0.042124397904527,1.07350632776833e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL2,C-C motif chemokine 2,41992,0.0356430554115468,0.00524066318600835,0.0253713555669705,0.0459147552561232,1.08117238421884e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,39481,0.0222887560220413,0.00327670291186377,0.0158664183147883,0.0287110937292943,1.08448370964883e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0370626579581832,0.00545120058651777,0.0263783048086084,0.0477470111077581,1.09776037121541e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH1,Protocadherin-1,42264,0.014135727249661,0.00207917353134408,0.0100605471282266,0.0182109073710954,1.09931519811819e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL11,Eotaxin,42296,0.0256418376583808,0.00377207298818672,0.0182485746015348,0.0330351007152268,1.10617811174373e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,39281,-0.076213646334269,0.0112367138821764,-0.0982376055433348,-0.0541896871252033,1.24310087659422e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGH,Gamma-glutamyl hydrolase,41933,0.0232216670589218,0.00343202085392782,0.0164949061852233,0.0299484279326204,1.37749333540013e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0320712272992414,0.00474372899384503,0.0227735184713052,0.0413689361271777,1.4301988339879e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0480327234100392,0.00710432955105632,0.0341082374899688,0.0619572093301095,1.43848586964735e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0383539624168762,0.00568104570616666,0.0272191128327895,0.0494888120009628,1.53858544544822e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL5,Fc receptor-like protein 5,42137,-0.0401988821245986,0.00597283768382387,-0.0519056439848934,-0.0284921202643038,1.76150519534648e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0458319168386157,0.00681417518099231,0.0324761334838708,0.0591877001933606,1.83103654941496e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SWAP70,Switch-associated protein 70,39930,0.0249174898833178,0.00371200886565758,0.017641952506629,0.0321930272600067,2.00220752053297e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR2,Complement factor H-related protein 2,39904,0.0388522987760877,0.00578980596874525,0.0275042790773471,0.0502003184748284,2.03277214216674e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0377759622285078,0.00563255509149578,0.0267361542491761,0.0488157702078395,2.06950251309728e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGF,Placenta growth factor,42296,0.0176988574109483,0.00264315889427143,0.0125182659781763,0.0228794488437203,2.22397752844031e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASSF2,Ras association domain-containing protein 2,41843,0.0384855472251113,0.00575779229840448,0.0272002743202385,0.0497708201299841,2.41684735438054e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXN,"Frataxin, mitochondrial",42262,0.0490036395732246,0.00733779479071709,0.0346215617834191,0.0633857173630301,2.51158458100977e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCT,Secretin,39649,0.0324877599531566,0.00487286680689229,0.0229369410116477,0.0420385788946655,2.73396031296658e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMNL1,Formin-like protein 1,41839,0.0424895312967256,0.00637417161347556,0.0299961549343135,0.0549829076591377,2.73488837175987e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPT,Dermatopontin,42310,0.0170962581663412,0.00256484212961949,0.012069167592287,0.0221233487403954,2.73630557994723e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF22,Kinesin-like protein KIF22,39575,0.0839292740863812,0.0125910931831195,0.0592507314474671,0.108607816725295,2.75918388240978e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL7,C-C motif chemokine 7,42119,0.0376659547197368,0.00566904466301592,0.0265546271802256,0.048777282259248,3.16659457901967e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN2,Alpha-actinin-2,39575,-0.0434323370636165,0.00654640590099276,-0.0562632926295623,-0.0306013814976707,3.408584416145e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1A,Protein phosphatase 1A,41843,0.0209550497509569,0.00316328961077737,0.0147550021138333,0.0271550973880805,3.62014339645001e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,42310,-0.0180850063838727,0.00273529969164652,-0.0234461937794999,-0.0127238189882455,3.93970739815817e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.026501965401358,0.0040152168196658,0.0186321404348131,0.034371790367903,4.25388760322658e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0488247767105017,0.00742356899572291,0.0342745814788848,0.0633749719421186,4.98081725272405e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.0483234687074161,0.00735024883991971,0.0339169809811734,0.0627299564336587,5.09912103949421e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBN,Nibrin,41913,0.0360099251883337,0.00549089058087932,0.0252477796498102,0.0467720707268572,5.65019391123481e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,41907,-0.055406923754439,0.00845063148992314,-0.0719701614746883,-0.0388436860341896,5.71020256992704e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0192410711361384,0.00294359485088725,-0.0250105170438774,-0.0134716252283994,6.51926224056535e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMB1,Laminin subunit beta-1,39638,0.0207611002039402,0.0031795696136803,0.0145291437611269,0.0269930566467536,6.88726393267268e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0348996374987811,0.00534526671385438,0.0244229147396265,0.0453763602579356,6.90829210605047e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0356321685330826,0.00546221702881586,0.0249262231566035,0.0463381139095617,7.17398944769388e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,41843,0.0254616988254461,0.00391227180062712,0.0177936460962169,0.0331297515546752,7.88153032895192e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMM2,Phosphomannomutase 2,39575,0.0394993798873123,0.00608187323628222,0.0275789083441992,0.0514198514304255,8.68491137420296e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP7,Matrilysin,41881,0.0340227441017275,0.00524028149055794,0.0237517923802339,0.044293695823221,8.74019464999898e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM2,Myomesin-2,39575,-0.0366674751336798,0.00564830954091398,-0.0477381618338712,-0.0255967884334884,8.850007071194e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL1,Delta-like protein 1,42181,-0.020087720407335,0.00309881937071992,-0.0261614063739461,-0.014014034440724,9.34072042514197e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,39575,0.0332956626805177,0.00513866426235413,0.0232238807263036,0.0433674446347318,9.60072221952668e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF1,Scavenger receptor class F member 1,42310,0.0277921091240769,0.00429141549972465,0.0193809347446166,0.0362032835035372,9.72614187391752e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0309489103890975,0.00478616269585623,0.0215680315052193,0.0403297892729757,1.03935534965744e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH1,Neurexophilin-1,41839,0.0253297433097001,0.0039172832623166,0.0176518681155595,0.0330076185038406,1.0406009209292e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID2,Nidogen-2,42137,0.0475151599116589,0.00736440398875768,0.0330809280936939,0.061949391729624,1.1413663815447e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,42217,-0.0208490641537137,0.00323497952523752,-0.0271896240231793,-0.0145085042842482,1.19585326645183e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.0158528320665569,0.00246165080862078,0.0110279964816602,0.0206776676514536,1.23594501148538e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",39638,0.057148150961255,0.00889236407362573,0.0397191173769485,0.0745771845455614,1.35819074468646e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0428348910067773,0.00666614660878607,0.0297692436535566,0.055900538359998,1.36495998629303e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,42070,0.0240114768863909,0.00373959479882206,0.0166818710806996,0.0313410826920821,1.40036869915984e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRB1,Chymotrypsinogen B,42137,0.0378804037145537,0.0059000605726933,0.0263162849920748,0.0494445224370326,1.40505659071177e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDK2,Protein sidekick-2,39736,0.0256121072730242,0.00399169530646494,0.0177883844723529,0.0334358300736955,1.45246922695144e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL3,Myosin light chain 3,39638,-0.0509197789678732,0.00795789057876203,-0.0665172445022467,-0.0353223134334996,1.63103001522369e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0392510277757924,0.00615493765084891,0.0271873499801286,0.0513147055714563,1.86268941309248e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELENOP,Selenoprotein P,39979,0.0145714801651654,0.00229468699367261,0.0100738936575671,0.0190690666727637,2.23380104337695e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL19,C-C motif chemokine 19,42249,0.0720177221074394,0.0113978250960111,0.0496779849192578,0.0943574592956211,2.72229384628818e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0437392810688042,0.00693430805738657,0.0301480372763265,0.0573305248612819,2.94000507424217e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPK2,Death-associated protein kinase 2,39657,0.0354077574641012,0.00561586788945567,0.0244006564007681,0.0464148585274343,2.99281999103284e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0473392110698945,0.00751773502536436,0.0326044504201803,0.0620739717196086,3.14860117808338e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0171288590329292,0.00272057257490219,0.0117965367861209,0.0224611812797375,3.16922023138108e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFAP1,Actin filament-associated protein 1,39736,0.053388543694985,0.00848109932874047,0.0367655890106537,0.0700114983793163,3.18957687477459e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0306538908800114,0.00488318987988611,0.0210828387154346,0.0402249430445882,3.54970879444528e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,39929,0.014422956512597,0.00231089913836526,0.00989359420140107,0.0189523188237929,4.49526186297156e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17A,Interleukin-17A,41877,-0.0270350139237135,0.0043396091100855,-0.0355406477794811,-0.0185293800679459,4.81051631557908e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH5,Cadherin-5,42310,-0.0191029511541451,0.00306925456618425,-0.0251186901038663,-0.013087212204424,4.98844088611126e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML2,Trem-like transcript 2 protein,42137,0.0216699637936466,0.00348206167511305,0.0148451229104251,0.0284948046768682,5.01115089938188e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0165565107378452,0.00266085680588847,-0.0217717900773866,-0.0113412313983038,5.07685622301302e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,39575,-0.029169861926535,0.0046924101909821,-0.0383669859008599,-0.0199727379522101,5.27191965646325e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XRCC4,DNA repair protein XRCC4,41839,0.0231214300897716,0.00372348808646067,0.0158233934403087,0.0304194667392345,5.47023935528843e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE,Angiotensin-converting enzyme,39990,-0.0169722599973214,0.00273607878406754,-0.0223349744140938,-0.011609545580549,5.72697135063459e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2orf69,UPF0565 protein C2orf69,39649,0.0370295656580216,0.00596989920495025,0.0253285632163191,0.0487305680997241,5.74828688077827e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP9,Caspase-9,39657,0.040103405282339,0.00647539042020896,0.0274116400587295,0.0527951705059486,6.10476087772869e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0367795166994391,0.00594159962609955,0.025133981432284,0.0484250519665942,6.22293432541281e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,39929,0.0426000498473898,0.00690936888165771,0.0290576868393407,0.0561424128554389,7.26301704506241e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3BP,Galectin-3-binding protein,39979,0.0195330861359952,0.00316927476152752,0.0133213076034013,0.0257448646685892,7.367062448339e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS2,Trypsin-2,42217,0.0355430137557812,0.00577421740067244,0.0242255476504632,0.0468604798610992,7.69570093101283e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS53,Serine protease 53,39929,0.0238084946376266,0.0038705976653031,0.0162221232136326,0.0313948660616207,7.9534563564921e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMSB10,Thymosin beta-10,42137,0.0472049649386819,0.00767704647066364,0.0321579538561812,0.0622519760211826,8.02440116486481e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.0145950390975353,0.00237429827314897,0.00994141448216335,0.0192486637129073,8.11331490331896e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAD,Chondroadherin,39736,0.0292377577134768,0.00475886771241243,0.0199103769971484,0.0385651384298051,8.32975089515225e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,42070,0.0449333426658765,0.00731763805753232,0.0305907720731132,0.0592759132586399,8.46188970720018e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0195784513793919,0.00319002513165016,0.0133260021213576,0.0258309006374262,8.62783905263245e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA1,Carboxypeptidase A1,42310,0.0400549409562335,0.00653644532474717,0.027243508119729,0.0528663737927379,9.14626293477585e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0191840963782855,0.00313279922285803,-0.0253243828550872,-0.0130438099014838,9.3998876263366e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL1,Follistatin-related protein 1,39638,-0.014420006713039,0.00235481717483059,-0.019035448375707,-0.00980456505037106,9.45844318804209e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.034997746125685,0.00571746095344029,0.023791522656942,0.046203969594428,9.54489194498068e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBKS,Ribokinase,41830,0.0306354752293177,0.00500509992878259,0.0208254793689038,0.0404454710897316,9.57070925676757e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAO1,Hydroxyacid oxidase 1,42262,0.0763814474547045,0.0124795011173609,0.0519216252646771,0.100841269644732,9.58020027048255e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.0161923195031419,0.00264972314611575,0.010998862136755,0.0213857768695288,1.02295653780034e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0250736654419028,0.00410954355824327,0.0170189600677459,0.0331283708160596,1.08713091856465e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,42296,0.0453401103968372,0.00743327614951643,0.030770889143785,0.0599093316498894,1.09187492818763e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENAH,Protein enabled homolog,41913,0.0296714761028583,0.00486939317758317,0.0201274654747953,0.0392154867309213,1.13541357165449e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LXN,Latexin,41960,-0.042225072353363,0.00692981417285266,-0.0558075081321542,-0.0286426365745718,1.13684441521624e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYAL1,Hyaluronidase-1,42077,-0.0141924530128014,0.00233192026851134,-0.0187630167390836,-0.00962188928651919,1.18783593820591e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIT2,Slit homolog 2 protein,41839,0.031708099797158,0.00521163398786275,0.021493297180947,0.041922902413369,1.20378802987726e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERI1,3'-5' exoribonuclease 1,39757,0.0211110618463881,0.00348067223410684,0.0142889442675387,0.0279331794252375,1.36037764383538e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA4,Carbonic anhydrase 4,42310,-0.0148580885415071,0.00245131570444974,-0.0196626673222286,-0.0100535097607856,1.38592506564437e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0352560650717606,0.00582572073645849,0.023837652428302,0.0466744777152193,1.47108349161377e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF6,SLAM family member 6,41843,0.023586753638844,0.00390098262923532,0.0159408276855427,0.0312326795921452,1.52138633765403e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.0400842458808415,0.00663181004404978,0.0270858981945039,0.053082593567179,1.54994665063612e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC1,Sialoadhesin,42185,-0.0253633895729024,0.00419894417937771,-0.0335933201644827,-0.0171334589813221,1.57727306277131e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN5,CCN family member 5,42137,0.023095463337996,0.00383541774897523,0.0155780445500045,0.0306128821259874,1.77140585494408e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPPK1,Epiplakin,39638,0.0450460681760591,0.00750445223336535,0.030337341798663,0.0597547945534552,2.0031245332341e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0386140475824377,0.0064347624224513,0.0260019132344331,0.0512261819304422,2.02286745237734e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENR,Density-regulated protein,39657,0.0349433310093781,0.00583229238373536,0.0235120379372568,0.0463746240814994,2.14582565644564e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0359562353618083,0.00602060668031469,0.0241558462683915,0.0477566244552251,2.41104385280103e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDM1,Nuclear protein MDM1,39649,0.0190156804360416,0.00318491611414406,0.0127732448523192,0.0252581160197639,2.43734726866742e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAL,Integrin alpha-L,39657,0.0264552608980689,0.0044340209162249,0.0177645799022681,0.0351459418938697,2.49935874318835e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0384126591669746,0.00644105908481135,-0.0510371349732048,-0.0257881833607443,2.52731150438599e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN5,Contactin-5,42170,0.0222917397011563,0.00373938792513315,0.0149625393678953,0.0296209400344173,2.56397383351224e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK1D,Casein kinase I isoform delta,39657,0.0389084494921842,0.00652609894115822,0.0261172955675141,0.0516996034168544,2.56817866726501e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0199635858499355,0.00334910578430669,-0.0265278331871766,-0.0133993385126944,2.58501924661396e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0153330208660748,0.00257819699891501,0.0102797547482014,0.0203862869839482,2.80819750591855e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0298458317772973,0.0050193177229803,0.0200079690402559,0.0396836945143387,2.81365473062764e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0409310855450143,0.00688841013223942,0.0274298016858251,0.0544323694042036,2.88600993238208e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0339757023991352,0.00572919626291137,-0.0452049270744414,-0.0227464777238289,3.11492357899746e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF1,Trefoil factor 1,42084,-0.0481632575512014,0.00813512172366444,-0.0641080961295837,-0.0322184189728191,3.28947533092884e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0259448763710585,0.00438791761962053,0.0173445578366023,0.0345451949055147,3.44627665817592e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY96,Lymphocyte antigen 96,42016,-0.0218407522207499,0.00369475157804578,-0.0290824653137196,-0.0145990391277801,3.47681319838767e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST3,Cystatin-C,42184,0.0171139558626386,0.0028966372544143,0.0114365468439866,0.0227913648812906,3.54112646271465e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,39934,0.0397453151845608,0.00672813045556477,0.0265581794916539,0.0529324508774678,3.57677093637364e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.050607893196602,0.00858186014962961,0.033787447303328,0.0674283390898761,3.79019018627787e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,39895,0.0271595168591142,0.00460592062345844,0.0181319124371357,0.0361871212810928,3.8156680300386e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGT,Angiotensinogen,39990,0.0129941527286681,0.00220539707661917,0.00867157445849454,0.0173167309988417,3.92395660168771e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0428386947017142,0.0072920215119154,0.0285463325383601,0.0571310568650684,4.33637550515849e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0216499503442401,0.00369811477077453,0.014401645393522,0.0288982552949582,4.92580078339087e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.0322920510024227,0.00552824049560367,0.0214566996310396,0.0431274023738059,5.30083524483028e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSN,Gelsolin,39943,0.0112134951273557,0.00191952879803846,0.00745121868320027,0.014975771571511,5.30597782604095e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSD,Cathepsin D,41225,0.0244199956368303,0.00418106114867902,0.0162251157854194,0.0326148754882411,5.32875445359299e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.02210917058223,0.0037866530788793,0.0146873305476266,0.0295310106168334,5.40517089645132e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL3,Follistatin-related protein 3,42084,-0.0192787938155876,0.00330490353901943,-0.0257564047520657,-0.0128011828791095,5.55579222449786e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD2,Sushi domain-containing protein 2,42137,-0.0166907728519208,0.00286524472853323,-0.0223066525198459,-0.0110748931839957,5.83221639996911e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.0216473519834674,0.00371816007603041,0.0143597582344478,0.0289349457324869,5.94290062140248e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0183269352198916,0.00314896735616326,-0.0244989112379716,-0.0121549592018116,6.01752945696676e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMS,Spermine synthase,39586,0.0378922950302389,0.00651327159526152,0.0251262827035263,0.0506583073569515,6.13264875654386e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,42310,-0.0191860238532589,0.00330846823978202,-0.0256706216032316,-0.0127014261032861,6.81551260282811e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.019874985241562,0.00342725566514399,-0.0265924063452442,-0.0131575641378798,6.85024845398593e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD1,Bromodomain-containing protein 1,39757,-0.017844614491314,0.00308273789093743,-0.0238867807575514,-0.0118024482250766,7.29051504223469e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGRN,Neugrin,39929,0.013153646181156,0.00227323358628901,0.00869810835202958,0.0176091840102825,7.38531178445323e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,42070,0.0125325429832417,0.00216642594085642,0.00828634813916308,0.0167787378273203,7.41705879172577e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0231477955459898,0.00400512841396866,-0.0309978472373684,-0.0152977438546112,7.6557408692174e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00942094137715344,0.00163049735788556,0.00622516655569775,0.0126167161986091,7.7256422318505e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.028766310047865,0.00498400745489587,0.0189976554362691,0.0385349646594609,8.0183345749355e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0177412155998301,0.0030763912152396,-0.0237709423816998,-0.0117114888179605,8.28575947707168e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD101,Immunoglobulin superfamily member 2,39930,0.0251942439952708,0.00437962512612148,0.0166101787480727,0.0337783092424689,9.01547037961675e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR3,Toll-like receptor 3,42296,0.0355092531287359,0.00617380384775162,0.0234085975871427,0.0476099086703291,9.02907986495973e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASS1,Argininosuccinate synthase,39575,0.0448895746350637,0.00784279094418576,0.0295177043844596,0.0602614448856678,1.06977117164198e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0298109933795093,0.00523282427747902,0.0195546577956504,0.0400673289633682,1.25104752710954e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF23,Fibroblast growth factor 23,42250,0.0290457331355897,0.00510429935934485,0.0190413063912738,0.0390501598799056,1.29313095052144e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0287350485777203,0.00505542132986598,0.0188264227711829,0.0386436743842576,1.34350777599067e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA2,Ephrin type-A receptor 2,41614,-0.0185676589319968,0.00326698760237531,-0.0249709546326524,-0.0121643632313412,1.34861884543889e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0500680291185366,0.00880873337124577,0.0328029117108949,0.0673331465261783,1.34902290091608e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0246933783116211,0.00434610415265916,-0.0332117424508331,-0.0161750141724092,1.36071875605281e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0201547521591766,0.00355204776833042,0.013192738533249,0.0271167657851042,1.42225122889714e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0172461278606765,0.00305440232864218,0.0112594992965378,0.0232327564248152,1.67215333463178e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0230393033127835,0.004096502484897,0.0150101584423853,0.0310684481831816,1.90090757063419e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLF4,Krueppel-like factor 4,39586,0.0231189128942577,0.00411356889445601,0.015056317861124,0.0311815079273915,1.95430653479891e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI1,Neuroserpin,39713,0.01647328753267,0.00293769523467206,0.0107154048727127,0.0222311701926272,2.10104536584136e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS1,"Nitric oxide synthase, brain",41839,-0.0332520403296816,0.00593214114629143,-0.0448790369764128,-0.0216250436829504,2.11922651421678e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVALB,Parvalbumin alpha,42208,0.0631606058723692,0.0112856205914504,0.0410407895131264,0.085280422231612,2.22875079000298e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0275931556412413,0.00493451143467056,-0.0372647980531956,-0.017921513229287,2.28968725078701e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFAP,Glial fibrillary acidic protein,41820,0.0256442926929405,0.00459737096140303,0.0166334456085906,0.0346551397772904,2.48026695358281e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,41820,0.0375779307501352,0.00673688989734891,0.0243736265513314,0.0507822349489391,2.4816855971671e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAC1,Cartilage acidic protein 1,42310,0.0174330873160367,0.00312934508038888,0.0112995709584745,0.0235666036735989,2.58283894827371e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.0227177398372759,0.00407988210102504,0.0147211709192668,0.0307143087552849,2.63204932864557e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.064640580991608,0.0116163394120459,0.0418725557439979,0.087408606239218,2.68684558604634e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.017558596250082,0.00316220810093817,-0.0237565241279208,-0.0113606683722432,2.87414515830448e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA7,Carbonic anhydrase 7,39757,-0.0188702637474785,0.00340024371603077,-0.0255347414308988,-0.0122057860640582,2.92728136818195e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0210220772766879,0.00379074910364115,0.0135922090335512,0.0284519455198246,2.99633885255773e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC16,Mucin-16,42070,0.106984397787697,0.0192965921088631,0.0691630772543253,0.144805718321069,3.00834855130809e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,39934,0.0203995519903059,0.00368150004164518,0.0131838119086813,0.0276152920719304,3.07295459380973e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0378405244299341,0.00683184171856306,0.0244501146615505,0.0512309341983177,3.10100475611589e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0219503396510365,0.00398769454533602,0.0141344583421779,0.0297662209598951,3.76889904052516e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMD,Dystrophin,39638,0.0286105591616734,0.00521434306888048,0.0183904467466677,0.0388306715766791,4.18087438140796e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0222362462585068,0.00405312663428899,0.0142921180553004,0.0301803744617132,4.18222898000501e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN1,Ficolin-1,39978,0.0308641879090123,0.0056493731873266,0.0197914164618521,0.0419369593561724,4.77218043872227e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOB,Elongin-B,39575,0.0216811283884629,0.00397764340761502,0.0138849473095374,0.0294773094673883,5.1243876647343e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDT,D-dopachrome decarboxylase,39966,0.0224359682884877,0.00412294913528461,0.0143549879833299,0.0305169485936456,5.38610765494948e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0245801738445637,0.0045195639015701,0.0157218285974863,0.0334385190916411,5.48390159204549e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR2,Interferon gamma receptor 2,42016,0.0289925779822701,0.00533755594591366,0.0185309683282794,0.0394541876362609,5.67584455250073e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS2,Thrombospondin-2,42137,-0.0212048472249112,0.00390387061832714,-0.0288564336368324,-0.01355326081299,5.67682004911217e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.0182528809385418,0.00336067361245646,0.0116659606581271,0.0248398012189564,5.69053636942761e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF2,Trefoil factor 2,42166,-0.0320368313411245,0.00590149064516825,-0.0436037530056543,-0.0204699096765948,5.77746706060556e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHPS,Deoxyhypusine synthase,39919,0.0221255832131968,0.0040802319281219,0.0141283286340778,0.0301228377923157,5.99358916263022e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0192530437525019,0.00355359358123543,0.0122880003332804,0.0262180871717233,6.13310644440987e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0375816240662196,0.00695820712222728,0.0239435381066542,0.0512197100257851,6.73769850402245e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEK,Angiopoietin-1 receptor,42181,0.0120724520093716,0.00223588105392902,0.0076901251436707,0.0164547788750725,6.79827909767604e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0167045835199573,0.00309456920169854,-0.0227699391552864,-0.0106392278846281,6.87349911863168e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0225958416541437,0.00419367750641282,0.0143762337415746,0.0308154495667128,7.24360825356456e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.016824496582162,0.00313146205983168,0.0106868309448919,0.0229621622194321,7.90898784476966e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,39586,0.041125998349399,0.00766991425967964,0.0260929664004269,0.0561590302983711,8.39788124629003e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.0305492869974015,0.00570049791988141,0.0193763110744339,0.0417222629203691,8.52998847657297e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP1,Guanylate-binding protein 1,39911,0.0351254941305869,0.00655593009987637,0.0222758711348292,0.0479751171263446,8.58849129627445e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0342165845696043,0.00639321618802488,0.0216858808410755,0.046747288298133,8.8430894251843e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0525483452607106,0.00982402017942602,0.0332932657090356,0.0718034248123856,9.02260155121753e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP6,Gastrotropin,41881,0.0306800821071706,0.00574632098907638,0.0194172929685809,0.0419428712457603,9.49562846195859e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA2,Annexin A2,39492,0.0381299242460641,0.00714768193819714,0.0241204676471977,0.0521393808449305,9.76819345933989e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICOSLG,ICOS ligand,42070,0.0102908044759806,0.00193291634713219,0.00650228843560147,0.0140793205163597,1.03151980665052e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0181286279817419,0.00342593367504345,0.0114137979786568,0.0248434579848271,1.23522123256396e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,42181,0.0158453102634954,0.00299861213184799,0.00996803048507335,0.0217225900419175,1.28197386862157e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.032105634438182,0.00608291972325442,0.0201831117806034,0.0440281570957607,1.32597181428401e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0137111871344573,0.00259759093856659,-0.0188024653740478,-0.00861990889486678,1.32700417569894e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.0280696874621951,0.00532109319862981,0.0176403447928807,0.0384990301315095,1.34681756200199e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0223673313889835,0.00424544097104709,-0.0306883956922358,-0.0140462670857312,1.40070145969423e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS7_LGALS7B,Galectin-7,42076,0.0233957271957034,0.00444689894612833,0.0146798052612918,0.0321116491301149,1.45363963327356e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,42119,-0.027879520099833,0.00530309846950957,-0.0382735931000718,-0.0174854470995943,1.48481823190632e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0196560041257063,0.00374002855635603,0.0123255481552485,0.0269864600961641,1.49802011594036e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.0552766492105667,0.0105409388741717,0.0346164090171901,0.0759368894039433,1.59965713195113e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM25,Transmembrane protein 25,39934,-0.024853452775571,0.00474966454480703,-0.0341627952833928,-0.0155441102677493,1.70057476288608e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,41814,0.0283516202346697,0.00543488156856241,0.0176992523602873,0.039003988109052,1.84989253729368e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.0287673395215449,0.00553348493112566,0.0179217090565386,0.0396129699865512,2.04190305955294e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR15L,Protein GPR15L,39930,0.0328236947885102,0.00631903749649525,0.0204383812953795,0.0452090082816409,2.08931180523546e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTB,Lymphotoxin-beta,39919,0.0180660340638091,0.00348316504242209,0.0112390305806618,0.0248930375469564,2.17784074380301e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0179951052717549,0.0034725850950359,0.0111888384854845,0.0248013720580252,2.2322709917764e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD48,CD48 antigen,42166,-0.0160910452736021,0.00310546838069329,-0.022177763299761,-0.0100043272474433,2.23242018336768e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYY,Peptide YY,39575,0.0525257982293073,0.0101501024932508,0.0326315973425356,0.0724199991160789,2.32057194402099e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0361665633520795,0.00699744479767135,0.0224515715486437,0.0498815551555154,2.39306597987692e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0149540291579072,0.00289987350368488,-0.0206377812251295,-0.00927027709068478,2.54755441649792e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POF1B,Protein POF1B,39657,-0.0237708168182688,0.00461023302420945,-0.0328068735457193,-0.0147347600908183,2.56506551463469e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN4,CCN family member 4,42262,0.0203412786673255,0.00395150389647311,0.0125963310302382,0.0280862263044128,2.6731680820193e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGF,Hepatoma-derived growth factor,42243,0.0473068119705558,0.00923090891981249,0.0292142304877233,0.0653993934533882,3.01880212498697e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5,T-cell surface glycoprotein CD5,42239,0.018386925296184,0.003593073673318,0.0113445008964808,0.0254293496958873,3.14111222866649e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0399406977672529,0.00780815710075014,-0.0552446856847232,-0.0246367098497826,3.18431874047359e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP8,Caspase-8,42224,0.0315529544472194,0.00617122704152854,0.0194573494458234,0.0436485594486153,3.21527953014571e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH6,Cadherin-6,42145,-0.0200811425291328,0.00393322249223879,-0.0277902586139209,-0.0123720264443448,3.34361933964035e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTN,Pleiotrophin,41900,0.0256851540160853,0.00503471176859008,0.0158171189496488,0.0355531890825219,3.4140818426923e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0431301559719601,0.00847197778967062,0.0265250795042057,0.0597352324397145,3.62051902859816e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK4,Kallikrein-4,42262,-0.0321856125368023,0.00632444788146416,-0.0445815303844721,-0.0197896946891326,3.64585230040818e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,39638,0.0405884753235857,0.00798691045168185,0.0249341308382892,0.0562428198088821,3.79845082674233e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,39736,0.0118793467575043,0.00234624483961524,0.0072807068718584,0.0164779866431501,4.19019183216061e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX,Glutaredoxin-1,42057,0.0284171705887413,0.00561318563737036,0.0174153267394954,0.0394190144379872,4.19097048946113e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF4,Neurotrophin-4,41843,0.0193538473586866,0.00382315561151745,0.0118604623601124,0.0268472323572608,4.19854036913387e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH1,Acid ceramidase,39876,0.0242511547179971,0.00479257816231525,0.0148577015198593,0.033644607916135,4.25530999082542e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL4,Myosin light chain 4,39638,-0.0264157553339145,0.00522474342466054,-0.0366562524462491,-0.0161752582215798,4.35249028183392e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENSA,Alpha-endosulfine,39919,0.027108589287996,0.00536684827178943,0.0165895666752887,0.0376276119007033,4.46074747561397e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0256010000465313,0.00508576179008109,0.0156329069379724,0.0355690931550903,4.86804136349357e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0217921553013258,0.00432913977268372,0.0133070413468657,0.0302772692557859,4.86914740222324e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,39638,0.0205080077711888,0.00407607941321836,0.0125188921212808,0.0284971234210968,4.94815571339691e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0176341803404908,0.0035095729328787,-0.0245129432889331,-0.0107554173920486,5.10929218269322e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.051801561519225,0.0103270662298674,0.0315605117086848,0.0720426113297652,5.34066339447563e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0314502254855371,0.00627312830855324,0.0191548940007728,0.0437455569703015,5.42832996573085e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,39575,0.0222150993808672,0.0044340286614101,0.0135244032045034,0.030905795557231,5.52379618173113e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGMN,Legumain,42185,0.0183634482943369,0.00366846922804268,0.0111732486073732,0.0255536479813005,5.63412624327664e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC2,Mucin-2,39966,0.0470579545076563,0.00940116935269738,0.0286316625763694,0.0654842464389431,5.65395183336372e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,39934,-0.039686149152159,0.00793792755069017,-0.0552444871515117,-0.0241278111528063,5.83205509228922e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0218828450586102,0.00437822403282428,0.0133015259542746,0.0304641641629458,5.87832411386837e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDHB15,Protocadherin beta-15,39919,-0.0200839862263629,0.00403397515848399,-0.0279905775369916,-0.0121773949157343,6.49531939158263e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDA,Cytidine deaminase,39946,0.024035820904045,0.00482800800626825,0.0145729252117593,0.0334987165963308,6.50497121893528e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB1,Carboxypeptidase B,42310,0.0311975407097352,0.00627110400832299,0.0189061768534221,0.0434889045660483,6.6103557887207e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0163933601440317,0.00329726653209206,0.00993071774113128,0.0228560025469322,6.73284113319832e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAM,Integrin alpha-M,42137,-0.015854255768914,0.00319222091294783,-0.0221110087582918,-0.00959750277953627,6.89931755348331e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.0157227834951282,0.00316567517398766,-0.0219275068361441,-0.00951806015411242,6.91484278649166e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAM,Basal cell adhesion molecule,42137,-0.0123208957293173,0.00248142110040252,-0.0171844810861062,-0.00745731037252833,6.94455575728433e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0204632805817696,0.00412135740160569,0.0123854200746225,0.0285411410889168,6.94936019115727e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00923548307227215,0.00186358064384709,0.00558286501033185,0.0128881011342124,7.30804167631175e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0144593382434669,0.00291884734146445,-0.0201802790327372,-0.0087383974541966,7.36707524797818e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,39736,0.0263500570655076,0.00532422070342116,0.0159145844868021,0.0367855296442131,7.56518677681767e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM,Paralemmin-1,39859,0.0153406860167801,0.00310166709716293,0.00926141850634077,0.0214199535272194,7.68681246944757e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0214751833408068,0.00435180746177733,0.0129456407157232,0.0300047259658904,8.12144347808495e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN1,Tetraspanin-1,41900,0.0362762518466466,0.00736561508954351,0.0218396462711414,0.0507128574221519,8.5338517803349e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.0238888166882054,0.00485699105553143,0.0143691142193638,0.033408519157047,8.85017010895951e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.0253480457445867,0.00515557291852317,0.0152431228242812,0.0354529686648921,8.93213810350701e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE6,Ribonuclease K6,39937,-0.016063548263181,0.00327044666056847,-0.0224736237178952,-0.00965347280846683,9.1536886398221e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAA4,Serum amyloid A-4 protein,39979,0.0163973996460096,0.00334604750827726,0.00983914652978617,0.022955652762233,9.68969726115618e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAM,Signal transducing adapter molecule 1,39919,0.0179386030682754,0.00366225972897054,0.0107605739994932,0.0251166321370577,9.80398211275122e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPA,Apolipoprotein(a),39775,-0.090735034508312,0.0185373358313098,-0.127068212737679,-0.0544018562789448,9.98223684121433e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,42093,0.020287185151121,0.00414685767260171,0.0121593441128216,0.0284150261894203,1.00874536493015e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO4,Roundabout homolog 4,39638,-0.00899397967075313,0.00184893443971916,-0.0126178911726027,-0.00537006816890357,1.16382876270607e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRELP,Prolargin,42123,0.0114949787093749,0.00236475129861934,0.00686006616408104,0.0161298912546688,1.18125560393382e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGN,Biglycan,41820,-0.0576277674224637,0.0119133767457541,-0.0809779858441418,-0.0342775490007857,1.33144146610712e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX6,Syntaxin-6,41843,0.0320293349992873,0.00662255454277962,0.0190491280954392,0.0450095419031353,1.33697568466034e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX5,Sorting nexin-5,39638,0.0145773526502177,0.00301984855176717,0.00865844948875404,0.0204962558116814,1.40336539036361e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0241251810645066,0.00502371064657127,0.014278708197227,0.0339716539317863,1.58558597512324e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP13,Collagenase 3,41839,-0.0156470078464747,0.00325843009835147,-0.0220335308392436,-0.0092604848537058,1.58801571291162e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,39934,0.0141708868861348,0.00295177721986525,0.0083854035351989,0.0199563702370707,1.60054327023825e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0261905016800814,0.00546064200495581,0.015487643350368,0.0368933600097948,1.6374027652015e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN4,Nectin-4,42181,-0.0162866601220076,0.00339631950173516,-0.0229434463454086,-0.00962987389860673,1.6408547594389e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP10,Bone morphogenetic protein 10,39736,0.0137001969014192,0.00287083873189579,0.00807335298690342,0.0193270408159349,1.84547271743716e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTPN,Myotrophin,41900,0.0156694622001065,0.00328611594826532,0.00922867494150644,0.0221102494587065,1.87678757516577e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,42199,0.014025154775303,0.00294216314801007,0.00825851500520328,0.0197917945454028,1.88969561820944e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,39638,0.0119390619785198,0.00250555354747999,0.00702817702545906,0.0168499469315806,1.91224315106114e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1B,Interleukin-1 beta,41825,0.0271831272383554,0.0057061507922433,0.0159990716855585,0.0383671827911523,1.9197146213421e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPL,Periplakin,39657,0.0156076549229277,0.00327646259955906,0.00918578822779198,0.0220295216180635,1.92617088325124e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS2,Growth arrest-specific protein 2,39757,0.0251497803726621,0.00528590597514202,0.0147894046613837,0.0355101560839404,1.98076745845452e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.0300390971862312,0.00632282516411973,0.0176463598645565,0.0424318345079058,2.05065749923764e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0270039795343183,0.00569153829942325,0.0158485644674488,0.0381593946011879,2.11571181581006e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FEN1,Flap endonuclease 1,41843,0.0306958344865075,0.00649299471170102,0.0179695648515735,0.0434221041214415,2.29607309444124e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0291270535989316,0.00617097244296458,0.017031947610721,0.0412221595871421,2.3874845807436e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSH,Pro-cathepsin H,41865,0.0355960559813006,0.00754751007234425,0.0208029362395058,0.0503891757230953,2.42661454087503e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0244126647712355,0.005180085140466,0.0142596978959221,0.0345656316465489,2.46832208571862e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QL2,Complement C1q-like protein 2,39657,0.0205689109860187,0.00436934525281908,0.0120049942904933,0.0291328276815441,2.53757279612874e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD72,B-cell differentiation antigen CD72,39736,0.0207533398770739,0.00440949678073819,0.0121107261868271,0.0293959535673208,2.55030431927533e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSA,Arylsulfatase A,42137,0.0214609472788179,0.00456036514021196,0.0125226316040025,0.0303992629536334,2.55161521162274e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A13,Protein S100-A13,39657,0.0169710935494627,0.00361351203791437,0.00988860995515049,0.0240535771437748,2.67758227882163e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,39657,-0.0596843402509484,0.0127202105889211,-0.0846159530052338,-0.034752727496663,2.7367500346376e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF5,Fibroblast growth factor 5,41913,-0.0161596943961822,0.0034473465657641,-0.0229164936650799,-0.00940289512728461,2.79203431303955e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL19,Interleukin-19,41756,-0.0347622584497262,0.00741946938840035,-0.0493044184509909,-0.0202200984484615,2.82383990068991e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.027096538872879,0.00578957314923011,0.015748975500388,0.03844410224537,2.89379355151941e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA7,Thyroxine-binding globulin,39979,0.00872140882127056,0.00186433754300333,0.00506730723698403,0.0123755104055571,2.92994395671434e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,39649,-0.0149173071572049,0.00319145150090021,-0.0211725520989693,-0.00866206221544047,2.98671637485642e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0457724631439136,0.00983786527241813,0.0264902472099741,0.0650546790778531,3.30781668223306e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0267256105588218,0.00574458845061918,0.0154662171956082,0.0379850039220354,3.31414375706028e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECM1,Extracellular matrix protein 1,39720,0.0172308409095595,0.00370387747450722,0.00997124105952533,0.0244904407595936,3.32348710778479e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.0173182959745414,0.00372754778333654,0.0100123023192018,0.024624289629881,3.4162756554819e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0148567117327927,0.00320578108046426,-0.0211400426505026,-0.00857338081508273,3.614188423193e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWF,von Willebrand factor,42310,-0.0346424244681694,0.00748611600060737,-0.0493152118293599,-0.019969637106979,3.73395431498076e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0186530316792998,0.00403202270278178,-0.0265557961767521,-0.0107502671818476,3.76522044692548e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARCO,Macrophage receptor MARCO,42145,0.0120154639288222,0.00261134203755932,0.00689723353520591,0.0171336943224385,4.23752774158985e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0184424107780807,0.00400883358124422,0.010585096958842,0.0262997245973193,4.26237309185236e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC13,Mucin-13,41839,0.0244368976998851,0.00531712941963052,0.0140153240374093,0.0348584713623609,4.34905684603709e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0194743216212252,0.00424995022008938,-0.0278042240526004,-0.01114441918985,4.64343533889282e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.0415668787281169,0.00907820185096942,0.0237736031002169,0.059360154356017,4.71905715594679e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.0109374693094444,0.00239338582057538,-0.0156285055177721,-0.00624643310111664,4.93316168347998e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0162675143309324,0.00356180843340212,-0.0232486588604006,-0.00928636980146428,4.98600052162046e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN2,Calsyntenin-2,42296,-0.0184583731061095,0.00404536073868231,-0.0263872801539268,-0.0105294660582922,5.09023670409128e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0197810090687283,0.00433965491529274,-0.0282867327027021,-0.0112752854347545,5.20500784844216e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVR,Poliovirus receptor,42249,0.0172143195000349,0.00377702936548804,0.00981134194367831,0.0246172970563914,5.21819808389621e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0192923968160221,0.00424000232406208,-0.0276028013711838,-0.0109819922608604,5.40852081903473e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANPEP,Aminopeptidase N,42187,0.0125307777871828,0.00275773629358679,0.00712561465175271,0.0179359409226129,5.57084137593816e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6,Interleukin-6,42070,-0.0342556876397271,0.00755153038355587,-0.0490566871914966,-0.0194546880879576,5.77558364310763e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0293585643234125,0.00647494169377049,0.0166676786036223,0.0420494500432026,5.84360805855791e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGA,Glycoprotein hormones alpha chain,42137,-0.028333196234061,0.00625433680175484,-0.0405916963655004,-0.0160746961026215,5.94407717895413e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0157493285327264,0.00348119659513228,0.00892618320626713,0.0225724738591857,6.11676911971657e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0180039606253761,0.00397988297660996,0.0102033899912206,0.0258045312595316,6.13895079523196e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0248495817587328,0.00549512959382871,0.0140791277548285,0.035620035762637,6.18607950032257e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD160,CD160 antigen,42296,-0.0221255178110042,0.00489509047025355,-0.0317198951327011,-0.0125311404893072,6.23752566540497e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0549743615953088,0.0121642631528539,0.031132405815715,0.0788163173749025,6.26629904159999e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOF,Apolipoprotein F,39990,0.01185628143174,0.00262517727622015,0.00671093397034854,0.0170016288931315,6.35398781158939e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMA,Granzyme A,42296,0.0154688485896578,0.00342763969758585,0.00875067478238954,0.0221870223969261,6.44572961504126e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,42217,0.0149331761105177,0.00330912026561921,0.00844730038990409,0.0214190518311314,6.45335884248776e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST5,Cystatin-D,41846,0.0255946289942584,0.0056876910312144,0.0144467545730782,0.0367425034154387,6.85311892888939e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CABP2,Calcium-binding protein 2,39649,0.0297645268237008,0.00662941943452383,0.0167708647320341,0.0427581889153676,7.20244585369163e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0262042795437418,0.00583906016040869,0.0147597216293408,0.0376488374581428,7.27058466080337e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFIC,Nuclear factor 1 C-type,39934,0.0207081473329214,0.00463749642093742,0.011618654347884,0.0297976403179587,8.07025476755894e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0231216991422259,0.00518775887999551,-0.0332897065470171,-0.0129536917374347,8.37989746490164e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPS,Colipase,42115,0.0331837488762185,0.00745710021153379,0.0185678324616122,0.0477996652908247,8.65757693590074e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.022056809605081,0.00495958428492578,0.0123360244066265,0.0317775948035355,8.78023004701635e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0252748228326071,0.00568826396620162,0.0141258254588519,0.0364238202063622,8.94278694886877e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18BP,Interleukin-18-binding protein,42217,-0.0140863170384703,0.00317348216740598,-0.020306342086586,-0.0078662919903546,9.11910298755287e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0104405108344011,0.00235231804613496,0.00582996746397657,0.0150510542048256,9.14870015675838e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,41839,0.0384718909655552,0.00867336685349454,0.0214720919327059,0.0554716899984045,9.25415090187106e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.0124304332172465,0.00280743579359693,0.00692785906179653,0.0179330073726965,9.61666644114915e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0266888007131571,0.00603370391511402,-0.0385148603867806,-0.0148627410395336,9.7981982521645e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,39575,0.0541064280542583,0.0122334594482035,0.0301288475357794,0.0780840085727372,9.83572624248524e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0161342680882009,0.00365190005759846,0.00897654397530791,0.0232919922010939,1.00551302217145e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,41740,-0.0446496416770828,0.0101278975266351,-0.0645003208292877,-0.024798962524878,1.04876638503955e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCOR1,REST corepressor 1,41900,0.0198950675215661,0.00451464951345035,0.0110463544752034,0.0287437805679288,1.05739998605732e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1,Integrin beta-1,42167,0.00938194368348798,0.00213253251937485,0.00520217994551328,0.0135617074214627,1.0935938607849e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD14,Monocyte differentiation antigen CD14,41932,0.0183391987471673,0.00416875515279731,0.0101684386476845,0.02650995884665,1.0949229272132e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.0199455463275076,0.00453566526941898,0.0110556423994464,0.0288354502555688,1.10533059199499e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0146524810349965,0.00334426037401542,-0.0212072313680667,-0.0080977307019263,1.18986285214255e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0408782661526253,0.00933354462836078,0.0225845186810382,0.0591720136242124,1.19930056650266e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0277495127459776,0.00634086474220566,0.0153214178512545,0.0401776076407006,1.21615573334126e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MB,Myoglobin,42310,-0.0248200538215308,0.00567195121185576,-0.0359370781967681,-0.0137030294462935,1.21810420037053e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.0131470234888594,0.00300675739746335,0.00725377898983123,0.0190402679878876,1.23969426323554e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.0139461535114555,0.00319018597351645,0.00769338900336322,0.0201989180195477,1.2447961573147e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGR1,Prostaglandin reductase 1,39958,0.0370142139293697,0.00847734492084051,0.0203986178845223,0.0536298099742171,1.27516326738567e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPB2,Coatomer subunit beta',39575,0.0190445130809009,0.00436539889904533,0.010488331238772,0.0276006949230297,1.29696468762802e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0432257878910877,0.00990840571428303,0.023805312691093,0.0626462630910824,1.29736923029046e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0134407126776087,0.00308258564456656,0.00739884481425821,0.0194825805409591,1.30892156130847e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,39795,-0.00362172670473869,0.000831016098419538,-0.00525051825764099,-0.0019929351518364,1.32311675077903e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD109,CD109 antigen,42137,-0.0150095813907825,0.0034497110811878,-0.0217710151099106,-0.0082481476716544,1.36530841775485e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0196946268126303,0.00453508035888012,0.0108058693092252,0.0285833843160353,1.41947939480409e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPH,Hephaestin,39958,0.0122790083711184,0.00282838167559184,0.00673538028695843,0.0178226364552784,1.42833316517363e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG2,Secretogranin-2,42193,0.014468625814443,0.00333383777541211,0.00793430377463522,0.0210029478542507,1.43557115797368e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR4,Proline-rich protein 4,39652,-0.0312497973395825,0.00720944578512526,-0.045380311078428,-0.017119283600737,1.47342249585018e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL11,C-X-C motif chemokine 11,42249,0.0341656606788321,0.00788590922719034,0.018709278593539,0.0496220427641251,1.48482878521037e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0295742461640095,0.00683096421858525,0.0161855562955824,0.0429629360324366,1.50563123491278e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APRT,Adenine phosphoribosyltransferase,42002,0.0205863118169929,0.00475882261141129,0.0112590194986267,0.029913604135359,1.52992091318542e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0308880654765076,0.00714419084414252,0.0168854514219882,0.0448906795310269,1.54890754108236e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0193630622371988,0.00447950844361852,0.0105832256877066,0.0281428987866911,1.55570335182142e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA1,BolA-like protein 1,39586,0.023901452568931,0.00552976390908928,0.013063115307116,0.034739789830746,1.55751119910624e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0151492782254095,0.00350749974284907,0.00827457872942529,0.0220239777213936,1.57994514230293e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH3,Neurexophilin-3,39657,0.0131355741693155,0.00304518889795087,0.00716700392933176,0.0191041444092992,1.62048605820181e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLO1,Lactoylglutathione lyase,41900,0.0245844159155615,0.00571293679530787,0.0133870597967581,0.0357817720343649,1.69484292237096e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0246167807559293,0.00572128434702299,0.0134030634357643,0.0358304980760944,1.69965280820129e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS4,Thrombospondin-4,42189,0.0197460986178976,0.00459494111899366,0.01074001402467,0.0287521832111251,1.74050166040615e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSZ,Cathepsin Z,42168,0.0140104988554499,0.00326132704406989,0.00761829784907294,0.0204026998618269,1.75157406849132e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.0193153533080465,0.00449712650559965,0.0105009853570712,0.0281297212590218,1.76114858439286e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP9,Fatty acid-binding protein 9,42119,0.0243713009250318,0.00569297587323635,0.0132130682134886,0.035529533636575,1.87386561501362e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCOF1,Treacle protein,39958,0.0140740462020274,0.00328918690496744,0.00762723986829117,0.0205208525357635,1.8937259479662e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XG,Glycoprotein Xg,42261,0.0149809463417731,0.00350219109768521,0.00811665179031009,0.0218452408932361,1.90210407781922e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,42070,0.0158142712556788,0.00371549198821925,0.00853190695876901,0.0230966355525885,2.09238675130389e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD1,Leiomodin-1,39934,-0.0149649393528268,0.00351753386523712,-0.0218593057286915,-0.00807057297696203,2.11309371730761e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0256485629079516,0.00603127534338476,0.0138272632349174,0.0374698625809857,2.13000014847951e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,39736,0.0105899246488522,0.0024962182258032,0.00569733692627788,0.0154825123714264,2.22943404741741e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD274,Programmed cell death 1 ligand 1,42016,0.014474269872131,0.00341365394175762,0.00778350814628602,0.0211650315979759,2.24905957504658e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRH,Corticoliberin,41830,0.0366657143821425,0.00865791422423253,0.0196962025026467,0.0536352262616382,2.301619935437e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEG1,Protein LEG1 homolog,39398,-0.030366569292437,0.00717141214582224,-0.0444225370982485,-0.0163106014866254,2.31069197762843e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,42249,0.0202175587751153,0.00477739864017271,0.0108538574403768,0.0295812601098538,2.33220962048141e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITM2A,Integral membrane protein 2A,42119,-0.0265249920775278,0.00626820431886266,-0.0388106725424986,-0.014239311612557,2.33489176348633e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0820144976337609,0.0194114347346209,0.0439680855539038,0.120060909713618,2.40446050382544e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.0129535462848663,0.0030711414300349,0.00693410908199794,0.0189729834877348,2.48632330481215e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0189893984245381,0.00450641106625673,-0.0278219641144013,-0.0101568327346749,2.5266333804528e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSS,Cathepsin S,39358,0.0103431458750675,0.00245901223618351,0.00552348189214786,0.0151628098579872,2.61782285445519e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYZL2,Lysozyme-like protein 2,39560,0.0155285056635915,0.00369266046300811,0.00829089115609563,0.0227661201710874,2.62883638139551e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.0128184160785458,0.00305015573172333,0.00684011084436812,0.0187967213127236,2.65662431080516e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIPF,Gastric triacylglycerol lipase,39638,0.0267765585952224,0.0063729159294583,0.0142856433734841,0.0392674738169606,2.67098434892025e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCND2,G1/S-specific cyclin-D2,39757,0.0158161435418266,0.00376458711012767,0.00843755280597637,0.0231947342776768,2.67456190187549e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP2,Neuropilin-2,42137,-0.0119390110286669,0.00284345624016155,-0.0175121852593835,-0.00636583679795027,2.70087771377411e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.0239908102685829,0.00571463857000464,0.0127901186713738,0.035191501865792,2.71180636487393e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP8,GTPase IMAP family member 8,39560,0.0213681026631887,0.00509125783917234,0.0113892372984109,0.0313469680279665,2.72585470655827e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.013359426169552,0.00318871365858993,0.00710954739871575,0.0196093049403883,2.81220822407141e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0144175350435414,0.00344725720684688,-0.0211741591689613,-0.00766091091812148,2.90398491045446e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0276245075207452,0.00660554992599539,0.0146776296657942,0.0405713853756962,2.91114016305741e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CX3CL1,Fractalkine,42016,-0.0141303290831665,0.00338019425414776,-0.0207555098212961,-0.00750514834503694,2.9293236191914e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,39945,0.0209889367363848,0.00502720949522966,0.0111356061257346,0.0308422673470349,3.00123353308965e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB2A2,Mammaglobin-A,39575,-0.013182012059558,0.00315908092589926,-0.0193738106743205,-0.00699021344479544,3.03282036772138e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY75,Lymphocyte antigen 75,42119,0.0163001756236691,0.00390757410371055,0.00864133038039648,0.0239590208669418,3.04582941896291e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.0163162022286462,0.00392051690977214,0.00863198908549281,0.0240004153717996,3.17817392939443e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,39934,0.0151458831051269,0.00365000547890559,0.00799187236647198,0.0222998938437819,3.35561476797718e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,39958,-0.016197266152895,0.00390587696561172,-0.023852785005494,-0.00854174730029606,3.39463105208626e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.00804482744450605,0.00194549861807251,-0.0118580047359282,-0.00423165015308392,3.56928690201408e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.0298628958139446,0.00723672443387607,0.0156789159235475,0.0440468757043417,3.70907624499042e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK3,NT-3 growth factor receptor,42249,0.00883636564349661,0.00214331738267457,0.00463546357345444,0.0130372677135388,3.76587243164554e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0129475007534695,0.00314334363196794,-0.0191084542721267,-0.00678654723481235,3.82716921806221e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0196377725448767,0.00477156654270444,0.010285502121176,0.0289900429685774,3.89008476110056e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RETN,Resistin,42105,-0.0177981609419695,0.00434194170254262,-0.026308366678953,-0.00928795520498593,4.17140829574949e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,42119,0.0204582638803913,0.00499117199499688,0.0106755667701975,0.0302409609905852,4.17561533467893e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.0168254941992156,0.00411269967260997,-0.0248863855575311,-0.00876460284090006,4.32387326300023e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIP,Gastric inhibitory polypeptide,39638,0.020990231130831,0.00513412034540755,0.0109273552538322,0.0310531070078298,4.37476498166121e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0201129372426474,0.00492020055359753,-0.0297565303276985,-0.0104693441575962,4.37946803437537e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0347896990141079,0.0085099339940107,-0.0514691696423689,-0.0181102283858469,4.37964484612926e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL12,Stromal cell-derived factor 1,41913,0.0163169887769511,0.0039937331872099,0.0084892717300197,0.0241447058238825,4.42114701024674e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_DRA,,42060,-0.0149316008558156,0.00367321609574474,-0.0221311044034752,-0.00773209730815586,4.83067752728916e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,39638,0.0211980331893797,0.00522880023368536,0.0109495847313563,0.031446481647403,5.06750586137569e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.0229646974531134,0.00566659539794809,0.0118581704731351,0.0340712244330916,5.09907015779904e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTNB,Dystrobrevin beta,39900,0.018654251161033,0.00460647611337492,0.00962555797881817,0.0276829443432479,5.16542383280412e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0143965409087971,0.00355853361530692,0.00742181502279554,0.0213712667947987,5.24669465310001e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA3,Carbonic anhydrase 3,42287,-0.0240278784116679,0.00594567093187679,-0.0356813934381464,-0.0123743633851894,5.34601665445243e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0164525927589236,0.00407370293961661,0.00846813499727501,0.0244370505205721,5.40952443755513e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0173615395029344,0.00431181904448496,-0.0258127048301249,-0.00891037417574383,5.69218598159529e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTN,Titin,39575,-0.0282611082692417,0.0070261818832566,-0.0420324247604246,-0.0144897917780588,5.80293704335687e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDCP1,CUB domain-containing protein 1,42016,0.0227544139412092,0.005664636717279,0.0116517259753424,0.0338571019070761,5.92842062016018e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.015489892623793,0.00386301277798324,0.00791838757894589,0.0230613976686402,6.11706889140632e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMB,RGM domain family member B,42249,0.0113383856435901,0.00283262008544871,0.00578645027611061,0.0168903210110695,6.29306051458939e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSL,Cathepsin L1,42145,0.00989862150670616,0.00247353354161757,0.00505049576513573,0.0147467472482766,6.31932392797477e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0160260103240013,0.00401411651147062,-0.0238936786864837,-0.00815834196151891,6.57455934669918e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.0307894298699459,0.00772273970185279,0.0156528600543144,0.0459259996855774,6.73745634140873e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A12,Protein S100-A12,41910,0.0295605196097604,0.00742434459336204,0.0150088042067708,0.04411223501275,6.8826421821066e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,39757,0.0288947406203285,0.00726184145633974,0.0146615313659026,0.0431279498747544,6.96486141552809e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0115057381543875,0.0028919712086857,-0.0171740017234114,-0.0058374745853635,6.97790129794479e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0191745642643955,0.00483457139325051,0.00969880433362454,0.0286503241951665,7.34967015894807e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0108972065095844,0.00275533072826324,-0.0162976547369804,-0.0054967582821885,7.6936937199061e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA10,Annexin A10,41839,-0.0325714712396209,0.00825801499610491,-0.0487571806319865,-0.0163857618472553,8.0471060204148e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST2,Bone marrow stromal antigen 2,42249,0.0202852388454098,0.0051517823374072,0.0101877454640917,0.0303827322267279,8.27375128760915e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.0108303251302625,0.00275118310187541,0.00543800625058666,0.0162226440099383,8.31360864665011e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.0229825229945339,0.00584001645319229,0.011536090746277,0.0344289552427908,8.34936717767904e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL1,Chordin-like protein 1,42166,0.0129868893495911,0.00330567046174846,0.00650777524456416,0.0194660034546181,8.58401389661748e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.02226875515093,0.0056772133343236,-0.0333960932862042,-0.0111414170156557,8.81760788975888e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD6,Programmed cell death protein 6,42145,-0.0279331480988887,0.00713366167071406,-0.0419151249734883,-0.0139511712242892,9.05909966402588e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNC,Tenascin,42217,-0.0191175022649067,0.00488388586256143,-0.0286899185555271,-0.00954508597428628,9.10690980897249e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XCL1,Lymphotactin,42262,0.0215775265454129,0.00551251564063103,0.0107729958897761,0.0323820572010497,9.11146074218132e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.021356139273469,0.00546801330637843,0.0106388331929673,0.0320734453539707,9.44395047912418e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0287165285024739,0.00735693060460022,0.0142969445174575,0.0431361124874904,9.53421053356529e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG4,Desmoglein-4,42018,0.0189090408521573,0.00484775357349396,0.00940744384810914,0.0284106378562055,9.64312302539139e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,39966,-0.00932332433465275,0.00239100896104662,-0.0140097018983041,-0.00463694677100137,9.70154327325087e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F3,Tissue factor,42174,-0.0102840048557581,0.0026414054683391,-0.0154611595737028,-0.00510685013781351,9.93287882298004e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN1,Nectin-1,39657,0.0130328853881914,0.00334960708894127,0.00646765549386651,0.0195981152825163,0.000100471193643577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LF,CMRF35-like molecule 1,42262,0.0235866274818169,0.00606936451643073,0.0116906730296127,0.0354825819340212,0.000102315978438868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS22,Brain-specific serine protease 4,39657,0.0136547674654917,0.00351586932140635,0.00676366359553528,0.0205458713354482,0.000103455435463737
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCP1,Plastin-2,39966,0.0187945215247008,0.00485632189156609,0.00927613061723125,0.0283129124321703,0.000109392361507414
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0138022975432653,0.00357530164790019,0.00679470631338097,0.0208098887731497,0.00011370365747991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTL1,Cytokine-like protein 1,39966,0.00998684056997926,0.00258809156629493,0.0049141811000412,0.0150595000399173,0.000114590831348826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS9,Galectin-9,42129,0.012197618800895,0.00317286995665044,0.00597879368586016,0.0184164439159299,0.000121426307347007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA9,Serpin A9,42025,0.0280556612497739,0.00731261741426414,0.0137229311178162,0.0423883913817316,0.000125315437999742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0184171007624582,0.00480122670001342,-0.0278275050944845,-0.00900669643043186,0.000125793672482216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,39757,0.0173527359590406,0.00452384144771191,0.0084860067215253,0.026219465196556,0.000125824472493962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0303494606931503,0.00793284953934773,0.0148010755960288,0.0458978457902719,0.000130949007996011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0200748804043706,0.00524744574409184,0.00978988674595056,0.0303598740627906,0.000131008062068255
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN3,Perilipin-3,42145,-0.0165201028810327,0.00433034606599591,-0.0250075811703847,-0.00803262459168077,0.000136809235725721
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG3,Desmoglein-3,42196,0.0135452504426757,0.00355248665351206,0.00658237660179203,0.0205081242835593,0.000137956289832498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.0138399885846133,0.00363201740240772,-0.0209587426933325,-0.00672123447589422,0.000139409223291693
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP4,Bone morphogenetic protein 4,41992,-0.0182312323802636,0.00478927308833804,-0.0276182076334062,-0.00884425712712106,0.000141472109536515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL34,Interleukin-34,41814,0.0140446163429757,0.00369029625704829,0.00681163567916108,0.0212775970067904,0.00014197085013698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0931348339809496,0.0244756039834388,0.0451626501734096,0.14110701778849,0.000142428852500438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASET2,Ribonuclease T2,42258,-0.010284792048594,0.00271058032718772,-0.0155975294898819,-0.00497205460730604,0.000148691351352497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NADK,NAD kinase,42145,0.0208942812455079,0.00552547628382437,0.0100643477292122,0.0317242147618037,0.000156590956075723
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",39929,0.0227544487738283,0.00601824276305852,0.0109586929582336,0.034550204589423,0.000157057089929491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTXR,Neuronal pentraxin receptor,42145,0.0130448218638775,0.00345138461766179,0.00628010801326041,0.0198095357144946,0.000157759900207866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2,Brorin,41973,0.015626859268947,0.00414306677773989,0.00750644838457679,0.0237472701533172,0.000162766396230551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0150649280577244,0.00399674837520275,-0.0228985548731218,-0.00723130124232698,0.000164566467664518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN4B,Sodium channel subunit beta-4,39638,0.0166335502210795,0.00441304069820681,0.00798399045259419,0.0252831099895649,0.000164637201277638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB37,Ras-related protein Rab-37,41913,0.0309490287795006,0.00821410661914738,0.0148493798059717,0.0470486777530294,0.000165409369393913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP1,Interstitial collagenase,41693,0.0343304783024583,0.00911190277080986,0.016471148871671,0.0521898077332456,0.00016551269430109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP9,Matrix metalloproteinase-9,42125,-0.022652527308341,0.00605066258716046,-0.0345118259791755,-0.0107932286375065,0.000182002223180168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JCHAIN,Immunoglobulin J chain,41913,-0.0231687170039243,0.00619920963051956,-0.0353191678797426,-0.0110182661281059,0.000186735702472816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERC2,ERC protein 2,39649,0.0278827859439917,0.00747148486336035,0.0132386756118054,0.042526896276178,0.000190998579931047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0209758925500995,0.00562219130557767,0.00995639759116728,0.0319953875090317,0.000191735257176754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAP,Cartilage-associated protein,39649,0.0185765545206566,0.00499903741567627,0.00877844118593116,0.0283746678553821,0.000203378962350974
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXN,Thioredoxin,39854,0.016153661750782,0.00435728838571701,0.00761337651477667,0.0246939469867874,0.000210508024486465
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST1,Cystatin-SN,38503,0.0401493018925154,0.0108370188910759,0.0189087448660067,0.061389858919024,0.000212684818065038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,39560,0.015809665111035,0.00427025929756574,0.00743995688780613,0.0241793733342638,0.000214724650199975
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0316959311153663,0.00857705374781799,0.0148849057696431,0.0485069564610896,0.000220546203021949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPL14,60S ribosomal protein L14,39638,0.0146009676801794,0.00396179600941702,0.0068358475017221,0.0223660878586368,0.000229399423886199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX7,Syntaxin-7,39657,0.0183521882817416,0.0049823444753934,0.00858679310997057,0.0281175834535127,0.000231201024685061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB2,Calretinin,41839,0.0109352117004048,0.00297072292768562,0.00511259476214097,0.0167578286386686,0.000233249813463848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1,Methionine aminopeptidase 1,41839,0.0107897720142485,0.00293311863157076,0.00504085949636984,0.0165386845321272,0.000235446454980451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0141684231393499,0.00385636848695645,0.00660994090491521,0.0217269053737845,0.000239672912783375
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNLY,Granulysin,42137,0.0200397184938181,0.00545591116859259,0.00934613260337663,0.0307333043842596,0.000240616101691817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSR,Insulin receptor,39657,0.00637708562597821,0.0017395865008819,0.00296749608424969,0.00978667516770673,0.00024766067148468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNF,Tumor necrosis factor,41880,0.0134797213499144,0.00367871029237897,0.00626944917685164,0.0206899935229772,0.000249028154917002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN4,Contactin-4,42137,-0.00869110865045436,0.00237670396933192,-0.0133494484303449,-0.00403276887056379,0.000256360721510943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPO,Lactoperoxidase,41647,-0.022766508986863,0.00622853594870944,-0.0349744394463335,-0.0105585785273925,0.000257996139708653
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.0161333605195796,0.00441565050921911,0.00747868552151019,0.0247880355176491,0.000259484556289333
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0174725175587825,0.00478692625152338,-0.0268548930117683,-0.00809014210579667,0.000263198497441402
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA11,Integrin alpha-11,42119,-0.0124624972509567,0.00342041893576138,-0.019166518365049,-0.00575847613686437,0.00026990084401809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.0382970623465483,0.0105124345660113,0.0176926905971661,0.0589014340959304,0.000270686429596169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.0229040282466578,0.00629135136990656,-0.0352350769316746,-0.0105729795616409,0.000273281513063086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGES2,Prostaglandin E synthase 2,39579,0.0205994142811686,0.00566475740918195,0.00949648975917198,0.0317023388031652,0.000277723096559037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCC,Netrin receptor DCC,39649,0.00823549441428035,0.00226558780707142,0.00379494231242037,0.0126760465161403,0.000279203502363047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX1,Heme oxygenase 1,42007,-0.018077253644792,0.00497744759641848,-0.0278330509337722,-0.00832145635581179,0.00028246576164637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0119427515590701,0.00329093406146388,0.00549252079860094,0.0183929823195393,0.000285571968392751
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0231930572786806,0.00639455061894968,0.0106597380655393,0.035726376491822,0.000288008310282626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF16,Fibroblast growth factor 16,39657,0.0171179277137412,0.00472031532349739,0.00786610967968635,0.0263697457477961,0.000288651040852929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMP,Cartilage oligomeric matrix protein,42042,0.0121693080599249,0.00336867875999494,0.0055666976903348,0.018771918429515,0.000304380064282955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.0101190689725698,0.00280610981940343,0.00461909372653912,0.0156190442186006,0.00031199510606348
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0133266563367758,0.00369713798119799,-0.0205730467799239,-0.00608026589362776,0.000313782184891993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMOD4,Tropomodulin-4,39560,-0.0146592450165036,0.00406667218915982,-0.0226299225072569,-0.00668856752575038,0.00031386704505189
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK3,Dickkopf-related protein 3,42310,-0.0107335417199709,0.0029815206475635,-0.0165773221891953,-0.00488976125074641,0.000319312248652976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD46,Membrane cofactor protein,42107,0.0104242656520746,0.00289735474316883,0.00474545035546372,0.0161030809486855,0.000321997515074787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0191158535756119,0.00532357754854069,0.00868164158047219,0.0295500655707517,0.000331107519157457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0209429337344856,0.00583603114055743,-0.0323815547699782,-0.00950431269899306,0.000333686040492729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNU13,NHP2-like protein 1,39575,0.0229647544118007,0.00640169854414496,0.0104174252652766,0.0355120835583248,0.000335585368295388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHISA5,Protein shisa-5,39966,-0.00940532485948581,0.00263196138189011,-0.0145639691679904,-0.0042466805509812,0.000353694253378786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,39736,0.0108569320228643,0.00303874214882883,0.00490099741115978,0.0168128666345688,0.000354625343686263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0224182589697223,0.00628451430003781,-0.0347359069977964,-0.0101006109416482,0.00036227585647302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF8,SLAM family member 8,41843,-0.0194016440288472,0.00544091877108568,-0.0300658448201752,-0.00873744323751929,0.0003639205260332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA1,GDNF family receptor alpha-1,42247,0.0102732760248021,0.00288516487504308,0.00461835286971765,0.0159281991798865,0.000371091754625047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12A_IL12B,Interleukin-12,42070,0.0276822678613482,0.00778579129911948,0.012422116915074,0.0429424188076224,0.000378575066814298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.0135514973997449,0.00381170866729434,0.00608054841184805,0.0210224463876418,0.000379232822672031
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTP1,Glutathione S-transferase P,41759,-0.0250490507765593,0.00706027986482103,-0.0388871993116086,-0.0112109022415101,0.000389691688864447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,42185,-0.00967422222666748,0.00272879422595114,-0.0150226589095317,-0.00432578554380324,0.000393579141159879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,39657,0.0111335361780497,0.00314288373727247,0.00497348405299568,0.0172935883031037,0.000398048555121491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0174195235305825,0.0049190432348952,-0.0270608482709771,-0.00777819879018789,0.000399609821227393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL1,Fc receptor-like protein 1,42145,0.0163531720263499,0.00463145264429146,0.00727552484353861,0.0254308192091611,0.00041553208045201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.013679310391852,0.00387494453417766,-0.0212742016788402,-0.00608441910486377,0.000416636627344048
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD3,Bromodomain-containing protein 3,39575,0.016994082895858,0.00481968980169785,0.00754749088453024,0.0264406749071858,0.000423655429077792
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,41920,0.0102297671935227,0.00290478303734298,0.00453639244033049,0.015923141946715,0.000430227400220006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYGD,Gamma-crystallin D,39929,0.0349819044918168,0.00994663415857742,0.0154865015410051,0.0544773074426285,0.000438229660672682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELL,L-selectin,39979,0.00831697338672958,0.00236637187484173,0.00367888451203979,0.0129550622614194,0.000442042354986465
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00948702269306753,0.0027019229898579,-0.014782791753189,-0.00419125363294605,0.000447527491144587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP7,GTPase IMAP family member 7,39736,-0.0114715500569757,0.00326895175482204,-0.0178786954964269,-0.00506440461752451,0.000451156745104085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0105561042222923,0.00301149252002119,0.00465357888305072,0.0164586295615338,0.000457608905727787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD7,FERM domain-containing protein 7,39649,0.0120474046324428,0.00344455013376488,0.00529608637026359,0.0187987228946219,0.000471440356468469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA4,Carboxypeptidase A4,39518,0.0156307927589678,0.00446988519453463,0.00686981777767988,0.0243917677402556,0.000472549202082727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0368648975943218,0.0105461276833951,0.0161944873348674,0.0575353078537761,0.000474831241995809
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0346326008164431,0.00991085945734104,0.0152073162800546,0.0540578853528315,0.000476632738224663
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,39575,0.0123538898998714,0.00353853612674866,0.00541835909144404,0.0192894207082988,0.000482668460013744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0122393894360236,0.00351429088696573,0.00535137929757077,0.0191273995744764,0.000497842566054948
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR1,Complement receptor type 1,39970,0.012512522021466,0.00359749733849435,0.00546142723801704,0.0195636168049149,0.000506835788013023
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.0197847930248961,0.00569352871467691,-0.0309441093056629,-0.00862547674412939,0.000512887143639116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0240263401322415,0.00692130890191672,-0.0375921055799983,-0.0104605746844848,0.000519438193475414
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0288304258593276,0.00832273079084658,0.0125178735092683,0.0451429782093869,0.000534108759888395
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,39906,0.0134575107793447,0.00388833981933435,0.00583636473344938,0.02107865682524,0.000540177917341482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0134046789376347,0.00387529216992037,-0.0210002515906786,-0.00580910628459073,0.000543813164031801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPJ,Centromere protein J,39757,0.0245791613808162,0.00712629788109397,0.010611617533872,0.0385467052277604,0.000564581643023968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,42145,0.0214436927725379,0.00621812586675458,0.00925616607369895,0.0336312194713769,0.000565260531436249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.0149189613594276,0.0043318383286573,-0.0234093644835959,-0.00642855823525925,0.000575263125222275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LUZP2,Leucine zipper protein 2,39919,0.0156525195675966,0.00455340367462875,0.00672784836532427,0.024577190769869,0.000589129795517012
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEO1,Neogenin,39934,0.00784217905874181,0.00229111060818718,0.00335160226669493,0.0123327558507887,0.00062182260196979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0184532768170637,0.00541970543470096,0.00783065416504986,0.0290758994690776,0.000663910967187392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0152641888882715,0.00450739161605309,0.00642970132080748,0.0240986764557356,0.000710421731263452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRD1,Natural killer cells antigen CD94,42296,0.01612863851469,0.00476792849435882,0.00678349866574677,0.0254737783636333,0.000719687865217419
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMCN2,Hemicentin-2,39721,-0.0198967606005417,0.00589272527890583,-0.0314465021471971,-0.0083470190538863,0.00073667023877512
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0101186492435826,0.00300727089649229,-0.0160129002007075,-0.00422439828645771,0.000768733577257122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,41913,0.0163356700830627,0.00485530283187846,0.00681927653258092,0.0258520636335445,0.000768987571315285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3D,Protein FAM3D,39930,-0.0298149878972146,0.00887294237381819,-0.0472059549498983,-0.0124240208445309,0.000781392069886471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD1,Polycystin-1,39958,0.009261403039022,0.00275735410279095,0.00385698899755174,0.0146658170804923,0.000785389380571073
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,39990,0.00919719683692466,0.00274841926140162,0.00381029508457749,0.0145840985892718,0.000821452399739471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,42262,0.0179084676826304,0.00536791773516799,0.00738734892170119,0.0284295864435597,0.000851573006683388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYT1,Synaptotagmin-1,39929,0.0135467959195175,0.00406406846189437,0.00558122173420452,0.0215123701048304,0.000860946524201721
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0211891307457279,0.00635796373227947,0.00872752183046014,0.0336507396609957,0.000862930687735482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN3,Calsyntenin-3,39929,0.0102293729108698,0.00306987804598657,0.00421241194073612,0.0162463338810035,0.000864456963392162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHPK,Sedoheptulokinase,39757,-0.0135048047762412,0.00405380008273218,-0.0214502529383963,-0.00555935661408616,0.00086692890402668
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX2,Sorting nexin-2,39919,0.0288045785251035,0.00865549024347312,0.0118398176478961,0.0457693394023108,0.000877833022106583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN2,Prefoldin subunit 2,41839,0.0185381003395328,0.00557452433161723,0.00761203264956302,0.0294641680295026,0.000884989341316921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPQ,Carboxypeptidase Q,39960,0.0126235799936866,0.00379681615248125,0.00518182033482339,0.0200653396525499,0.000887683759172661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0116022980356303,0.00349147341893761,-0.018445585936748,-0.00475901013451257,0.000892792713744795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEB,Nebulin,39575,-0.0134101651116223,0.00403928850219123,-0.0213271705759171,-0.00549315964732754,0.000903327284441353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAL,Galanin peptides,42185,0.0223404583030051,0.00673093146271887,0.00914783263607614,0.0355330839699341,0.000905541305684516
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY2,Protein canopy homolog 2,41900,0.020426456887088,0.00616102957142549,0.00835083892709406,0.032502074847082,0.000917473984103509
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBD,Thrombomodulin,42145,0.00990623887876439,0.00298822497558693,0.00404931792661401,0.0157631598309148,0.00091853794192124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00651457289373567,0.00196767830964626,-0.0103712223806423,-0.00265792340682899,0.00093321966056026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,39560,0.0192814663835524,0.00583150782271215,0.00785171105103655,0.0307112217160682,0.000947971290046533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WNT9A,Protein Wnt-9a,41913,-0.00973628995906045,0.00294817159399498,-0.0155147062832906,-0.0039578736348303,0.000960850106805565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,39586,0.0250311071288059,0.00758467604384174,0.0101651420828761,0.0398970721747358,0.000969164587747396
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.0104152462911296,0.00315947968830844,0.00422266610204503,0.0166078264802141,0.000982037858693405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGF,Beta-nerve growth factor,42016,0.00405896414966932,0.00123237446413194,0.00164351019997071,0.00647441809936792,0.000991647376061571
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,39575,0.0148307891234425,0.00450581165575339,0.00599939827816582,0.0236621799687191,0.000999763646300163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,41802,0.00968284671474785,0.0029446862160448,0.00391126173130004,0.0154544316981957,0.00101078047723539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSC,Dipeptidyl peptidase 1,42123,0.0147370017195451,0.00448632095426202,0.00594381264919158,0.0235301907898987,0.0010228723680779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPR,Nucleoprotein TPR,39575,0.0162456893262972,0.00495852318315171,0.00652698388731983,0.0259643947652745,0.00105497220866416
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POSTN,Periostin,39966,-0.0125672407960254,0.00383796373348415,-0.0200896497136543,-0.00504483187839646,0.00106182493860224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0164546386011257,0.00503445789210402,0.00658710113260182,0.0263221760696496,0.00108493942580199
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0291513677924374,0.0089226886531148,-0.0466398375525424,-0.0116628980323324,0.00108984916541163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA,Lymphotoxin-alpha,42119,0.013182676413729,0.00404461888927134,0.00525522339075713,0.0211101294367008,0.00111958630424324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL21,C-C motif chemokine 21,42185,-0.012574631296678,0.00386894399599601,-0.0201577615288301,-0.00499150106452578,0.00115626673498405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.0139973652283608,0.00431095985134739,0.00554788391971994,0.0224468465370017,0.00116947622803591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00989915359279843,0.00305322506691119,0.0039148324616525,0.0158834747239444,0.00118964291816386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A16,Protein S100-A16,41814,-0.0198273928032031,0.00614969061980342,-0.0318807864180178,-0.0077739991883884,0.00126663611253103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.00672435641911812,0.00210230110491425,0.0026038462534862,0.01084486658475,0.00138430760604049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2,T-cell surface antigen CD2,39575,-0.0126284396298994,0.00394936051480068,-0.0203691862389087,-0.00488769302089005,0.00138973852485886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLASP1,CLIP-associating protein 1,39560,0.0244025890926868,0.00763176446375179,0.00944433074373327,0.0393608474416403,0.00139016803338642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOSB,Protein fosB,41839,0.0124056972224816,0.00388616525823077,0.00478881331634927,0.0200225811286139,0.00141488172239697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0191872205353228,0.00601336527532259,-0.0309734164749551,-0.00740102459569051,0.00142217880573302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0124836819655454,0.00391388018839475,0.00481247679629164,0.0201548871347991,0.00142874153851791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL5,Insulin-like peptide INSL5,39930,0.0330383732476166,0.0103860508906961,0.0126817135018522,0.0533950329933811,0.00147146434705569
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,39638,0.0105340924226774,0.00332695012431129,0.00401327017902731,0.0170549146663276,0.00154816255806543
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99,CD99 antigen,42137,-0.00638025792883006,0.00201574061312551,-0.0103311095305561,-0.00242940632710406,0.00155310221843386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.024542776749844,0.00776376158663797,0.00932580404003358,0.0397597494596544,0.0015754733099228
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIM,Vimentin,41900,0.0367249690892468,0.0116198249075932,0.013950112270364,0.0594998259081295,0.00157827893094088
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,41839,0.018733831594997,0.00592809898449384,0.00711475758538904,0.0303529056046049,0.0015802933200824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL3,Fc receptor-like protein 3,41913,0.0171087290750665,0.00541720464474654,0.00649100797136328,0.0277264501787697,0.00159089858377825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTG,Protogenin,42262,0.0078299897609657,0.00248369626021138,0.00296194509095139,0.01269803443098,0.00162198211790742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH17,Protocadherin-17,42145,-0.0119145976402915,0.0037877893426399,-0.0193386647518657,-0.00449053052871731,0.00166145994040609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MET,Hepatocyte growth factor receptor,42158,0.00610479481085745,0.0019414050783542,0.00229964085728321,0.00990994876443168,0.00166716446354636
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0129975306252469,0.00413606653940873,0.0048908402080058,0.021104221042488,0.00167952041613291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN15,Lipocalin-15,39934,-0.0193252150855999,0.0061512063932351,-0.0313815796163407,-0.00726885055485909,0.00168405280061965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0195820525161213,0.0062413629007967,0.00734898123055976,0.0318151238016828,0.00170787716942074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TK1,"Thymidine kinase, cytosolic",39757,0.0150035092162262,0.00478558491132766,0.00562376279002398,0.0243832556424284,0.00172214167930186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MST1,Hepatocyte growth factor-like protein,39854,0.0214280130359356,0.00683753073510865,0.00802645279512266,0.0348295732767486,0.00172953535018897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTN3,Myeloblastin,41800,-0.0152304792933493,0.00486966425283629,-0.0247750212289085,-0.00568593735779023,0.00176608532835884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.00740007729711874,0.00236809976201528,-0.0120415528306687,-0.00275860176356879,0.0017823955180485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00695399874155898,0.00223080376121914,0.00258162336956947,0.0113263741135485,0.00182994910847777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBP1,Z-DNA-binding protein 1,39657,0.0130842508103626,0.00419836143807328,0.00485546239173894,0.0213130392289862,0.00183472056293046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0129729751304476,0.00416303032349756,0.00481343569639236,0.0211325145645028,0.00183560741764671
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGCR6,Protein DGCR6,39586,0.0132188022001183,0.00424847059998533,0.00489179982414703,0.0215458045760895,0.00186663312049715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.00986724814187339,0.00317877820196956,-0.0160976534177337,-0.00363684286601306,0.00191343729586531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHCY,Adenosylhomocysteinase,42145,0.0209361364690177,0.00679961958966241,0.00760888207327934,0.034263390864756,0.00208101064470976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL9,C-X-C motif chemokine 9,42185,-0.0201106672837489,0.00656818461903989,-0.0329843091370671,-0.00723702543043069,0.00220417898670853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK3,Prostate-specific antigen,39966,0.0355172757045409,0.0116124081781524,0.0127569556753622,0.0582775957337196,0.00222919126012677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.0312788070464064,0.0102708924322161,-0.05140975621355,-0.0111478578792629,0.00232934859487691
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA1,Carbonic anhydrase 1,41890,0.0173468431933864,0.00569720986928792,0.00618031184958203,0.0285133745371907,0.00233293637842139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.014437233371534,0.00474792430036012,0.0051313017428282,0.0237431650002399,0.00236454570386422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00903028485828442,0.00297971756880239,0.00319003842343174,0.0148705312931371,0.00244550336776064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,39657,-0.00894068451576874,0.00295201769006935,-0.0147266391883047,-0.0031547298432328,0.00246200329539243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRSF1,G-rich sequence factor 1,39486,0.0255377323654456,0.0084496550526522,0.00897640846224727,0.0420990562686439,0.00251411753353212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00800547724898464,0.00264879141787763,-0.0131971084280248,-0.00281384606994448,0.00251430248682661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0136565046247841,0.00453379368136493,-0.0225427402402594,-0.00477026900930884,0.00259978568297444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.00950465696405639,0.0031631155995015,0.00330495038903345,0.0157043635390793,0.00266207111083826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT1A1,Sulfotransferase 1A1,42249,-0.0390027177378788,0.0129892746421119,-0.0644616960364182,-0.0135437394393394,0.00268092660696225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0163550283131549,0.00544836907317801,0.00567622492972602,0.0270338316965838,0.00268867704659423
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD209,CD209 antigen,42171,0.0118276917825631,0.0039448017993895,0.00409588025575969,0.0195595033093665,0.00271983779080799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASN,Vasorin,41975,0.00828766700667765,0.00276995581236776,0.00285855361443685,0.0137167803989185,0.00277675185054064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.0116566100527648,0.00389736931700186,0.00401776619144115,0.0192954539140885,0.00278762258440235
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA,Adenosine deaminase,42296,0.0107085383442164,0.00358904660818598,0.00367400699217183,0.0177430696962609,0.0028531397132951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSE,Cathepsin E,39736,0.0160539276423526,0.00539107565073381,0.00548741936691435,0.0266204359177909,0.00290883212631137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,42144,0.00718956001010167,0.0024157708492196,0.00245464914563126,0.0119244708745721,0.00292461541632038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CILP,Cartilage intermediate layer protein 1,39966,0.0166707009381046,0.00560364458339939,0.00568755755464184,0.0276538443215674,0.00293628722627042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00890322255029156,0.00299981617577019,0.00302358284578198,0.0147828622548011,0.00300462087275849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0143052793044073,0.0048275993245678,-0.0237673739805602,-0.00484318462825436,0.00304961704498343
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,39930,0.00911470762191706,0.0030805093543528,0.00307690928738557,0.0151525059564486,0.00309446564894868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL6,Fc receptor-like protein 6,42119,-0.020508200334972,0.00693411139414513,-0.0340990586674964,-0.00691734200244752,0.00310599077170002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00898274749678084,0.00303733990308064,-0.0149359337068189,-0.00302956128674279,0.00310735208370124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI2,Serpin I2,39930,0.0172273917018651,0.00586087524069498,0.0057400762301029,0.0287147071736272,0.00329523964566231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNR,Tenascin-R,42016,0.0124517299880984,0.00423702854094038,0.0041471540478553,0.0207563059283416,0.00330059268450933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2,Ataxin-2,39586,0.0315273573566743,0.0107558310331035,0.0104459285317913,0.0526087861815572,0.0033836477370109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0186531558207011,0.00636446721218863,0.00617880008481138,0.0311275115565908,0.00338739066982149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0102274896767607,0.00349551868323307,0.00337627305762388,0.0170787062958975,0.0034405422864815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOH,Beta-2-glycoprotein 1,42137,-0.0107683192120367,0.00370127289215968,-0.0180228140806697,-0.00351382434340375,0.00362763996854639
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.0257389512869695,0.00886017972253456,0.00837299903080173,0.0431049035431372,0.0036796923029208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.0105171082331647,0.00362780506108159,-0.0176276061528846,-0.0034066103134448,0.00374919357746311
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAT,Catalase,39827,0.0153425002603554,0.00530629815915815,0.00494215586840542,0.0257428446523054,0.00384295532302749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.0103120583907284,0.00356728471462583,0.00332018035006174,0.017303936431395,0.00384972319133474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0194716779111369,0.00673690677678002,0.00626734062864806,0.0326760151936257,0.00385601939206294
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0107830386404704,0.00373549025278195,0.00346147774501781,0.0181045995359231,0.00390120580054527
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.0194845986311016,0.00675400709632617,0.00624674472230226,0.0327224525399009,0.00392176600539752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,41843,0.0155116289369781,0.00538770010019866,0.00495173674058869,0.0260715211333674,0.00399473717148404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0089310761495642,0.0031065279734953,0.00284228132151341,0.015019870977615,0.00404859155358103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0134839446355321,0.00469787406930453,0.00427611145969519,0.0226917778113689,0.00410960970712418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.0130558071790515,0.00454899296625516,0.0041397809651914,0.0219718333929116,0.00411054380826195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0132555835342654,0.00462214369100449,0.00419618189989662,0.0223149851686342,0.00413916575432938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SATB1,DNA-binding protein SATB1,39934,0.00849643823692018,0.00296920282605843,0.00267680069784566,0.0143160757759947,0.00422384394215798
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,39934,0.0100437495367302,0.00351708842031865,0.00315025623290562,0.0169372428405547,0.00430200853966854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXTL1,Exostosin-like 1,39575,0.0137938329106778,0.00483082658933061,0.00432541279558977,0.0232622530257658,0.00430663451786992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,39919,0.0167685050090246,0.0058739929651264,0.00525547879737681,0.0282815312206723,0.00431553728619806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLNS1A,Methylosome subunit pICln,39649,-0.0096815860095805,0.0034048091165162,-0.0163550118779522,-0.00300816014120875,0.00447024311551821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA11,Serpin A11,42310,-0.0119435536044754,0.00422506196912648,-0.0202246750639633,-0.00366243214498753,0.00470785827930051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM2,Paralemmin-2,39929,0.0111084065262398,0.00393486101163625,0.0033960789434328,0.0188207341090469,0.00476484295114475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,42126,0.00829400087899177,0.00294366722631538,0.00252441311541363,0.0140635886425699,0.00484580986581882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBLN2,Fibulin-2,39966,-0.00918141028530284,0.00325867311222651,-0.0155684095852668,-0.00279441098533888,0.00484780612267664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.00733220415852147,0.00260582392967126,0.0022247892563658,0.0124396190606771,0.00490347381458063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00612264772651696,0.00218075531800756,-0.0103969281498118,-0.00184836730322214,0.00500004034714049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00841536805776445,0.00300190358581792,-0.0142990990859676,-0.00253163702956133,0.00506480599775618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0203047546354534,0.00725852846094427,0.00607803885200264,0.0345314704189042,0.00516082618527626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.014730917392406,0.00526868298557214,0.0044042987406846,0.0250575360441274,0.00518363502630758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMB,Granzyme B,42119,0.0190961395962864,0.00685370421834685,0.00566287932832655,0.0325293998642462,0.00533958841884485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRUNE2,Protein prune homolog 2,39757,0.00814740913792463,0.00292932685400738,0.00240592850407018,0.0138888897717791,0.00542283953531309
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB1,Lamin-B1,39908,0.0171886985681956,0.00619558748945028,0.00504534708887311,0.0293320500475182,0.00554036894234843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL4,Delta-like protein 4,39638,0.0248131786798121,0.00894397413413575,0.00728298937690604,0.0423433679827182,0.00554152975205244
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADM,Pro-adrenomedullin,42262,0.00732767069051777,0.002645170755299,0.00214313601013172,0.0125122053709038,0.00560963230143437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.0145222201099748,0.00527109370617088,0.00419087644587984,0.0248535637740697,0.00587768496711722
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0100824305965752,0.00367168428170315,0.00288592940443699,0.0172789317887133,0.00604257576427595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG4,Regenerating islet-derived protein 4,42144,-0.0141435153116793,0.00515506720512912,-0.0242474470337324,-0.00403958358962622,0.00608468728650954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMMT,MICOS complex subunit MIC60,39919,0.0123803674720004,0.00451925609252446,0.00352262553065246,0.0212381094133484,0.0061634657253467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROCR,Endothelial protein C receptor,39575,-0.00960710368633599,0.00351549321306987,-0.0164974703839529,-0.00271673698871904,0.00629009547543463
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.010299475485932,0.00376889994311898,-0.0176865193744452,-0.00291243159741884,0.00629061753466217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF9,Fibroblast growth factor 9,39539,0.0114164767294254,0.00418509319287043,0.00321369407139931,0.0196192593874514,0.00638424519285229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.0148768069681256,0.00546152420996618,-0.0255813944196593,-0.00417221951659186,0.00646126897426744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00867377760301542,0.00318657826466226,0.00242808420427739,0.0149194710017535,0.00649781039681713
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN2,Neuroligin-2,39586,-0.0129107968174355,0.00474398869220033,-0.0222090146541482,-0.00361257898072288,0.00650874766008945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKLR,Pyruvate kinase PKLR,42143,-0.0170772747788556,0.00629912464882085,-0.0294235590905445,-0.00473099046716674,0.00671540046091313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.013964016421323,0.00515194462695861,0.00386620495248413,0.0240618278901619,0.00672809906823826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC1,Hamartin,39657,0.0203498152028257,0.0075130643432416,0.0056242090900722,0.0350754213155793,0.00676736658913603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0244616067774321,0.00903649320465361,-0.0421731334585532,-0.00675008009631105,0.00680002053412532
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA2,Carbonic anhydrase 2,42103,0.0181558843025412,0.00670934705617776,0.00500556407243275,0.0313062045326496,0.00681726099224034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0094715438150933,0.0035007018656877,-0.0163329194718412,-0.0026101681583454,0.00682642795440456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0150229529921593,0.0055718376568885,-0.0259437547996608,-0.00410215118465788,0.00702362010598617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.0106660663665173,0.00396518135767015,0.00289431090548379,0.0184378218275508,0.00715741971624672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0189484396323429,0.00704689596145053,0.00513652354789989,0.032760355716786,0.00717752203397535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,41913,0.0169313993164337,0.00629697251211674,0.00458933319268493,0.0292734654401825,0.00717952502607527
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0105044166516137,0.00390782113519692,0.00284508722662773,0.0181637460765997,0.00719586558713774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.00650115219527856,0.00242285244957284,-0.0112499429964413,-0.0017523613941158,0.00729968769922115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,42032,0.00779136359004965,0.00291056156490938,0.00208666292282726,0.013496064257272,0.0074390859210705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMR1,Synaptic functional regulator FMR1,41843,0.00976776477022287,0.00365024193713919,0.00261329057343006,0.0169222389670157,0.00746155483465683
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN8,Septin-8,39906,-0.00885070740310699,0.00330931466080005,-0.0153369641382751,-0.00236445066793889,0.00749521177976803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0109835187345303,0.00411424571784429,-0.0190474403415051,-0.00291959712755552,0.00760260445859704
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,39657,0.0283353739946339,0.010624727090902,0.00751090889646592,0.0491598390928018,0.00766596961990852
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0166727715479967,0.00625320325775904,-0.0289290499332044,-0.00441649316278899,0.00767877340167739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSAP,Gamma-secretase-activating protein,41843,0.0226744147838774,0.00851159369926862,0.00599169113331087,0.0393571384344439,0.00773237650512893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN8,Tetraspanin-8,39930,0.0256896311060763,0.00967495399187614,0.00672672128199911,0.0446525409301536,0.00793554102896627
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,39958,0.00901744287629356,0.00340057031296331,0.00235232506288548,0.0156825606897016,0.00801883696671183
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00905254780921806,0.00341561126969289,0.00235794972061999,0.0157471458978161,0.0080503537673546
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.01809256537709,0.00683143509976902,0.00470295258154272,0.0314821781726373,0.00809828869896198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE1,Ribonuclease pancreatic,39990,-0.00662884401587991,0.00250664996611952,-0.0115418779494742,-0.00171581008228565,0.00819231101121851
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK15,Kallikrein-15,39900,0.0140106824545725,0.00532784177742811,0.00356811257081345,0.0244532523383316,0.00855733453555761
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00884637986225358,0.00337429483807309,-0.0154599977448768,-0.00223276197963033,0.00876136993449108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0229776845676247,0.00877356940705049,0.00578148852980571,0.0401738806054436,0.00883169545832885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME2,Proteasome activator complex subunit 2,41955,-0.00925872035220212,0.0035684614575265,-0.0162529048089541,-0.00226453589545018,0.00948052963701873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.00888493584895486,0.00342837685655891,-0.0156045544878103,-0.0021653172100994,0.00956369716628696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX3,Syntaxin-3,39929,0.00999924439587724,0.00386978323237384,0.00241446926042451,0.01758401953133,0.00978059564572589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR1,Folate receptor alpha,42110,-0.00769685886308213,0.00298264405517539,-0.0135428412112259,-0.00185087651493837,0.00987478980929596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,42070,0.0151211808003522,0.00588175127173807,0.00359294830774558,0.0266494132929588,0.0101551618878918
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0305258813676646,0.0118897221636197,0.00722202592696998,0.0538297368083591,0.010256693367953
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,42262,0.00952863657280615,0.00371568124233634,0.00224590133782694,0.0168113718077854,0.01034487426823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC2,Stanniocalcin-2,42113,0.00622322818740169,0.00242690261509451,0.00146649906181645,0.0109799573129869,0.0103500829781234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC51B,Organic solute transporter subunit beta,39575,-0.0188618573286377,0.00736443669232967,-0.0332961532456038,-0.0044275614116715,0.0104441221366273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,39657,-0.014508335128865,0.0056808411602316,-0.025642783802919,-0.0033738864548111,0.0106654885015164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA14,Carbonic anhydrase 14,42262,0.00946553727611992,0.00371100751889547,0.00219196253908479,0.016739112013155,0.01076256800647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.00875743301740637,0.00343579384568955,-0.0154915889549579,-0.00202327707985484,0.0108202775945094
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFC1,Cryptic protein,41843,0.0123139585899558,0.00483443960867003,0.00283845695696258,0.0217894602229491,0.0108724253207882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB2,Integrin beta-2,42079,-0.00737451614087346,0.00290554404710981,-0.0130693824732087,-0.00167964980853823,0.0111572686481942
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMBS,Porphobilinogen deaminase,42262,0.0103145617199276,0.00406486182779225,0.00234743253745478,0.0182816909024004,0.0111759542356844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0104318800316675,0.00411620796811262,0.00236411241416678,0.0184996476491682,0.0112792069469729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00791102536420854,0.00312706563759117,0.00178197671452985,0.0140400740138872,0.0114223742760041
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00567515583783279,0.00224534323243865,0.00127428310225305,0.0100760285734125,0.0114983352960978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL8,Interleukin-8,42035,0.0172380798159964,0.00685713569982877,0.00379809384433205,0.0306780657876608,0.0119523869716478
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB1A1,Uteroglobin,42165,0.0135841097151878,0.00541833313377413,0.00296417677299047,0.0242040426573851,0.0121854513486387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTO1,Protein LTO1 homolog,41913,0.0104690749747801,0.00417904504615378,0.00227814668431866,0.0186600032652415,0.0122522896331313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0146563188669423,0.00585381113845218,-0.0261297886983086,-0.00318284903557603,0.012301075831499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0134858699073716,0.00540256378283115,0.00289684489302251,0.0240748949217206,0.0125651027421978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.00947544170695757,0.00380047183304696,-0.0169243664997296,-0.00202651691418553,0.0126733640941822
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN1,Calsyntenin-1,41839,0.0127658896046983,0.0051207138723624,0.00272929041486795,0.0228024887945286,0.0126793531757034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCN,Decorin,41900,-0.00579232582940103,0.00232790129135993,-0.0103550123604665,-0.00122963929833557,0.0128506467140087
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.0109841542534473,0.00443449856643536,-0.0196757714436606,-0.00229253706323397,0.0132649506852275
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.0068495356110846,0.00277430115828012,-0.0122871658813136,-0.00141190534085557,0.0135669109374379
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.0135350283980949,0.00548389693819583,-0.0242834663969587,-0.0027865903992311,0.0135967283902267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE3,Eosinophil cationic protein,42081,0.027163690197939,0.0110103377051962,0.0055834282957544,0.0487439521001237,0.0136332696031599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA8,Carbonic anhydrase-related protein,39657,0.00666542646192516,0.00270492961063964,0.00136376442507146,0.0119670884987789,0.0137479124743306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,39951,0.00371042965864842,0.00151157105996517,0.000747750381116684,0.00667310893618016,0.0141157386177366
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABO,Histo-blood group ABO system transferase,39990,0.0360322124268642,0.0147007742144771,0.00721869496648907,0.0648457298872393,0.014259262077566
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0131415760443781,0.00536433467595545,-0.0236556720092508,-0.00262748007950541,0.0143059216911261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPS,Calcyphosin,39929,0.023612488490661,0.00963952366207847,0.00471902211298721,0.0425059548683348,0.0143185448718485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBH,Dopamine beta-hydroxylase,39978,0.0282269730295646,0.0115621809107204,0.00556509844455257,0.0508888476145767,0.0146488511061288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0132045426793759,0.00542254056128001,-0.0238327221794847,-0.00257636317926703,0.0148998816934181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCG22,Protein PBMUCL2,39575,-0.0143195037877323,0.00589562352094265,-0.0258749258887799,-0.0027640816866847,0.0151633239798385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00684674592722193,0.00282468798462564,-0.0123831343770882,-0.00131035747735567,0.0153679693992328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.00920435816769707,0.00379817200455271,0.00175994103877376,0.0166487752966204,0.0153934007829113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ULBP2,UL16-binding protein 2,42016,-0.00965083040689878,0.00398348328079155,-0.0174584576372502,-0.00184320317654735,0.0154183113296573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,39560,-0.00928503871579838,0.00383661304288521,-0.0168048002798534,-0.00176527715174337,0.0155318213686642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.0171347678327473,0.00708939370371023,0.00323955617347522,0.0310299794920193,0.0156637835637608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUK1,Guanylate kinase,39575,-0.00986776143002105,0.00408560457676732,-0.017875546400485,-0.00185997645955711,0.0157405948069555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D2,DCN1-like protein 2,39560,-0.0195601155420512,0.00810738286118393,-0.0354505859499717,-0.00366964513413068,0.0158541979047364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,42129,0.0185935217884038,0.00771872164897947,0.00346482735640409,0.0337222162204036,0.0160145659904262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.0119280963565041,0.00495524426196366,-0.0216403751099529,-0.00221581760305532,0.0160904516453058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.0190085627312785,0.00791412320012129,-0.0345202442035162,-0.00349688125904079,0.0163259371377654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1A,Interleukin-1 alpha,41913,0.0140543453132683,0.00585508749472508,0.00257837382360716,0.0255303168029295,0.0163923858728812
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.012698608034588,0.00530242797309367,-0.0230913668618516,-0.00230584920732437,0.0166430568554615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,39657,0.0156619461649514,0.00654838728681229,0.00282710708279926,0.0284967852471035,0.0167859757427462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKCQ,Protein kinase C theta type,41913,0.0103239470773496,0.0043274709002308,0.00184210411289721,0.018805790041802,0.0170616209873188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.00763285503119489,0.00320079631048598,0.00135929426264236,0.0139064157997474,0.0171080110293347
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0148302121310391,0.00622536809328412,-0.027031933593876,-0.00262849066820224,0.017222344696782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL14,C-C motif chemokine 14,42152,0.0097369713756055,0.00408887556506419,0.00172277526807968,0.0177511674831313,0.0172638699809734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC1,Glypican-1,42262,0.0071071954236188,0.00298804235800155,0.00125063240193577,0.0129637584453018,0.0173947431262458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.00725360647625912,0.00305221853350117,0.00127125815059683,0.0132359548019214,0.0174914436203828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0139891380761429,0.005902709336652,0.00241982777630493,0.0255584483759808,0.0178045771581817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.00716877478464204,0.00302966826085581,0.00123062499336464,0.0131069245759194,0.0179861008875404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0102179070617677,0.00431905943802472,-0.0186832635602961,-0.00175255056323921,0.0180097033840794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,39575,-0.00629489569925146,0.00268112436244604,-0.0115498994496457,-0.00103989194885722,0.018899444179565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00707794738265827,0.00301696421997436,0.00116469751150853,0.012991197253808,0.0189886642067119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36G,Interleukin-36 gamma,39624,0.0159668449951341,0.0068247155719791,0.00259040247405509,0.0293432875162132,0.0193241232403582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.014462790724147,0.00618538425354618,0.00233943758719651,0.0265861438610975,0.0193903789994477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L,Seizure 6-like protein,42181,0.00648158618400282,0.00278236810597698,0.00102814469628794,0.0119350276717177,0.0198460416337626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0100925518653933,0.00433718390387127,-0.018593432316981,-0.0015916714138056,0.0199808807929746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D1,DCN1-like protein 1,39586,-0.0177703304391936,0.00765123877412795,-0.0327667584364843,-0.00277390244190276,0.0202218968957472
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMS1,PMS1 protein homolog 1,39649,0.0115353387052116,0.00501109975983413,0.00171358317593667,0.0213570942344865,0.0213560749682623
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,39638,0.0132462238690773,0.00575543432938109,0.00196557258349034,0.0245268751546642,0.0213810192728944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00844620492651865,0.00368595833515304,0.00122172658961869,0.0156706832634186,0.0219558679244944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APLP1,Amyloid-like protein 1,42145,-0.0117680913458327,0.00513958854878398,-0.0218416849014493,-0.00169449779021607,0.0220542964224486
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.0076645244248291,0.00334969988183767,0.00109911265642727,0.0142299361932309,0.0221459904073815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.010694111714007,0.0046765809672745,0.00152801301814897,0.019860210409865,0.0222295433138922
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBB,Inhibin beta B chain,39736,0.0120674016626811,0.00530663944476663,0.00166638835093851,0.0224684149744237,0.0229837566453497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX9,Transcription factor SOX-9,39649,0.00636965241190141,0.00280158278088958,0.000878550161357821,0.011860754662445,0.0230097119065603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRC,Chymotrypsin-C,42122,0.0150176153540178,0.00660773129959048,0.00206646200682051,0.0279687687012152,0.0230578391013293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB8,Serpin B8,42296,0.0134244810021505,0.00590906278267489,0.00184271794810775,0.0250062440561933,0.0231112487945926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPE,Carboxypeptidase E,42134,0.00898077927203389,0.00395501086860316,0.0012289579695717,0.0167326005744961,0.0231787034763799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0338152556530356,0.0149057069598423,-0.0630304412943266,-0.00460007001174459,0.0233113340289738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFLAM,Pikachurin,39930,0.00711088721114934,0.00313505335540638,0.000966182634552832,0.0132555917877458,0.0233365506706753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10,Interleukin-10,41913,-0.0176191897644399,0.00778151680731668,-0.0328709627067806,-0.00236741682209919,0.023575624604196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B2M,Beta-2-microglobulin,39979,-0.00700295264879356,0.00309340144771417,-0.0130660194863133,-0.000939885811273793,0.0236029673668931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00720062460857095,0.00318084448909939,-0.0134350798072057,-0.000966169409936146,0.0236090371291508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.0115665990453559,0.00512009487798294,0.00153121308450934,0.0216019850062025,0.0238990886287679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,42070,0.00590673640244628,0.0026258615543946,0.000760047755832862,0.0110534250490597,0.0245001528391046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,39649,0.0115510267320129,0.005142531544372,0.00147166490504382,0.021630388558982,0.0247124632246572
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA6C,Semaphorin-6C,39657,0.00588375005109584,0.00262043852724618,0.000747690537693329,0.0110198095644983,0.0247666129817464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRN,Progranulin,42077,0.0057061096513503,0.00254254835418909,0.000722714877139675,0.0106895044255609,0.0248325963744089
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH7B,Myosin-7B,39560,-0.00977539264414099,0.00435719354163951,-0.0183154919857544,-0.00123529330252754,0.0248840519074995
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,39889,-0.00619273509342484,0.00276752391733183,-0.0116170819713952,-0.000768388215454462,0.0252636664743858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0268605578906522,0.0120162797019367,-0.0504124661064481,-0.00330864967485638,0.0254108011048043
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0130559549454675,0.00584686540973296,0.00159609874239091,0.0245158111485441,0.0255663126457092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0111413820140545,0.00499335184359609,0.00135441240060621,0.0209283516275029,0.0256848971512653
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22,Interleukin-22,39919,-0.015899453564781,0.00713438792983669,-0.0298828539072609,-0.00191605322230108,0.0258623642852361
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.0156140449116942,0.00700714947793599,0.00188003193493968,0.0293480578884488,0.0258804306658045
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00814685285317897,0.00367082937627346,0.000952027275682998,0.015341678430675,0.0264832154488646
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDK,Midkine,42129,0.0114727879128383,0.00517357936732263,0.00133257235288599,0.0216130034727907,0.0266005380888209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRTN,Neurturin,41913,0.0111185785334806,0.00501391857725962,0.00129129812205178,0.0209458589449095,0.0266028487705949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPG,Macrophage-capping protein,42015,0.0131748323845655,0.0059550100943747,0.00150301259959112,0.02484665216954,0.0269561888141053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,39586,0.00997809639907118,0.00451531964148872,0.00112806990175328,0.0188281228963891,0.0271373888958037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO6,Unconventional myosin-VI,39934,0.00838371480412967,0.0037962536031185,0.000943057742017413,0.0158243718662419,0.0272350882607261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0116857791752233,0.00530674154338894,-0.0220869926002656,-0.00128456575018097,0.0276809529575965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00776231870270279,0.00352766789358301,0.00084808963128008,0.0146765477741255,0.0277981780898522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0149330975132935,0.00681262006812389,-0.0282858328468163,-0.00158036217977068,0.0284021939846321
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO1,R-spondin-1,42016,0.00755280968166373,0.00344913113503505,0.000792512656995028,0.0143131067063324,0.0285579591538748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR2,Complement receptor type 2,42217,0.0103285020889584,0.00472030849753495,0.0010766974337899,0.0195803067441269,0.0286793289662544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00746741350140844,0.00341444153560841,-0.0141597189112009,-0.000775108091615954,0.0287591222609376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00544368128414705,0.00249330659278789,0.00055680036228278,0.0103305622060113,0.0290333483403592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALY,RNA-binding protein Raly,39919,0.0106447435070091,0.00487589429278967,0.0010879906931413,0.0202014963208768,0.0290462192573195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR2,TGF-beta receptor type-2,42181,-0.00755806410541997,0.00346329910872193,-0.0143461303585149,-0.000769997852324998,0.0291022060261207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.00777476599523304,0.00356391836914358,0.000789485991711626,0.0147600459987545,0.029165338513959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.00981526130125233,0.00450016188890745,0.000994943998993728,0.0186355786035109,0.0291977047880929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNXB,Tenascin-X,42137,0.00576667723707433,0.00264442408063236,0.000583606039034906,0.0109497484351138,0.0292232835251813
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,39586,-0.0128365583012613,0.00589709651452584,-0.0243948674697319,-0.00127824913279065,0.0295197697406928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,42145,0.0168857484650714,0.00776073824107279,0.00167470151256871,0.0320967954175741,0.0295880804746404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.0137348595542284,0.00632579300462468,0.00133630526516399,0.0261334138432927,0.0299336966625587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAP,Prosaposin,39886,0.00628485570168959,0.00289595748914983,0.000608779022955927,0.0119609323804232,0.0300112093827868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.00935053085402229,0.00432197381163159,-0.0178215995248202,-0.000879462183224364,0.0305213279875708
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH12,Protocadherin-12,39934,0.00558524062949047,0.00258679211358107,0.000515128086871577,0.0106553531721094,0.030860393039492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12B,Interleukin-12 subunit beta,42296,0.0119510709801715,0.0055404565458912,0.00109177615022476,0.0228103658101183,0.0310186998408013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,39757,0.0149744144881241,0.00694285867184393,0.00136641149130997,0.0285824174849382,0.031041905303381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0115365403708147,0.00536430787344336,-0.0220505838027637,-0.00102249693886573,0.031528355858592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0116639824257459,0.00542568441258797,0.00102964097707344,0.0222983238744183,0.0315910348628771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0302188113142035,0.014061155353916,-0.0577786758078789,-0.002658946820528,0.0316476242112565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.01238149641021,0.00578628554673846,0.00104037673860259,0.0237226160818173,0.0323925248147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRAS,GTPase Hras,39750,0.0214973405343311,0.0100537889345659,0.00179191422258197,0.0412027668460802,0.0325195315597269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,42070,-0.01022754129695,0.00478482465864586,-0.0196057976278959,-0.000849284966004109,0.0325756604420861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MBL2,Mannose-binding protein C,39826,0.023950359818863,0.0112101638846938,0.00197843860486308,0.0459222810328629,0.0326613684629146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.00883636604292148,0.00413881770632566,-0.0169484487473198,-0.000724283338523181,0.0327824800968302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.00837504865357624,0.00393253189963277,0.000667286130295999,0.0160828111768565,0.0332198052065157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,39958,-0.00738005350174899,0.00347295976245368,-0.0141870546361582,-0.000573052367339785,0.0336078044883836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD55,Complement decay-accelerating factor,41714,0.00564667738841217,0.00266366291305335,0.00042589807882761,0.0108674566979967,0.034033893410534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC2,MAM domain-containing protein 2,39958,-0.00764121107532456,0.00360691451088202,-0.0147107635166533,-0.000571658633995793,0.03415527189868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,42185,0.00619918502191874,0.00292783616249759,0.00046062614342346,0.011937743900414,0.0342502699799679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,39930,0.0107904648575436,0.00509883219322315,0.00079675375882619,0.0207841759562609,0.0343442774757725
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.012528499282963,0.00592655997753389,-0.0241445568389294,-0.000912441726996564,0.034537250143716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAFB2,Scaffold attachment factor B2,39934,0.00583816418327202,0.0027644235864307,0.000419893953867846,0.0112564344126762,0.0347175321777307
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.0180245715427584,0.00853942761177337,-0.0347618496618342,-0.00128729342368256,0.034812958110208
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0137667407804273,0.00652345495545804,0.000980769067729573,0.0265527124931251,0.0348504371268477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0107311061334699,0.00509147645212391,0.00075181228730707,0.0207103999796328,0.0350822365356702
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00547539494370999,0.00259827102416577,-0.0105680061510749,-0.000382783736345072,0.0351121318434399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.00569586940401891,0.00270701528914443,0.000390119437295834,0.011001619370742,0.0353869682019246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCC1,Regulator of chromosome condensation,39919,0.0111043841503116,0.00528292183014994,0.000749857363217728,0.0214589109374055,0.0355805798772198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO1,Roundabout homolog 1,42144,0.00509007950421363,0.00242187814458236,0.000343198340832203,0.00983696066759506,0.0355973261080817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0122159802180802,0.0058126858270195,0.000823115997121954,0.0236088444390384,0.0356100962083618
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0107884250837354,0.00513439942468551,0.000725002211351803,0.020851847956119,0.0356412735367442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.016108199187083,0.00768577947514772,-0.0311723269583726,-0.00104407141579351,0.0361188049942739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRNN,Cornulin,41749,0.0142688336398899,0.00681287434097653,0.000915599931575931,0.0276220673482039,0.0362441134431832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.015011355247351,0.00717946962348854,-0.0290831157093885,-0.000939594785313445,0.0365624184314224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PZP,Pregnancy zone protein,39979,0.0070423757557586,0.00337314372478071,0.000431014055188418,0.0136537374563288,0.036840036266064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,41843,0.00783101015637426,0.00376015698805596,0.000461102459784572,0.0152009178529639,0.0373042412091791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP4,Guanylate-binding protein 4,41839,0.010262831691226,0.00495548879440505,0.000550073654192098,0.0199755897282599,0.0383778553019424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOC,Myocilin,42137,-0.00934769664223891,0.00452414862519163,-0.0182150279476145,-0.000480365336863313,0.0388306478656417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPF,Centromere protein F,39757,0.011275652018134,0.00547012696411991,0.000554203168458972,0.021997100867809,0.0392961621655822
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00527899416532343,0.00257323216486118,-0.0103225292084513,-0.000235459122195521,0.0402409037397537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.00779800738290105,0.00381797205060196,0.000314782163721201,0.0152812326020809,0.0411310108187994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00676498145429091,0.00331317857939208,0.000271151438682428,0.0132588114698994,0.0411912354725111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD83,CD83 antigen,42119,0.00710155915217174,0.00348750999930008,0.000266039553543581,0.0139370787507999,0.0417413428201525
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKAP12,A-kinase anchor protein 12,39736,0.00439760320414784,0.00215981679689357,0.000164362282236432,0.00863084412605924,0.0417639193750172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00622355008861507,0.00307587428988925,-0.012252263696798,-0.000194836480432147,0.043061916150283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A11,Protein S100-A11,42027,0.00940246368912584,0.00467968718430368,0.000230276807890627,0.0185746505703611,0.044535083411101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00909634968735054,0.00453445591869056,0.000208816086717051,0.017983883287984,0.0448711152329637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC4A1,Band 3 anion transport protein,39966,-0.0096874943597119,0.00483087125682511,-0.0191560020230891,-0.00021898669633468,0.0449513697812455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,39929,0.00781087789633433,0.00392501553826247,0.000117847441339893,0.0155039083513288,0.046612208704662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.010986097696998,0.00552275755988912,-0.0218107025143807,-0.00016149287961535,0.0466985755190039
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.00869117040805958,0.00437126277685649,-0.0172588454506983,-0.000123495365420856,0.0468038528959283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK8,Kallikrein-8,41668,0.00736892727692491,0.00370823355482163,0.000100789509474519,0.0146370650443753,0.0469233037621774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMA,Repulsive guidance molecule A,42249,-0.00645405526280694,0.00325118301718099,-0.0128263739764817,-8.17365491321918e-05,0.0471488182057195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSF,Cathepsin F,42181,0.00807588459400604,0.00407533206449661,8.82337475926944e-05,0.0160635354404194,0.0475384796818943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0138946297771033,0.00701222297635359,-0.0276385868107564,-0.000150672743450294,0.0475608023152673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.0105481922003747,0.00532697642068849,0.00010731841582525,0.0209890659849241,0.0477111956095056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,39757,0.0106490827008515,0.00538052211553646,0.0001032593544,0.0211949060473029,0.0478190131757703
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.00442213777332309,0.00223704446913036,-0.00880674493281859,-3.75306138275929e-05,0.0480874791841191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0113768239430443,0.00577156742176514,6.45517963846487e-05,0.022689096089704,0.0487279002612226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0146452329932737,0.00744190399793367,5.91011573237137e-05,0.0292313648292237,0.0490951168482304
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.00742052198317018,0.00377303380098146,-0.0148156682330939,-2.53757332465193e-05,0.0492400164959127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.0245567409527501,0.0125066020422192,4.38009500004326e-05,0.0490696809554998,0.0496087381004261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.013085305214352,0.00666615550971155,-0.0261509700133867,-1.96404153173877e-05,0.0496772226816162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL14,C-X-C motif chemokine 14,41913,0.0113412139618692,0.00578433928407467,3.9089650828595e-06,0.0226785189586555,0.0499376756604484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAP1A,Ras-related protein Rap-1A,39657,-0.0137533492499796,0.00702273248646288,-0.0275179049234469,1.1206423487611e-05,0.0502076993324219
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR1,Cadherin-related family member 1,41839,0.00817684007906092,0.00417965922147371,-1.52919950275419e-05,0.0163689721531494,0.0504459529121456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOPH1,Enolase-phosphatase E1,39919,0.0105274386018088,0.00540260563127898,-6.16684354980308e-05,0.0211165456391156,0.0513696295018019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0079148389730815,0.00406830826051788,-0.0158887231636966,5.90452175335456e-05,0.0517410860622816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1,DNA topoisomerase 1,39930,0.0237813542599318,0.0122345461621386,-0.000198356217859855,0.0477610647377234,0.0519458426792611
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF3,Neurotrophin-3,42119,0.00675307171160724,0.0034784631534691,-6.47160691921826e-05,0.0135708594924067,0.0522311105098239
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARTN,Artemin,41913,0.00884220232967316,0.0045740063590257,-0.000122850134017203,0.0178072547933635,0.0532399256194518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX5,Syntaxin-5,39657,0.00780353109737973,0.00403923503803721,-0.000113369577173204,0.0157204317719327,0.0533933056418909
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEBP1,Heme-binding protein 1,41900,-0.0101549070158331,0.00526413825564325,-0.0204726179968939,0.000162803965227633,0.0537430502777778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G1B,Phospholipase A2,42299,-0.0086900058282977,0.00450783201517276,-0.0175253565780363,0.000145344921440901,0.0539059759429612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX18,Sorting nexin-18,39930,0.00854325100823986,0.00443646240084836,-0.000152215297422922,0.0172387173139026,0.0541680967858022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.0136448327961864,0.00709180023355578,-0.000255095661582922,0.0275447612539557,0.0543716560759829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD177,CD177 antigen,42123,-0.0250665277965558,0.013029530006272,-0.050604406608849,0.000471351015737406,0.0543975625767086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR5,Proline-rich protein 5,39657,0.00921795007108028,0.00479149482866031,-0.000173379793093932,0.0186092799352545,0.0544034060589602
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.0114018864979624,0.00597426267553996,-0.0231114413420207,0.000307668346095915,0.0563523570581527
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1B,Protein phosphatase 1B,39657,0.0118973142860421,0.00626431892888034,-0.000380750814563407,0.0241753793866475,0.0575616729007202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH1,Cadherin-1,41697,-0.00768859617722565,0.00406173845719527,-0.0156496035533284,0.000272411198877076,0.0583888909077626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0041538719267618,0.00220014570117438,-0.000158413647539974,0.00846615750106358,0.0590476606289596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YY1,Transcriptional repressor protein YY1,39657,0.00533159262955367,0.00283255000148829,-0.000220205373363388,0.0108833906324707,0.0598271015145034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB2,Lamin-B2,39929,-0.00547750952159838,0.00291094702840339,-0.011182965697269,0.00022794665407226,0.0599032856455163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,41839,0.0104659392739728,0.00557046121150161,-0.000452164700570357,0.0213840432485159,0.0602899161691742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.021991538340249,0.0117193658853894,-0.000978418795114205,0.0449614954756123,0.0606067759895206
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSG1,Tryptase gamma,39657,0.00497590249941912,0.00266070803996617,-0.000239085258914576,0.0101908902577528,0.061490469536372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSMB,Beta-microseminoprotein,42103,-0.0131832575814279,0.0070621743585879,-0.0270251193242602,0.000658604161404373,0.0619592796161062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00794080315833681,0.00425883541435622,-0.016288120570475,0.000406514253801381,0.0622710223163156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300A,CMRF35-like molecule 8,39736,0.00578918952841217,0.00310726130414009,-0.000301042627702409,0.0118794216845268,0.062472196185657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRC1,Macrophage mannose receptor 1,39990,-0.00536644334288684,0.00288198496885178,-0.0110151338818363,0.000282247196062659,0.0626196616231457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00686267376790974,0.00368871169910338,-0.000367201162332878,0.0140925486981524,0.0628480286408113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SBSN,Suprabasin,39954,-0.00668837204403278,0.00360389155362775,-0.0137519994891432,0.000375255401077613,0.0634972772435746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,39560,-0.00735327361737001,0.00396819517290901,-0.0151309361562717,0.000424388921531641,0.0639017070339635
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,39575,0.00799266237980541,0.00432039147443566,-0.00047530491008849,0.0164606296696993,0.0643424748883091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0115890531164031,0.00629017097408197,-0.0239177882256038,0.000739681992797539,0.0654426134202251
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSHB,Follitropin subunit beta,39638,-0.00765524123097375,0.00416139683932878,-0.0158115790360582,0.000501096574110654,0.0658560959983399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK14,Kallikrein-14,42262,0.00861450045688598,0.00468382775821477,-0.000565801949214958,0.0177948028629869,0.0659073223332469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0129147835687763,0.00703361291030961,-0.000871097735430546,0.0267006648729831,0.0663619888774758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCF2,Neutrophil cytosol factor 2,42097,0.0153894319004514,0.00839970536523444,-0.00107399061540806,0.031852854416311,0.0669526635106404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP8,Neutrophil collagenase,42224,-0.0132301392692494,0.00723292326022918,-0.0274066688592986,0.000946390320799739,0.0673982058070456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0060756613000269,0.00334281223601172,-0.000476250682556079,0.0126275732826099,0.0691582159139557
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00473390253762861,0.00260521361444505,-0.00037231614668369,0.00984012122194092,0.0692300282955633
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,39560,0.0113371037113738,0.00626210965417287,-0.000936631210805028,0.0236108386335526,0.0702566886899062
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD302,CD302 antigen,42070,0.00568156326781475,0.00315062316155126,-0.000493658128825727,0.0118567846644552,0.0713612316141878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0123392905627128,0.00686195383038304,-0.00111013894483794,0.0257887200702636,0.0721647719799842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD3,Extracellular superoxide dismutase,39990,-0.0110090536708649,0.00615971529341859,-0.0230820956459654,0.00106398830423552,0.0739209837708924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00841030327413668,0.00470580272194331,-0.0008130700608722,0.0176336766091456,0.0739295750412063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.00711787841308647,0.00399435716509933,-0.0149468184566812,0.000711061630508205,0.074774367496926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.0147225551964374,0.00829117117139575,-0.0309732506923731,0.00152814029949829,0.0758116592675864
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB7,Integrin beta-7,42262,-0.0082693624187221,0.00466483223135104,-0.0174124335921701,0.000873708754725932,0.0763002004643207
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0136532312581376,0.00772986787866162,-0.0014973097840392,0.0288037723003143,0.0773741099722354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFD,Vascular endothelial growth factor D,42275,-0.00688990253605266,0.00390134384512903,-0.0145365364725056,0.000756731400400243,0.0774125973567582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGM2,Phosphoglucomutase-2,39649,0.0108618545430225,0.00615408607950519,-0.00120015417280767,0.0229238632588527,0.0775943193087063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3,Galectin-3,42196,0.00528170221505995,0.00299682175546808,-0.000592068425657475,0.0111554728557774,0.0780183706247845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA6,Carbonic anhydrase 6,42103,-0.0111199101435157,0.00633492671722221,-0.0235363665092713,0.0012965462222398,0.0792249248320939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGBL1,Integrin beta-like protein 1,39966,-0.00701041859750789,0.00399503032856967,-0.0148406780415044,0.000819840846488668,0.0793230618545276
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B4,Protein ATP1B4,39560,-0.00745232936161086,0.00425506432767702,-0.0157922554438578,0.000887596720636099,0.0799046108272861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK2,Protein AHNAK2,39638,0.00553097058734307,0.00316001442455818,-0.00066265768479097,0.0117245988594771,0.0800944883426237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB5,Serpin B5,41900,0.00859583728927805,0.00492788145643227,-0.0010628103653292,0.0182544849438853,0.0811251647884705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.0127303403418202,0.00733232744188553,-0.0271017021279158,0.00164102144427547,0.0825567831563766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00605470960391883,0.00348763917401204,-0.000781063177144778,0.0128904823849824,0.0825831734996764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A14,Zinc transporter ZIP14,41839,-0.00591551182034655,0.00340901530444782,-0.0125971818170643,0.00076615817637118,0.0827188683549545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSP90B1,Endoplasmin,41774,0.0111407807344873,0.00642112793706588,-0.00144463002216182,0.0237261914911364,0.0827607778502355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.022115768651849,0.0127602864552732,-0.00289439280048635,0.0471259301041844,0.0830884148219424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,39919,0.0105384907355944,0.00608596164110126,-0.0013899940809641,0.0224669755521528,0.0833708943815002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2B,Sodium channel subunit beta-2,39649,-0.0049504581225395,0.00286006980611998,-0.0105561949425346,0.000655278697455656,0.0834998088220486
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB1,Calbindin,42070,0.00790886149911416,0.00457861149255901,-0.0010652170263015,0.0168829400245298,0.0841278676682732
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00515991477384404,0.00298915217786164,-0.000698823494764766,0.0110186530424529,0.0843369489111166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIT,Citron Rho-interacting kinase,39649,0.00800735498479077,0.00464512149122516,-0.00109708313801055,0.0171117931075921,0.0847682518799214
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300E,CMRF35-like molecule 2,42232,-0.00727937089117046,0.00422680206250714,-0.0155639029336845,0.00100516115134353,0.085057161261522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL20,C-C motif chemokine 20,42296,0.015037426245634,0.00874793841526951,-0.00210853304829423,0.0321833855395623,0.0856427947019786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.00805603523155164,0.0046869570837121,-0.00113040065252407,0.0172424711156274,0.0856753661586623
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDAN1,Codanin-1,39929,0.00380931402708002,0.00221864556916987,-0.000539231288492919,0.00815785934265296,0.0860147744584696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAX,Apoptosis regulator BAX,41814,0.0159048981422079,0.00927182187672087,-0.00226787273616503,0.0340776690205808,0.0862950642297037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00641750804774335,0.0037454556550563,-0.0137586011316537,0.000923585036166996,0.0866640693740191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.0106619710806661,0.00622884642288401,-0.0228705100695187,0.00154656790818661,0.086978142587388
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA1,Annexin A1,39699,0.00770478214726454,0.00451885090199751,-0.00115216562065059,0.0165617299151797,0.0882165743363285
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.00966519782855572,0.00568060368675742,-0.00146878539748883,0.0207991810546003,0.0888881163666548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.00688473328135786,0.00405005363734019,-0.0148228384105446,0.00105337184782891,0.0891757224160565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0122258733057044,0.00719458639105579,-0.00187551602076498,0.0263272626321737,0.0892876008287631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROS,Uroporphyrinogen-III synthase,39649,0.0113611499137388,0.00670253383312975,-0.00177581639919551,0.0244981162266731,0.0900935491879283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.011922507729289,0.00703515026209542,-0.025711402242996,0.00186638678441803,0.0901596460814908
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GKN1,Gastrokine-1,41538,0.00485858921483676,0.00286881558262863,-0.000764289327115353,0.0104814677567889,0.0903678324364135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NINJ1,Ninjurin-1,41843,0.00929054827443877,0.00548975426711059,-0.00146937008909799,0.0200504666379755,0.0906040801788522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL4,Early placenta insulin-like peptide,39919,-0.00823168097263555,0.00487812224300747,-0.0177928005689302,0.00132943862365909,0.0915407220237885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,39586,0.0157168199078206,0.00932961040950671,-0.00256921649481252,0.0340028563104538,0.0920909019294169
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL1,Interferon lambda-1,41839,-0.00773784611061105,0.00459409622468599,-0.0167422747109956,0.00126658248977349,0.0921468639716203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.012924364001321,0.0076906877599926,-0.00214938400826446,0.0279981120109065,0.0928794313238264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN1,Transcobalamin-1,39806,-0.00606781721740628,0.00361659461486263,-0.013156342662537,0.00102070822772448,0.093419717914761
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMCH,Pro-MCH,39575,-0.0140175527237502,0.00837759595242566,-0.0304376407905045,0.00240253534300411,0.0943126904116531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRND,Prion-like protein doppel,39929,-0.00829755497072041,0.00496123434498781,-0.0180215742868965,0.00142646434545569,0.0944577279915985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0061873955677516,0.00370230159375646,-0.0134439066915143,0.00106911555601105,0.0947039786681684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0055309056619429,0.00331121660148783,-0.012020890200859,0.000959078876973236,0.0948723714284198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00576802956337119,0.0034538818027502,-0.0125376378967616,0.0010015787700192,0.0949451907153323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,42057,0.00798397002386602,0.00478977970108842,-0.00140399819026729,0.0173719382379993,0.0955622852217367
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,39090,0.0095438106619028,0.00574305557164922,-0.00171257825852967,0.0208001995823353,0.0965827304025438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON1,Spondin-1,42144,-0.00547629575713614,0.00329803978045449,-0.0119404537268269,0.000987862212554663,0.0968431078903729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR2,Toll-like receptor 2,39757,-0.0038986385490309,0.00234839640563581,-0.00850149550407708,0.00070421840601528,0.0969168138751161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOC,Brother of CDO,41900,-0.0038873513876044,0.00235308262423835,-0.00849939333111156,0.000724690555902771,0.0985530548283067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRLB,Fc receptor-like B,41843,-0.010288361499102,0.00622902709217673,-0.0224972545997684,0.00192053160156441,0.0986234442023041
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.00636192699404982,0.00385258961030201,-0.0139130026302418,0.00118914864214212,0.098692805521268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA10,Ephrin type-A receptor 10,41839,0.0109352212652698,0.00664484035444689,-0.00208866582944611,0.0239591083599857,0.0998552448279464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB5,Integrin beta-5,42181,0.00638200593534968,0.0038849106727975,-0.00123241898333343,0.0139964308540328,0.100454147016733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",39575,-0.00671542118415155,0.00409262272987676,-0.01473696173471,0.0013061193664069,0.100855122303531
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME1,Nucleoside diphosphate kinase A,39657,-0.0036532520887427,0.002228037843184,-0.00802020626138335,0.000713702083897942,0.101101754407607
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0246057088623008,0.0150314737257227,-0.00485597964011575,0.0540673973647174,0.101665547811844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.00449114264966349,0.00276057471259176,-0.000919583787016358,0.00990186908634334,0.103788855261265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,42212,0.0137671420762899,0.00846305727136232,-0.00282045017558021,0.0303547343281601,0.103816774499644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53BP1,TP53-binding protein 1,39657,-0.0141751548747593,0.00873263427166559,-0.0312911180472239,0.00294080829770523,0.104566773248265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO3,R-spondin-3,42262,-0.00459952651755292,0.00284143369579013,-0.0101687365613016,0.000969683526195727,0.105527501226302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00488078733189529,0.00304501440467816,-0.0108490155650645,0.0010874409012739,0.108989404035148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0242898741325205,0.0151599272887612,-0.0540033316184926,0.00542358335345152,0.10912544089647
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,42262,-0.00995919798827538,0.00621681405796288,-0.0221441535418826,0.00222575756533186,0.109183641902613
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171B,Protein FAM171B,39919,0.00430397142178592,0.00269090685320203,-0.000970206010490057,0.00957814885406189,0.109748522315878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP29,Dual specificity phosphatase 29,39649,-0.0109159063686487,0.00682828635287531,-0.0242993476202843,0.0024675348829869,0.109931337118565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.00575831134955864,0.00360852922969066,-0.00131440594063504,0.0128310286397523,0.110568430502121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0058738695571314,0.00368860916282996,-0.00135580440201532,0.0131035435162781,0.111314995059225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4,Interleukin-4,41913,0.0152085428885776,0.00955090381842792,-0.00351122859554108,0.0339283143726963,0.111326035409471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALB,Ras-related protein Ral-B,39657,0.00479014048937462,0.0030115015880502,-0.00111240262320378,0.010692683601953,0.111724768370621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00556079555242218,0.00350364724774851,-0.0124279441580092,0.0013063530531649,0.112508629511005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,42137,-0.00430739576079105,0.00272565052380961,-0.00964967078745788,0.00103487926587579,0.114057324474791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI16,Peptidase inhibitor 16,39990,0.00385966336817577,0.00244859542244093,-0.000939583659808461,0.00865891039615999,0.114989872115765
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOD,Apolipoprotein D,39468,0.00678411327551416,0.00431574586074183,-0.00167474861153983,0.0152429751625681,0.115992516757921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.00969640152591817,0.00616866070351344,-0.00239417345296817,0.0217869765048045,0.116001902468034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB39B,Ras-related protein Rab-39B,39575,0.0146758238319073,0.00937350789906203,-0.00369625165025432,0.0330478993140688,0.117454630901786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.00530398799099094,0.00338999603438237,-0.0013404042363985,0.0119483802183804,0.117699876363222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.00429560906575558,0.00275267517935571,-0.00969085241729277,0.00109963428578162,0.118659964099709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNG,Uracil-DNA glycosylase,39919,0.00555703736599425,0.00356951897773862,-0.00143921983037344,0.0125532945623619,0.119545254820375
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,39757,0.00828487550810245,0.00532775825131515,-0.00215753066447525,0.0187272816806801,0.119964982164098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI4,Protein-arginine deiminase type-4,41814,0.0114793999063434,0.00738338137308587,-0.00299202758490495,0.0259508273975917,0.120026739436528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH2,Growth hormone variant,41843,0.0254581924646276,0.0163801487132442,-0.00664689901333111,0.0575632839425863,0.120158206733642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.00492283227124433,0.00318018152183092,-0.0111559880540329,0.00131032351154428,0.121652783526671
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",41900,-0.00681278561601316,0.00441425305366434,-0.0154647216011953,0.00183915036916895,0.122767023745553
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,41987,-0.00579543542668061,0.00375754131329626,-0.0131602164007413,0.00156934554738006,0.123012745386787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EP300,Histone acetyltransferase p300,39657,0.00480929018771519,0.00312687117511855,-0.00131937731551717,0.0109379576909476,0.12406453705926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC4,MANSC domain-containing protein 4,39575,0.0105921173988989,0.00689986241870154,-0.00293161294175615,0.0241158477395539,0.124783158788413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0104941091076868,0.0068368257252428,-0.00290606931378907,0.0238942875291627,0.124826773122638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF7,Fibroblast growth factor 7,39560,-0.0120850641886677,0.00789660742145043,-0.0275624147347106,0.0033922863573751,0.125943596209026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,39966,-0.00537886952145367,0.00351957039806998,-0.0122772275016708,0.00151948845876349,0.126472237499106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2BP,LRP2-binding protein,39649,-0.0120184252192911,0.00787836012307205,-0.0274600110605124,0.00342316062193009,0.127163471517965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAG,Myelin-associated glycoprotein,39649,0.00750991438484698,0.00493249909628181,-0.00215778384386535,0.0171776126135593,0.127903097664774
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX1,Neuronal pentraxin-1,42137,0.00642931949013497,0.00422458962688645,-0.00185087617856247,0.0147095151588324,0.128062447654581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00679570035730635,0.00446643589149959,-0.0155499147046455,0.00195851399003284,0.128161326081479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00519472723055281,0.00342152014065814,-0.0119009067062428,0.00151145224513715,0.128979711630886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.00906502062550021,0.0059709043836089,-0.0207679932173737,0.00263795196637324,0.128993033035377
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,42119,0.00562621044541028,0.00370724622681742,-0.00163999215915185,0.0128924130499724,0.129132283028356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00532882254734278,0.00351175573529555,-0.0122118637885221,0.00155421869383649,0.129183404525308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG3,Proteoglycan 3,39966,-0.00765692477452985,0.00504762614589464,-0.0175502720204833,0.00223642247142364,0.129310706228716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDI2,Protein DDI1 homolog 2,39736,0.0115410687125577,0.00761199046369617,-0.0033784325962868,0.0264605700214022,0.12950485089422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAST,Gastrin,39929,-0.0200887969360264,0.0132850096434353,-0.0461274158371596,0.00594982196510684,0.130526096811548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD1,Glutamate decarboxylase 1,39560,0.00404174038935909,0.00267576191665479,-0.00120275296728429,0.00928623374600247,0.130944526090867
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUCL3,Mucin-like protein 3,39560,-0.0065227226357554,0.0043296396056313,-0.0150088162627928,0.00196337099128195,0.131960543924067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC5D,Netrin receptor UNC5D,39657,0.00398542122871164,0.00265180521176233,-0.00121211698634254,0.00918295944376581,0.132891137705958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00632977619697069,0.0042124110477619,-0.00192654945664263,0.014586101850584,0.13295337381658
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00317511157404688,0.00211370672904015,-0.00731797676296556,0.000967753614871812,0.133086288177303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,39930,-0.00660136619967051,0.00442685780630581,-0.0152780075000299,0.00207527510068888,0.135934708538397
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGN,Mimecan,42137,-0.00650938304305451,0.00437511459270326,-0.0150846076447529,0.00206584155864389,0.136821659245333
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0254594574990239,0.0171133199947681,-0.00808264969072152,0.0590015646887693,0.136854112627091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB6,Ephrin type-B receptor 6,41997,0.00492685995856376,0.00331835700022353,-0.00157711976187436,0.0114308396790019,0.137639226874959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD82,CD82 antigen,39757,-0.00623843706634985,0.00420437647104966,-0.0144790149496072,0.00200214081690748,0.137891291980426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,39586,-0.0083945993525419,0.00566519838504304,-0.0194983881872263,0.00270918948214245,0.138426504355168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,39930,0.00801442321997903,0.00541380200620772,-0.00259662871218811,0.0186254751521462,0.138802674767243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.00970488990937411,0.00656601034717746,-0.0225742701898419,0.00316449037109371,0.139422968634103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR4,Toll-like receptor 4,39657,0.00425948161630985,0.00288292835873792,-0.00139105796681646,0.00991002119943617,0.139574324146856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00474562198975748,0.00321352290959821,-0.01104412689257,0.00155288291305501,0.139762100083222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNG,Interferon gamma,41913,0.017046850508371,0.0115556730277975,-0.00560226862611202,0.0396959696428541,0.14018425184487
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO6,Coronin-6,39586,-0.00583336942533085,0.00396295689383965,-0.0136007649372566,0.00193402608659486,0.141056549377676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMD,Osteomodulin,42185,-0.0061076956304555,0.00414984079372601,-0.0142413835861585,0.00202599232524747,0.141100664689808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OCLN,Occludin,39934,0.00659000983295236,0.00449091078206514,-0.00221217529989532,0.0153921949658,0.142292155388322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,42119,0.00659042759703205,0.00450599452767808,-0.00224132167721699,0.0154221768712811,0.143602539844488
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,42247,-0.00419239837826306,0.00286741630338264,-0.00981253433289304,0.00142773757636692,0.143741708266021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00646109365885315,0.00444043048237733,-0.0151643374043127,0.00224215008660642,0.14568030074176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM19,Probable RNA-binding protein 19,39575,-0.00709377796668459,0.00488215091854285,-0.0166627937670286,0.0024752378336594,0.146251623064696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00866005371666169,0.00597267244036265,-0.00304638426644911,0.0203664916997725,0.147102136543752
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEFL,Neurofilament light polypeptide,41797,-0.0069230714076005,0.00477987548170277,-0.0162916273517379,0.00244548453653693,0.147534834088159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,39560,0.00588015465035216,0.00406067764638268,-0.00207877353655789,0.0138390828372622,0.147625448026243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,41839,0.00743826001851173,0.00514691412885609,-0.0026496916740462,0.0175262117110697,0.14842867380927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0044629341132555,0.00309033013132021,-0.00159411294413211,0.0105199811706431,0.148716675288726
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,39919,0.00424877884277929,0.00294259267933506,-0.00151870280871743,0.010016260494276,0.148797721097385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RYR1,Ryanodine receptor 1,39575,-0.00494534994902794,0.00342760298024931,-0.0116634517903166,0.00177275189226071,0.149104998417227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,41843,-0.00444247958298189,0.00308399403038872,-0.0104871078825438,0.00160214871658001,0.149750897452961
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0103934895218089,0.0072196374945395,-0.0245439790111063,0.00375699996748853,0.150004332793456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN4,Prefoldin subunit 4,39560,-0.00771469986751639,0.00536252855513365,-0.0182252558355783,0.00279585610054556,0.150283650538398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST6,Cystatin-M,41864,0.00718728106885221,0.00503447774509536,-0.00268029531153469,0.0170548574492391,0.153427096821226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0100631294909576,0.00705468766019162,-0.0238903173049332,0.00376405832301793,0.153768150033178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.00989560248964516,0.00693767964491945,-0.00370224961439696,0.0234934545936873,0.15378912531102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.00776352514500331,0.00544449939845516,-0.0029076936759688,0.0184347439659754,0.153913432361322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPS10,40S ribosomal protein S10,39575,-0.00603905123432417,0.00423904429904312,-0.0143475780604487,0.00226947559180034,0.154293875520338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGN,Cingulin,39649,-0.00540313658389534,0.00379501925747273,-0.0128413743285419,0.00203510116075121,0.154548777169007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLHL41,Kelch-like protein 41,39934,-0.00757674159391183,0.00532181220302304,-0.018007493511837,0.00285401032401333,0.154556640722438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00455487311478735,0.00319983901851689,-0.0108265575910804,0.00171681136150574,0.154628507730513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00684631549326704,0.00481687330064354,-0.0162873871625284,0.0025947561759943,0.155252147387506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRK1,Protein BRICK1,41839,0.00652218016839783,0.00459026164039917,-0.00247473264678454,0.0155190929835802,0.155377150462794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00461365285396503,0.00326006342631479,-0.011003377169542,0.00177607146161196,0.157031857008121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG3,Secretogranin-3,42144,-0.00475473897159079,0.00336538084613335,-0.0113508854300122,0.00184140748683058,0.157726251209371
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX101,Testis-expressed protein 101,39649,0.00881921001100264,0.00624514871794073,-0.0034212814761612,0.0210597014981665,0.157928152510588
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEL1L,Protein sel-1 homolog 1,39638,0.00449494842724273,0.00318904808082034,-0.00175558581116513,0.0107454826656506,0.158716921581024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00880240742238685,0.00624852480812689,-0.0210495160463156,0.00344470120154186,0.158946991679917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00516819615171609,0.00367043401147109,-0.0123622468141994,0.00202585451076725,0.159141048808479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPN3,Calpain-3,39919,-0.00555800374201715,0.00395381384878757,-0.0133074788856408,0.00219147140160648,0.159831086771165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.00538480278280035,0.00383419971047527,-0.00213022864973118,0.0128998342153319,0.160223816929071
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAG,S-arrestin,39586,-0.00744063552747216,0.00530700072763186,-0.0178423569536306,0.00296108589868629,0.160931092875241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSPN,Claspin,41820,0.00503584748311161,0.00359301825103752,-0.00200646828892194,0.0120781632551452,0.16106875588063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUOX2,Dual oxidase 2,41900,0.00996522714149958,0.00711365575870567,-0.00397753814556354,0.0239079924285627,0.161279637275975
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPE4,NXPE family member 4,39575,-0.00452473372740925,0.00324829938916154,-0.0108914005301659,0.00184193307534737,0.163661719692734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00556903586011706,0.00399821817321355,-0.0134055434796156,0.00226747175938151,0.163684005983946
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL15,C-C motif chemokine 15,42310,0.00612238998859814,0.00440415243197931,-0.00250974877808132,0.0147545287552776,0.16450883172684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00373638160292527,0.00270183166148166,-0.00155920845357878,0.00903197165942932,0.166721641052717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD70,CD70 antigen,42119,0.00617145371849016,0.00446706751406647,-0.00258399860908011,0.0149269060460604,0.167134356178262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYMP,Thymidine phosphorylase,42070,-0.00928052175784562,0.00672451906655639,-0.0224605791282961,0.00389953561260491,0.167578166763037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,42296,0.00343747241945749,0.00249498836158778,-0.00145270476925456,0.00832764960816955,0.168302725993474
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PREB,Prolactin regulatory element-binding protein,41913,0.00394849064222539,0.00286951253760775,-0.0016757539314858,0.00957273521593658,0.168840313806719
NMR metabolomics,X23503.Total Lipids in Medium VLDL,H2AP,Huntingtin-interacting protein M,39560,-0.00704092584825169,0.00511875520821579,-0.0170736860563546,0.00299183435985127,0.168999872352695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0077578814235508,0.00564909856917656,-0.00331435177203526,0.0188301146191368,0.169687690249163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.00583563672895994,0.00425585997643737,-0.0025058488248573,0.0141771222827772,0.170335640945625
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.00523416370347876,0.00382446534850057,-0.00226178837958237,0.0127301157865399,0.171147050529476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L15,Bcl-2-like protein 15,39657,-0.0078586696550987,0.00575029108090927,-0.0191292401736809,0.00341190086348347,0.17176095173717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00689233124166304,0.00505398272973003,-0.0167981373919339,0.00301347490860783,0.172676579985478
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA1,Ephrin-A1,42113,-0.00405753759125754,0.00297912055696233,-0.00989661388290371,0.00178153870038864,0.173223195296944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC44A4,Choline transporter-like protein 4,39649,-0.00949598250646311,0.00697686682288946,-0.0231706414793264,0.00417867646640024,0.173520306271976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM25,RNA-binding protein 25,39560,-0.0064205056367756,0.00475736031034815,-0.015744931845058,0.00290392057150676,0.177174077205202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.00593111459149763,0.00439863948022017,-0.0145524479727292,0.00269021878973389,0.177557427476544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.011054412732279,0.00820863002297771,-0.00503450211275735,0.0271433275773153,0.178110355570124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.007411504896216,0.00550414794509655,-0.00337662507617324,0.0181996348686052,0.178159229933806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN7,Tetraspanin-7,39586,-0.013329567612017,0.0099021405155379,-0.0327377630224713,0.00607862779843732,0.178288396425878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH3,Cadherin-3,42249,0.00500883929989325,0.00372341980710386,-0.00228906352203032,0.0123067421218168,0.178574770350819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBS,Cystathionine beta-synthase,39638,0.00705367632554499,0.00524808751233112,-0.00323257519862401,0.017339927849714,0.178960809902139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.00373715162167672,0.00279254429208443,-0.00173623519080876,0.0092105384341622,0.180833942654247
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6B,Ras-related protein Rab-6B,41839,0.00639504899573278,0.00478649493417824,-0.00298648107525657,0.0157765790667221,0.18155231496167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTR,Methionine synthase,39575,0.00875789810972205,0.00663242129835204,-0.00424164763504795,0.0217574438544921,0.186706448205268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPLX2,Complexin-2,39560,-0.00411207753317646,0.00311474617255678,-0.0102169800313878,0.00199282496503483,0.186796932861908
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN10,Ataxin-10,41839,0.0097851721376343,0.00741283647090205,-0.00474398734533372,0.0243143316206023,0.186847572064622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.00383802489987462,0.00291546476384607,-0.00187628603726368,0.00955233583701291,0.188054065108919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.0045518686692118,0.00346419425955647,-0.0113416894179425,0.00223795207951889,0.188876603610203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.00874371677062389,0.0066551974473076,-0.0217879037673468,0.00430047022609901,0.188929754162011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",39575,-0.00839561221984972,0.00639487504893706,-0.0209295673157664,0.00413834287606691,0.189255651328179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00783464114668152,0.00597399534484748,-0.00387438972921955,0.0195436720225826,0.189730669737099
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00321000779405932,0.0024505904175916,-0.00801316501253886,0.00159314942442022,0.190259058820913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00662915641685791,0.00507355114121642,-0.0165733166536421,0.00331500381992628,0.191372298304644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00415583435810806,0.00318704145799601,-0.00209076689956411,0.0104024356157802,0.192267307486439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00530828218473127,0.0040811789361964,-0.0133073928996762,0.00269082853021367,0.193397025478586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOS,Proto-oncogene c-Fos,39539,-0.00476451560578016,0.00366757324148588,-0.0119529591590925,0.00242392794753216,0.193939687136542
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00347541673697537,0.00267719467173231,-0.00872271829357069,0.00177188481961995,0.194259966899688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00543680617902328,0.00420111478705447,-0.01367099116165,0.00279737880360349,0.195646110829426
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THY1,Thy-1 membrane glycoprotein,42249,-0.00381734631532628,0.00295483557143449,-0.00960882403533789,0.00197413140468532,0.196414326874925
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00831451827498629,0.00644395298408097,-0.020944666123785,0.00431562957381241,0.196974570810563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERVV_1,,39575,0.00569129323082597,0.00442444451769002,-0.00298061802384647,0.0143632044854984,0.198355247312029
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00681620316991883,0.00530258111101954,-0.00357685580767946,0.0172092621475171,0.198657545154042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI2,Protein-arginine deiminase type-2,41913,-0.00741668638582633,0.00577007931442027,-0.0187260418420901,0.0038926690704374,0.198685406856301
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALMS1,Alstrom syndrome protein 1,39757,-0.00579040008373325,0.00450557359458658,-0.014621324329123,0.00304052416165646,0.198761728081526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN6,Prefoldin subunit 6,39649,0.00843334137161963,0.00657538924078501,-0.00445442154031899,0.0213211042835582,0.199672636364115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MELTF,Melanotransferrin,39958,0.00390792138529636,0.00305030222214262,-0.00207067097010318,0.00988651374069589,0.200164067885226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.00361525766262462,0.0028293935698063,-0.00193035373419572,0.00916086905944496,0.201359243925782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0066336704956094,0.00519213492828805,-0.016810254955054,0.00354291396383518,0.201403829421344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00386741931085754,0.00303372019494707,-0.00207867227123873,0.0098135108929538,0.202402999923819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD9,Enhancer of filamentation 1,39657,0.00437435171530201,0.00343867653345928,-0.00236545429027819,0.0111141577208822,0.203363176755869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMP,Olfactory marker protein,39586,-0.00617629295137159,0.00486682018025112,-0.0157152605046638,0.0033626746019206,0.204446101415357
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5,Interleukin-5,41913,0.0177391823762824,0.0139794051519854,-0.00966045172160897,0.0451388164741737,0.20448066918821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBQLN3,Ubiquilin-3,39575,-0.00723907909370818,0.00570914640546421,-0.018429006048418,0.00395084786100166,0.204832264205414
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00454844432962692,0.00358898125269794,-0.0115828475849149,0.00248595892566103,0.205057055199225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00966165706446615,0.00764638003021313,-0.00532524779475158,0.0246485619236839,0.206410383344166
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX2,Transcription factor SOX-2,39915,0.00314506968178538,0.00249146613002766,-0.00173820393306884,0.0080283432966396,0.206853593598032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF174,Zinc finger protein 174,39657,0.0047124022315506,0.00373464654326851,-0.00260750499325568,0.0120323094563569,0.207044948014116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,42145,0.00584656589759549,0.0046558229008689,-0.00327884698810755,0.0149719787832985,0.209227016707662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,41900,0.00658364529539522,0.0052461698311829,-0.00369884757372326,0.0168661381645137,0.209521421003979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.00657046572552187,0.00524368955719831,-0.00370716580658682,0.0168480972576306,0.210219313768494
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTOA,Otoancorin,39586,-0.00667925294217214,0.00533339469731661,-0.0171327065489127,0.00377420066456842,0.210470648725434
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAU,Urokinase-type plasminogen activator,42137,-0.00360945778672693,0.0028891997382146,-0.00927228927362754,0.00205337370017369,0.211579429549081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB44,Ras-related protein Rab-44,39919,0.00567185715762902,0.00454833982546955,-0.00324288890029129,0.0145866032155493,0.212417060652622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0132958267099403,0.0107013323282368,-0.0342704380732844,0.00767878465340386,0.214098449540661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MENT,Protein MENT,39736,-0.00299479878509401,0.00241619391915092,-0.00773053886662982,0.0017409412964418,0.215197779410145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDRG1,Protein NDRG1,41839,0.0082458367835267,0.00667218032210158,-0.00483163664779239,0.0213233102148458,0.216534986285076
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RA,Interleukin-17 receptor A,42137,0.0055442403467274,0.00448894774252647,-0.00325409722862448,0.0143425779220793,0.216819617003747
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,39657,0.00895981238884587,0.00725945876908037,-0.00526872679855165,0.0231883515762434,0.217144951585471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_A,,39934,-0.00409610735365355,0.0033299926808411,-0.0106228930081021,0.002430678300795,0.218698306291797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00563045366338205,0.00457880305381018,-0.00334400032208589,0.01460490764885,0.218843615244941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00582065259516376,0.00477684448975389,-0.00354196260475386,0.0151832677950814,0.223054047508159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,39649,0.00955946446197971,0.00785154625461323,-0.00582956619706222,0.0249484951210216,0.223430018291091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH15,Cadherin-15,42230,0.00849216595187675,0.00699448897060044,-0.00521703243050013,0.0222013643342536,0.224722011405843
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB1,Scavenger receptor class B member 1,41839,0.00681440463757617,0.00561482009383956,-0.00419064274634936,0.0178194520215017,0.22490453725629
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0143708729874491,0.0119626883650153,-0.0378177421828791,0.00907599620798089,0.229656858742448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.00831302906522516,0.00699735880147303,-0.00540179418566198,0.0220278523161123,0.234849307063049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXOSC10,Exosome component 10,39575,-0.00702163583081571,0.00591840443920021,-0.0186217085316481,0.0045784368700167,0.235487332257496
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00500474051019848,0.00422559923422251,-0.00327743398887765,0.0132869150092746,0.236285141733547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00737419872554253,0.00622644676554249,-0.00482963693492075,0.0195780343860058,0.236305354181867
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.00392721976067657,0.00332955662764816,-0.010453150750867,0.00259871122951383,0.238218931943419
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,42119,0.00577579612214915,0.00490021956672228,-0.00382863422862651,0.0153802264729248,0.238545934651931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP7,Retinoid-binding protein 7,39930,-0.00745666590945837,0.00633483048054025,-0.0198729336513173,0.00495960183240052,0.239184294091186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,39767,0.004763172221909,0.00405281536576888,-0.003180345894998,0.012706690338816,0.239909806010903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI2B,Protein EVI2B,39560,-0.00476636809682978,0.0040600145716354,-0.0127239966572352,0.0031912604635756,0.240429316175571
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI3,Elafin,41966,-0.00667404482661553,0.00568573888930359,-0.0178180930496506,0.00447000339641951,0.240487285187798
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.00993592314602028,0.00850626351491569,-0.026608199635255,0.00673635334321448,0.242803338375621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00880564345244093,0.00754617613164108,-0.00598486176557559,0.0235961486704574,0.24327474297221
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNPO1,Transportin-1,39757,0.00419824120560988,0.0036001018067257,-0.0028579583355725,0.0112544407467923,0.243580697879113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00694557047089543,0.00596314587261505,-0.00474219543943007,0.0186333363812209,0.244145744455529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.00612485190201225,0.00527306550511751,-0.0164600602920426,0.00421035648801807,0.245444742456583
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00539591236694393,0.00465887307024576,-0.0145273035846256,0.00373547885073776,0.246806955468288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0059641881429661,0.00515584471079064,-0.00414126749018356,0.0160696437761158,0.247386632169073
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF1,Formylglycine-generating enzyme,39657,0.00773513146890558,0.00670997528285112,-0.00541642008548261,0.0208866830232938,0.249025239231354
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,39649,0.00489413558447954,0.0042603144034404,-0.00345608064626364,0.0132443518152227,0.250674325571302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAEP,Glycodelin,42016,-0.0121196502300704,0.0105995993938075,-0.0328948650419331,0.00865556458179223,0.252890281111594
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLON5,IgLON family member 5,39560,-0.0107108486871214,0.00941418021931272,-0.0291626419169743,0.00774094454273156,0.255255742939215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,39929,-0.00544046524970869,0.00478248171538077,-0.014814129411855,0.00393319891243762,0.255319112737078
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00523041437772634,0.00459923831443101,-0.0142449214740111,0.00378409271855844,0.255464899133641
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVPL,Envoplakin,39757,0.0038380735276701,0.00338815408411832,-0.00280270847720181,0.010478855532542,0.257325993578172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00631548842801553,0.00559231662636372,-0.0172764290156884,0.00464545215965736,0.258789587865006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GJA8,Gap junction alpha-8 protein,39560,-0.00714343284520656,0.00634073991036969,-0.0195712830695311,0.00528441737911803,0.25993928940533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OBP2B,Odorant-binding protein 2b,41979,0.00652999201486922,0.00579854269342481,-0.00483515166424341,0.0178951356939819,0.260124921233485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.00673860580528693,0.00600895824770029,-0.0185161639707795,0.00503895236020564,0.262130841209355
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR1,TGF-beta receptor type-1,39657,-0.00250206147311871,0.00223261325278388,-0.00687798344857512,0.00187386050233769,0.2624453004056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTNNA1,Catenin alpha-1,39586,-0.00383386774129141,0.00343260341576246,-0.0105617704361858,0.002894034953603,0.264062384414644
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,41843,-0.00362377289938372,0.00325501577213097,-0.0100036038127604,0.00275605801399299,0.26560458251082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL25,Interleukin-25,39510,0.00388536701436593,0.00349043931283262,-0.00295589403878601,0.0107266280675179,0.265670444979282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP1,Dipeptidase 1,41997,-0.00517108800897748,0.00465035040392919,-0.0142857748006787,0.00394359878272374,0.266167501699929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP6,Guanylate-binding protein 6,39575,-0.00504241914619472,0.00453970753887978,-0.0139402459223991,0.00385540763000965,0.266706093009747
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,42145,0.00321494011189656,0.00290543725402864,-0.00247971690599957,0.0089095971297927,0.268518828845601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00339630143159804,0.00307233533966639,-0.00941807869734416,0.00262547583414808,0.268986199904197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPE,Coatomer subunit epsilon,41839,0.00518207797967013,0.00468848475578481,-0.00400735214166809,0.0143715081010083,0.269059332576269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00514064069161143,0.00466393567550101,-0.00400067323237054,0.0142819546155934,0.270393402914041
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD9,COMM domain-containing protein 9,39919,0.0044316750461035,0.0040400286016621,-0.00348678101315421,0.0123501311053612,0.272690300474553
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS8,Prostasin,42080,-0.00461169986416044,0.00422059275899888,-0.0128840616717983,0.00366066194347737,0.274559827571179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,42118,-0.00535583913582975,0.00491039808464951,-0.0149802193817428,0.00426854111008329,0.275418260978738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.00586382383699554,0.00538322673184989,-0.00468730055743025,0.0164149482314213,0.276051243321264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00682239560349339,0.00627795677356494,-0.0054823996726939,0.0191271908796807,0.27718339969497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A3,Protein S100-A3,39919,0.00469962901180757,0.00432646279240707,-0.00378023806131028,0.0131794960849254,0.277390633729879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GL3,Endophilin-A3,39690,0.00937386245651316,0.00864458967550135,-0.00756953330746947,0.0263172582204958,0.278228005369401
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WIF1,Wnt inhibitory factor 1,42262,-0.00369020652015717,0.00340318753413439,-0.0103604540870606,0.00298004104674624,0.278233972681267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLN,Mesothelin,42048,-0.00637286995530049,0.00588184051697615,-0.0179012773685737,0.00515553745797276,0.278613838560791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIF,Leukemia inhibitory factor,41839,0.00541508806767969,0.00505964964236435,-0.00450182523135445,0.0153320013667138,0.284526479712735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,39638,0.0104372465376048,0.00976571214503774,-0.00870354926666917,0.0295780423418788,0.285199167700821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D17,TBC1 domain family member 17,41839,0.00464879478064085,0.00435205531150077,-0.00388123362990067,0.0131788231911824,0.285457108163864
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL24,Interleukin-24,41913,-0.00520955132709135,0.00487983142104957,-0.0147740209123485,0.0043549182581658,0.285734833009947
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00372645607489119,0.00350009885777697,-0.010586649836134,0.00313373768635167,0.287043372634381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB118,Beta-defensin 118,39586,0.00614815452979143,0.00578438671431706,-0.00518924343027001,0.0174855524898529,0.287856162922558
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLGN,Calmegin,39649,-0.00492109558023542,0.00463179494308644,-0.0139994136686848,0.00415722250821401,0.288050253501352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRAXIN,Draxin,42016,-0.00457323250078057,0.00430453706785068,-0.0130101251537679,0.00386366015220677,0.288063525003938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN2,Nectin-2,42129,-0.00332236476098046,0.00312794279607795,-0.00945313264129325,0.00280840311933233,0.288183604971589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPN1,Epsin-1,39757,0.0046617463279553,0.00438943364730236,-0.00394154362075732,0.0132650362766679,0.288241319061865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFB,Vascular endothelial growth factor B,39657,0.00318249252633855,0.00299967849125757,-0.0026968773165263,0.00906186236920339,0.288738277885167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0060127493378737,0.00567127505512169,-0.00510294977016481,0.0171284484459122,0.289067760366734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK1,Cyclin-dependent kinase 1,39560,0.00392690376133667,0.00370718859500123,-0.00333918588486574,0.0111929934075391,0.289501393284525
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.00782718322622412,0.00739757491287049,-0.0223264300554503,0.00667206360300204,0.290040515206188
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.00422824743904965,0.00399720580904519,-0.0120627708247782,0.00360627594667893,0.290169373780203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00815335419521582,0.0077378203954414,-0.023319482170281,0.00701277377984932,0.292042347160813
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCP2,Non-specific lipid-transfer protein,41843,0.0078984810318976,0.00750065567778872,-0.00680280409656828,0.0225997661603635,0.292342448391225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.0113137214825472,0.0107571037495445,-0.0323976448316544,0.00977020186655999,0.292940082146069
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1,Programmed cell death protein 1,42232,-0.00445679929793661,0.00423846783025576,-0.0127641962452379,0.00385059764936467,0.293042192754111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00517129344240428,0.00492313474005732,-0.00447805064810807,0.0148206375329166,0.293554297284631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBZ,Hemoglobin subunit zeta,39958,-0.0114230839370124,0.0108901222116855,-0.0327677234719161,0.00992155559789129,0.29422808921127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,39575,0.00416749718288104,0.00397608685516541,-0.00362563305324316,0.0119606274190052,0.294597015990963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR3,Folate receptor gamma,42132,-0.0202525890689042,0.0194159710918953,-0.0583078924090189,0.0178027142712105,0.296925632470609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JUN,Transcription factor AP-1,41913,-0.00507701350276255,0.00488568735280051,-0.0146529607142516,0.00449893370872645,0.298748951741059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,39649,0.0038386172188271,0.0037214018467916,-0.00345533040088443,0.0111325648385386,0.302330092551652
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00538817782345176,0.00523140057734135,-0.00486536730813729,0.0156417229550408,0.303047118285638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",39958,-0.00566381793435392,0.00551441584602678,-0.0164720729925664,0.00514443712385857,0.304398545400455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,39586,0.0122240550042998,0.0119274850801231,-0.0111538157527415,0.0356019257613411,0.30544973332034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN1,Contactin-1,42310,0.00276742055753026,0.0027021123099831,-0.00252871957003661,0.00806356068509713,0.305773371889819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCNA,Proliferating cell nuclear antigen,39560,0.00669683825751864,0.00655120260329569,-0.00614351884494091,0.0195371953599782,0.306694442478289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOBR,Apolipoprotein B receptor,39638,-0.00445279356203635,0.00435714108978207,-0.0129927900980092,0.00408720297393651,0.306825526061622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH23,Cadherin-23,39929,-0.00276236606991434,0.00271616598447821,-0.00808605139949163,0.00256131925966294,0.309170722867293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRL,Prolactin,42249,-0.00756223587212199,0.00743931363555503,-0.0221432905978098,0.00701881885356587,0.309398261614924
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00301767895445042,0.00298568991496108,-0.00886963118777415,0.0028342732788733,0.312175536614955
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.00457510488348913,0.00452671516056591,-0.0134474665981983,0.00429725683122005,0.312182980375866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,41900,0.0048905680808024,0.00484044625500258,-0.00459670657900266,0.0143778427406075,0.31234371805865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNB2,Ephrin-B2,39649,-0.00589559219790597,0.00586593450969167,-0.0173928238369016,0.0056016394410897,0.314891934254178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00373364067825205,0.00372210256524797,-0.0110289617061381,0.00356168034963397,0.315834634261519
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK4,Dickkopf-related protein 4,41992,0.00468058421732659,0.00466820364890368,-0.00446909493452463,0.0138302633691778,0.316046861858667
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPEP,Aspartyl aminopeptidase,39929,-0.00579314710674304,0.00577846376366253,-0.0171189360835216,0.00553264187003552,0.316103764946476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCIN,Adseverin,39586,-0.0075001424120261,0.0074897997921467,-0.0221801500046336,0.00717986518058143,0.316664752669498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00579477626002153,0.00580043989981296,-0.0171636384636549,0.00557408594361186,0.317805269871287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.005790928439864,0.00579904841647675,-0.0171570633361584,0.00557520645643043,0.318010462313723
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR3,Small proline-rich protein 3,39929,0.00637987522960291,0.00639557848208024,-0.00615545859527435,0.0189152090544802,0.318521507878422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA1,Laminin subunit alpha-1,39575,-0.0052130533030018,0.00524759963226125,-0.0154983485822339,0.00507224197623026,0.32052880987974
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.00460523482873939,0.00463628655160593,-0.00448188681240824,0.013692356469887,0.320583841401913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.00822578829703218,0.00830816447688999,-0.0245097906717366,0.0080582140776722,0.322154088526998
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANK2,Ankyrin-2,39575,-0.00702349327611826,0.00709661188123807,-0.0209328525633449,0.00688586601110836,0.322344212884342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00395494336837955,0.00400932340718613,-0.0118132172464644,0.00390333050970528,0.32394065597489
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,39575,0.0046306822503449,0.00471684307630188,-0.00461433017920679,0.0138756946798966,0.326252861568522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.00430050189862926,0.00438789292378224,-0.00429976823198393,0.0129007720292424,0.327062662875581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX33,Testis-expressed protein 33,39757,-0.00380514376295521,0.00391338780670462,-0.0114753838640963,0.00386509633818585,0.330902476544129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TUBB3,Tubulin beta-3 chain,39586,-0.00282124374187373,0.00290538638424574,-0.00851580105499537,0.00287331357124791,0.331550192875661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00212911022314643,0.00219330480736242,-0.00216976719928392,0.00642798764557678,0.331703236159796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00758826286944122,0.00782831886615851,-0.00775524210822945,0.0229317678471119,0.332399327838939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00481381212868245,0.00496722147339506,-0.0145495662165368,0.00492194195917187,0.332508869129651
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.00789233076632993,0.00814659679337752,-0.00807499894869002,0.0238596604813499,0.332667971350771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXK,Tyrosine-protein kinase TXK,39757,-0.00718555184537636,0.00743004853265311,-0.0217484469693764,0.00737734327862374,0.333518243262287
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBN,Ameloblastin,41913,-0.00267567459677306,0.00276846177226313,-0.0081018596704088,0.00275051047686269,0.333819499169393
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00321863245435092,0.00333022435898209,-0.00974587219795582,0.00330860728925397,0.333819757016662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00458424717855901,0.00475809262954382,-0.0139101087324649,0.00474161437534688,0.335336376827104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN4,Alpha-actinin-4,41913,0.00306456983784084,0.00319243134072891,-0.00319259558998783,0.0093217352656695,0.337098543017457
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT1,Diamine acetyltransferase 1,39575,-0.00471084143565707,0.00491103500850625,-0.0143364700523293,0.00491478718101518,0.337461013948956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDNRB,Endothelin receptor type B,39657,0.0042522886601891,0.0044507026812368,-0.00447108859503503,0.0129756659154132,0.339386423910612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA4,Ephrin type-A receptor 4,39736,-0.00282965985671148,0.00296893151868529,-0.00864876563333464,0.00298944591991168,0.340565002698236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASQ2,Calsequestrin-2,39575,0.00456726061255554,0.00483119587380272,-0.00490188330009779,0.0140364045252089,0.344491567280657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00325716467156981,0.00344734629833068,-0.00349963407315832,0.0100139634162979,0.344764559750233
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCL2,Phosducin-like protein 2,39560,-0.00501199599504768,0.00530581748993895,-0.015411398275328,0.00538740628523266,0.344872323071306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00372038789789569,0.00394641973562439,-0.00401459478392812,0.0114553705797195,0.345838863548162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.00547309351517166,0.0058319282876032,-0.0169036729588739,0.00595748592853062,0.348023226103913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00612765183351477,0.00653229867705801,-0.0189309572405485,0.00667565357351894,0.348236933543632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00285801016691783,0.00305253833382677,-0.00884098530121829,0.00312496496738264,0.349152393235045
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,42145,0.001651838927169,0.00177510175420652,-0.00182736051107578,0.00513103836541378,0.352097728548181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.00602600552349192,0.00647911306499476,-0.00667305608389781,0.0187250671308817,0.352356510539885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPTC,Opticin,42070,-0.00425413280783352,0.00459243769815713,-0.0132553106962215,0.00474704508055445,0.354288844081256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00490159103962537,0.00529587998898874,-0.00547833373879256,0.0152815158180433,0.354701315206037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG1,Arginase-1,42015,0.00472410331111183,0.0051159637450836,-0.00530318562925202,0.0147513922514757,0.355813119950943
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFA,Protransforming growth factor alpha,42119,0.00422074042745893,0.00457308287706436,-0.0047425020115872,0.0131839828665051,0.356048185664143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00424803510891247,0.0046066448535343,-0.0132770590218397,0.00478098880401477,0.35646848683
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHH,Sonic hedgehog protein,39657,-0.00399481205829127,0.00433262860595891,-0.0124867641259707,0.0044971400093882,0.35653322522158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TG,Thyroglobulin,39919,-0.00974326669387686,0.010616764132436,-0.0305521243934514,0.0110655910056977,0.358782566010679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.00364643726578221,0.00397501605555122,-0.00414459420309818,0.0114374687346626,0.35898454429217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHIT1,Chitotriosidase-1,42207,-0.0145124410156241,0.0158321062480765,-0.045543369261854,0.0165184872306059,0.359344279324754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC8,Histone deacetylase 8,39657,0.00560203415156475,0.00611475619972777,-0.00638288799990169,0.0175869563030312,0.35960818411263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100P,Protein S100-P,41900,0.00493895413156277,0.00541623759374419,-0.00567687155217584,0.0155547798153014,0.361848866120648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJP3,Tight junction protein ZO-3,39586,-0.00385001400166947,0.00422204442036407,-0.012125221065583,0.00442519306224411,0.361849887664466
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,39560,0.00309629058855339,0.00339627331675403,-0.00356040511228451,0.0097529862893913,0.361960947249048
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGR,Progesterone receptor,39657,0.00924968159500479,0.0101780923627671,-0.0106993794360187,0.0291987426260283,0.363484267124866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MN1,Transcriptional activator MN1,39649,-0.00540721011006637,0.00597253788185043,-0.0171133843584932,0.00629896413836048,0.365302135943851
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFRC,Transferrin receptor protein 1,42200,-0.0034043680595299,0.00379145269701154,-0.0108356153456725,0.00402687922661272,0.369251570132665
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00258945873167436,0.00288517772002183,-0.00824440706291714,0.00306548959956841,0.369469015484592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00657405697061501,0.00734484528675648,-0.0209699537326577,0.00782183979142769,0.370776098247749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN3,CCN family member 3,42299,0.00304710429292188,0.00343597150506638,-0.00368739985700822,0.00978160844285198,0.375188872047022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.00416102612493509,0.00472044776605745,-0.00509105149653752,0.0134131037464077,0.378068344138872
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKKL1,Dickkopf-like protein 1,42070,-0.0074335567014979,0.00847545755245317,-0.0240454535043061,0.0091783401013103,0.380465083746307
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLGAP5,Disks large-associated protein 5,39934,0.00438621063229411,0.00501401065877124,-0.00544125025889753,0.0142136715234857,0.381706254689536
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00320330199625219,0.00367227188804758,-0.00399435090432107,0.0104009548968255,0.383066777376405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENND2B,DENN domain-containing protein 2B,39575,-0.00433508176256209,0.00497481226007277,-0.0140857137923047,0.00541555026718054,0.383551516014515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA5,Annexin A5,41780,-0.00267629879412567,0.00307250276178182,-0.00869840420721804,0.00334580661896671,0.383743559794336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00375862948115033,0.00432624645509543,-0.0122380725331374,0.00472081357083672,0.384977230603135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00533898697547487,0.00614943708788335,-0.00671390971677649,0.0173918836677262,0.385299751843992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",39586,0.00720047840400773,0.00835275965390916,-0.00917093051765422,0.0235718873256697,0.388680009353564
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.0036472754278767,0.00423786532231701,-0.011953491459618,0.00465894060386464,0.389455150711061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPO,Myeloperoxidase,42137,-0.00390828792896981,0.00455065593346547,-0.0128275735585621,0.00501099770062251,0.390443689116733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00425094394259583,0.00495838939193629,-0.00546749926559929,0.013969387150791,0.391284822919892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HK2,Hexokinase-2,41900,0.00235150002867053,0.00276287453516771,-0.00306373406025818,0.00776673411759924,0.394725607766749
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.00287479181468515,0.00338861077792155,-0.00951646893941138,0.00376688531004108,0.396247450556142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,39750,-0.00859888219146606,0.0101936906150088,-0.0285785157968833,0.0113807514139511,0.398939313689978
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00565198299884123,0.00671164467205581,-0.0188068065560706,0.00750284055838816,0.399741107057515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,39575,-0.00270721945987828,0.00322044536200917,-0.00901929236941626,0.0036048534496597,0.400570693485007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH4,Cadherin-4,39586,0.00396136682440425,0.00472204844884041,-0.00529384813532296,0.0132165817841315,0.401538881725372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A14,Protein S100-A14,39934,0.00440101729408052,0.00525504771511111,-0.00589887622753727,0.0147009108156983,0.40233834190969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD7,T-cell antigen CD7,39636,-0.00377831945641466,0.00454772367320402,-0.0126918578558945,0.00513521894306521,0.406095821122293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00453706167183452,0.00547919058008471,-0.0152762752088006,0.00620215186513151,0.407658363023814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZU1,Azurocidin,41751,0.00628147426769,0.00761477542785637,-0.00864348557090848,0.0212064341062885,0.409439897091469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00489167561471858,0.00595224362519129,-0.00677472189065635,0.0165580731200935,0.411193575325302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRAL,GDNF family receptor alpha-like,39574,-0.00527412714500293,0.00642562060010935,-0.0178683435212173,0.0073200892312114,0.411779999768805
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM2,Isthmin-2,39966,0.00361171430446649,0.00440371394963758,-0.00501956503682317,0.0122429936457561,0.412146724927833
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR1B,Cornifin-B,39757,-0.00713600300657859,0.00876695848056319,-0.0243192416284824,0.0100472356153253,0.415682004193031
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL21R,Interleukin-21 receptor,39657,-0.00446185280703663,0.00549870760351871,-0.0152393197099333,0.00631561409586004,0.417132433193231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.003449554964494,0.00425463880703278,-0.0117886470262783,0.00488953709729026,0.417511892712042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13,Interleukin-13,41913,-0.00398047705129266,0.00491793984788951,-0.0136196391531561,0.00565868505057077,0.418311664334499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,42281,0.00425637634804003,0.0052670600511799,-0.00606706135227256,0.0145798140483526,0.419039951731442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSD1,Tryptase delta,39934,-0.00298718339818746,0.00371025173608678,-0.0102592768009175,0.00428491000454262,0.420769576355549
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00312141519886806,0.0038798402310116,-0.0107259020516508,0.00448307165391467,0.42111323725533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00245727458431731,0.00305454151559296,-0.00844417595487952,0.00352962678624489,0.421142192370308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.00281703409014654,0.00350340435674217,-0.00968370662936119,0.00404963844906811,0.421362023085837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.0024876915686199,0.00309427708738217,-0.00855247465988896,0.00357709152264915,0.421434422143889
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0037969937992792,0.00472785537110281,-0.0130635903266407,0.0054696027280823,0.421927832413506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB2,Plexin-B2,42255,0.0019788477600944,0.0024743367544697,-0.0028708522786662,0.00682854779885501,0.423870285801369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NENF,Neudesin,39919,-0.00909828873428339,0.0113918575030127,-0.0314263294401883,0.0132297519716215,0.424500890577009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,39657,0.00741766146187607,0.00930362617524756,-0.0108174458416091,0.0256527687653613,0.42530141029825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTKN2,Rhotekin-2,39575,-0.00411231355821431,0.00517025115541217,-0.0142460058228222,0.00602137870639354,0.426409782008556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00215046151389832,0.00270994635217766,-0.00316103333636989,0.00746195636416654,0.427478156856224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00525120751640788,0.00662771082664614,-0.0182415207366343,0.00773910570381856,0.42819626470272
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELB,Transcription factor RelB,39657,0.00377335994350411,0.00476399255509987,-0.00556406546449162,0.0131107853514998,0.4283436631159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0047785019077054,0.00604584775642388,-0.0070713596948854,0.0166283635102962,0.429324451472246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,39638,-0.00330147388083751,0.0041846181782386,-0.0115033255101852,0.00490037774851015,0.430155470146562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00385927675280368,0.00491597123801087,-0.00577602687369761,0.013494580379305,0.432441993766115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.00476069596705728,0.00606891060259784,-0.00713436881403448,0.016655760748149,0.432795915444489
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSTB,Cystatin-B,41959,0.00344003042173172,0.00438996564225415,-0.00516430223708641,0.0120443630805498,0.433281615909568
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEF,Thyrotroph embryonic factor,39575,0.00339912929781719,0.0043483425808572,-0.00512362216066292,0.0119218807562973,0.434403722292124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.00265046900344221,0.00340015567091162,-0.00401383611154456,0.00931477411842898,0.43569326765292
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.00786276102733301,0.0101319078774761,-0.0277213004671862,0.0119957784125202,0.437742368546096
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3B,Protein FAM3B,42070,-0.00273858287516258,0.00355979088615527,-0.00971577301202691,0.00423860726170174,0.441722766724098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00243617552553281,0.00317019080232865,-0.00377739844703134,0.00864974949809696,0.442228498714448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UMOD,Uromodulin,42274,0.00418180801584216,0.00544325246460422,-0.00648696681478212,0.0148505828464664,0.442348742216577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.00183539350986342,0.00239524395763012,-0.00285928464709162,0.00653007166681846,0.443531419501447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG2,"Arginase-2, mitochondrial",39919,-0.00325885590977082,0.00427417509219792,-0.0116362390904787,0.0051185272709371,0.445805811056407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS8,Regulator of G-protein signaling 8,41913,-0.0049291769580101,0.00646662235138288,-0.0176037567667205,0.00774540285070035,0.445924860665454
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPT,Microtubule-associated protein tau,41839,0.00406120963630853,0.00533999364149113,-0.00640517790101408,0.0145275971736312,0.446953147924447
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.00305571124259345,0.00405080383027463,-0.00488386426474482,0.0109952867499317,0.450657034020019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTNL10,Butyrophilin-like protein 10,39560,-0.00305037704888504,0.00405232715829374,-0.0109929382791408,0.00489218418137069,0.451618137372972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0029092134977716,0.00386820815516103,-0.0104909014818872,0.00467247448634402,0.452014532026796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.0028659773493861,0.00381109947623787,-0.00460377762404013,0.0103357323228123,0.452059533905211
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00360953476556662,0.00481033550334748,-0.0130377923521277,0.00581872282099443,0.453047565318731
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.0060192945261536,0.00812408511243646,-0.0219425013465291,0.00990391229422185,0.458757736367415
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM2,Junctional adhesion molecule B,42249,0.002045124913054,0.00276187590583028,-0.00336815186237334,0.00745840168848135,0.459019104705615
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00361360246910756,0.00489936047224323,-0.00598914405648916,0.0132163489947043,0.460793417299866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.00198139949266314,0.00271755046262287,-0.00730779839940396,0.00334499941407768,0.465945640722918
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLVRB,Flavin reductase,42137,-0.00468751965902589,0.00644583381732155,-0.0173213539409761,0.00794631462292435,0.467105635557193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KEL,Kell blood group glycoprotein,41839,-0.00264857608753507,0.00365773340856942,-0.00981773356833113,0.00452058139326099,0.46901523869392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDN1,Endothelin-1,39638,-0.0021543968695871,0.00298123089208034,-0.00799760941806456,0.00368881567889037,0.469908115285274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF20,Fibroblast growth factor 20,39657,-0.00314352025859353,0.00438330497335896,-0.0117347980063771,0.00544775748919003,0.473292037476373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL2,Interferon lambda-2,39586,-0.00425745215827336,0.00594163345632913,-0.0159030537326785,0.00738814941613174,0.47366966488205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15,Interleukin-15,42119,-0.00237998280704151,0.00332875635789804,-0.00890434526852167,0.00414437965443866,0.474635866731263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL6B,Myosin light chain 6B,39649,-0.00659517400862822,0.00925308784216146,-0.0247312261792647,0.0115408781620082,0.476013137597053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,39560,0.00453364767193714,0.00637827779801095,-0.00796777681216432,0.0170350721560386,0.477226433355165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3A,Uroplakin-3a,39586,0.0034841728048065,0.00491717905825806,-0.0061534981493793,0.0131218437589923,0.478605479016762
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN3,Matrilin-3,41992,0.00236394838345494,0.00334058861233325,-0.00418360529671823,0.00891150206362811,0.479178509498569
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,39586,0.00427138840213123,0.0060405399163619,-0.00756806983393809,0.0161108466382005,0.479506719697022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHC1,SHC-transforming protein 1,39560,-0.00839090889863175,0.0118875279172299,-0.0316904636164024,0.0149086458191389,0.480291335372353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BEX3,Protein BEX3,39560,-0.00334510061193053,0.00475289436433536,-0.0126607735660278,0.00597057234216678,0.481570508686413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAN,Versican core protein,42249,-0.00213596410058182,0.00304154236263759,-0.0080973871313515,0.00382545893018785,0.482526844138063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.00359337657350088,0.00511774831854512,-0.0136241632778493,0.00643741013084756,0.482606441579113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",42070,-0.00740302397954554,0.0105456203820704,-0.0280724399284036,0.0132663919693125,0.48269138313068
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00437662569566782,0.00624559646870006,-0.0166179947743199,0.0078647433829843,0.483471491880982
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00259041276303008,0.00370761524186162,-0.00985733863707886,0.0046765131110187,0.484770762416696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.00529398248646999,0.00759081130705843,-0.00958400767536454,0.0201719726483045,0.485554357473336
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6,Seizure protein 6 homolog,39649,0.00220607999598417,0.00317520178503627,-0.00401731550268691,0.00842947549465525,0.487205168028794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.00595903738189198,0.00860359154373738,-0.0228220768076172,0.0109040020438333,0.48855865348953
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.00701879883190898,0.0101626037136337,-0.026937502110631,0.012899904446813,0.489799891558586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5A,Cytochrome b5,39560,-0.00499564719092307,0.00723353661254723,-0.0191733789515156,0.0091820845696695,0.489817077111906
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRV1,Acrosomal protein SP-10,39657,0.00742921787785613,0.0107953066509024,-0.0137295831579125,0.0285880189136248,0.491347822916541
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLNL,Mesothelin-like protein,39649,0.00264583718228269,0.00384511839146918,-0.0048905948649969,0.0101822692295623,0.491402419054735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36A,Interleukin-36 alpha,39657,-0.00399285649969477,0.00583424508292142,-0.0154279768622208,0.00744226386283122,0.49374787066947
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAND5,DAN domain family member 5,39657,0.0037958725459061,0.0055542163047395,-0.00709039141138331,0.0146821365031955,0.494354664228417
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00245197992426198,0.00360572356524956,-0.00951919811215111,0.00461523826362716,0.496502932815806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.00266696301186896,0.00392454742652336,-0.0103590759678547,0.00502514994411681,0.49679498232854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLINT1,Clathrin interactor 1,39560,0.0034502911859858,0.00507798728980914,-0.00650256390204012,0.0134031462740117,0.496860550878046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STEAP4,Metalloreductase STEAP4,39586,0.00500806176488949,0.00738984868521984,-0.00947604165814139,0.0194921651879204,0.497979518264571
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAVL4,ELAV-like protein 4,39586,-0.00562646388063275,0.00832090652970793,-0.0219354406788603,0.0106825129175948,0.49893806264386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRING1,SREBP regulating gene protein,39560,-0.00426026489779173,0.0063076990116009,-0.0166233549605295,0.00810282516494603,0.499431384649037
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA4,Apolipoprotein A-IV,39979,-0.00236176071700876,0.00349733317007912,-0.00921653373036385,0.00449301229634632,0.499496793982193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.00716842653246611,0.0106392026646399,-0.0136844106902281,0.0280212637551603,0.500466112879147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS2,Podocin,39657,-0.00696908164651245,0.0103485873251826,-0.0272523128038703,0.0133141495108454,0.500685847491155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00367842173330473,0.00546388319658088,-0.0143876327986033,0.00703078933199379,0.500818440339669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,39930,0.00327965532821492,0.00488596931817961,-0.00629684453541711,0.012856155191847,0.502081688917064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00177584822542577,0.00266906164905646,-0.00345551260672489,0.00700720905757642,0.50584350018057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNN,Tenascin-N,39966,-0.00290973028969959,0.00438585276463807,-0.0115060017083902,0.00568654112899103,0.507065150654717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMPD3,AMP deaminase 3,39929,0.00461451004474114,0.00699351851564803,-0.009092786245929,0.0183218063354113,0.509378478653785
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPACAM2,HEPACAM family member 2,39929,0.00289152266255744,0.00443456268601079,-0.00580022020202371,0.0115832655271386,0.514387082556694
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.0176341225723532,0.0270454038486656,-0.0706431141157378,0.0353748689710314,0.514402362986565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,39638,0.00253957596884247,0.00392742122306479,-0.00515816962836452,0.0102373215660495,0.517886928605129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD2,Glutamate decarboxylase 2,39657,-0.00297342806124256,0.00460126090694146,-0.0119918994388478,0.0060450433163627,0.518150126531657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.00265996770900394,0.00412518748286616,-0.00542539975741374,0.0107453351754216,0.519060234872995
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00323542890275023,0.00502453817266896,-0.00661266591568093,0.0130835237211814,0.519637117505215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.00193329018429843,0.00300898196681454,-0.00783089483925493,0.00396431447065807,0.520555555021669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA2,Carboxypeptidase A2,42205,-0.0042969105854901,0.00672572779411534,-0.0174793370619562,0.00888551589097596,0.522913920422382
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00442078313121011,0.00692518051085603,-0.0179941369324879,0.00915257067006772,0.523250125364849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,42145,0.00204372705129984,0.00320353834140676,-0.00423520809785741,0.00832266220045708,0.523510964293892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.00194885679608842,0.00306784955631065,-0.0079618419264573,0.00406412833428046,0.525274906190887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3,Interleukin-3,39560,0.0039436112872374,0.00622295765917422,-0.00825338572474407,0.0161406082992189,0.526276945815249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4C,Semaphorin-4C,42070,-0.00178359284832041,0.00281793655972762,-0.00730674850538654,0.00373956280874573,0.526781697135705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00324228151142499,0.00512906542580983,-0.0132952497460123,0.00681068672316228,0.52730931981389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAGE2A,G antigen 2A,39560,-0.00418304571109009,0.00664099698039817,-0.0171993997926705,0.00883330837049032,0.528784797908048
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,41843,0.00292661794519992,0.00467874470274443,-0.00624372167217916,0.012096957562579,0.53164487385246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.00251395526513601,0.00402258010535605,-0.00537030174136186,0.0103982122716339,0.532009321472234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSCA,Prostate stem cell antigen,39930,0.0163603443141243,0.0263566316570097,-0.0352986537336147,0.0680193423618633,0.534789964261638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00477766806317287,0.00770532185000236,-0.0103247627628318,0.0198800988891775,0.535239160583347
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKIV2L,Helicase SKI2W,39575,-0.00248821932977284,0.0040180556891323,-0.0103636084804721,0.00538716982092647,0.535758246086095
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.00199279273483297,0.00322039938662073,-0.00431919006294365,0.0083047755326096,0.536058989499771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP1,Retinol-binding protein 1,39649,-0.0043981057099143,0.00712245028314757,-0.0183581082648835,0.00956189684505495,0.536918386349537
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.0023797251019355,0.00385756621620019,-0.00518110468181688,0.00994055488568787,0.537312756439175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,41946,0.0023908204964926,0.00390324712170448,-0.00525954386204818,0.0100411848550334,0.540203600884154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.00241695759457017,0.00398103459000518,-0.00538587020184,0.0102197853909803,0.543782866024971
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00400066338277603,0.00659796576358179,-0.00893134951384427,0.0169326762793963,0.54429621547383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G15,Phospholipase A2 group XV,42181,-0.00168245360586186,0.00277913044973296,-0.00712954928733847,0.00376464207561475,0.544931008175604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.00512189302693036,0.00850875954508357,-0.0115552756814334,0.0217990617352942,0.547216334525722
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH4,Myosin-4,39575,-0.00279949227826041,0.00465237566075392,-0.0119181485733381,0.00631916401681726,0.547363691852479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00155359315472742,0.00258200529994414,-0.00350713723316309,0.00661432354261793,0.547386149768485
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA2,GDNF family receptor alpha-2,42070,0.0012691877541227,0.00211257228150572,-0.00287145391762852,0.00540982942587392,0.547997713959539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL9,Interleukin-9,39757,-0.00341653609463862,0.0056977190858715,-0.0145840655029468,0.00775099331366952,0.548763528412727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.00152218415857982,0.00254418591397397,-0.00650878854996881,0.00346442023280917,0.549650256372021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.00347270818406363,0.00582083172052865,-0.0148815383562998,0.00793612198817253,0.5507867791152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA7A,Semaphorin-7A,42272,-0.00171924970230102,0.0028888368785374,-0.00738136998423433,0.00394287057963229,0.55176267581844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00165347399388216,0.00278066571933725,-0.00710357880378316,0.00379663081601885,0.552099015052934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20,Interleukin-20,41913,0.00278879360646586,0.00472149496836504,-0.00646533653152961,0.0120429237444613,0.554758935336103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00352613456940882,0.00601036648795593,-0.00825418374698481,0.0153064528858024,0.557433387021234
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00244874293238152,0.00419768669755365,-0.00577872299482363,0.0106762088595867,0.559666093522324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,39649,0.00327720037465141,0.00562265531695906,-0.00774320404658835,0.0142976047958912,0.560001899709902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST7,Cystatin-F,42148,0.00553736743519726,0.00954543021359913,-0.013171675783457,0.0242464106538516,0.561852354594867
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.0175518986544077,0.0302741475156431,-0.0768892277850682,0.0417854304762528,0.562082594203131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL25,C-C motif chemokine 25,42296,0.00287777562858454,0.00496614449250653,-0.00685586757672825,0.0126114188338973,0.562275654250165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.00240432265964063,0.00416689533781351,-0.00576279220247385,0.0105714375217551,0.563947198402449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.00169113577872945,0.00293431776344873,-0.00406012703763005,0.00744239859508896,0.564403511200928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00285733160019279,0.00495899501449811,-0.0068622986282235,0.0125769618286091,0.564497441084956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,39649,0.00237718820090708,0.00413657976800615,-0.00573050814438498,0.0104848845461991,0.565522945554662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00243572856151087,0.00425763273044692,-0.00590923159016509,0.0107806887131868,0.567275903152455
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00410819349439888,0.00719693501229114,-0.0182141861184895,0.00999779912969175,0.568129661216187
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLI2,Zinc finger protein GLI2,39657,-0.00189584517337595,0.00337100847014836,-0.00850302177486674,0.00471133142811484,0.573856938948574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COLEC12,Collectin-12,42123,0.00155448992075254,0.00276761136087769,-0.00387002834656773,0.00697900818807281,0.574348795305209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00274482798943829,0.0048984647012873,-0.00685616282508482,0.0123458188039614,0.575255900238277
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00166636352604634,0.00297609238934205,-0.00749950460915676,0.00416677755706407,0.575545601093058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00304135916168864,0.00544427573751065,-0.0137121396072095,0.00762942128383223,0.576422377264589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL28,C-C motif chemokine 28,42075,0.00330295233994156,0.00595319678573475,-0.00836531336009856,0.0149712180399817,0.579027029178936
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPB41L5,Band 4.1-like protein 5,39649,-0.00349171566191715,0.00630590532549483,-0.015851290099887,0.00886785877605271,0.579780630526086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXDNL,Peroxidasin-like protein,39919,-0.00316951079200572,0.00579939204434953,-0.0145363191989308,0.00819729761491937,0.584716110804548
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00225932656513686,0.00415294999403938,-0.00588045542318032,0.0103991085534541,0.586430199308582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00398474838652257,0.00733489646927222,-0.0183611454662961,0.010391648693251,0.586962355051909
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP4,Caspase-4,39757,-0.00909759037778838,0.0168413846293075,-0.0421067042512311,0.0239115234956543,0.589075037478682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,39929,0.00221935774084852,0.00412323198558886,-0.00586217695090564,0.0103008924326027,0.590410331190659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00219150658504514,0.00408881565228683,-0.00582257209343704,0.0102055852635273,0.591986068413218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.00199306142573364,0.00374006577459144,-0.00932359034393287,0.00533746749246558,0.594116834255386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00264824669571229,0.00499955323665967,-0.00715087764814067,0.0124473710395652,0.596332633079887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD5,Sushi domain-containing protein 5,39695,-0.00184973091141776,0.00350058636821258,-0.00871088019311441,0.00501141837027889,0.597228128752481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0050847274987397,0.00967079629560488,-0.0138700332406459,0.0240394882381253,0.599050544018111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN1,Neuroligin-1,39649,0.00356880331260905,0.0068115063730259,-0.00978174917852171,0.0169193558037398,0.600332551775139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200,OX-2 membrane glycoprotein,42119,-0.00143584193144322,0.00274831551568108,-0.00682254034217814,0.0039508564792917,0.601369539835834
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOP56,Nucleolar protein 56,39575,-0.00593768238544496,0.0113734535845217,-0.0282296514111074,0.0163542866402175,0.601635589940758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.00144565283860813,0.00277146861491992,-0.00687773132385118,0.00398642564663491,0.60194359727729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF830,Zinc finger protein 830,39919,-0.00406257426992201,0.00786649383469561,-0.0194809021859254,0.0113557536460814,0.605557028867229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRN1,Neuritin,39934,0.00182179030764335,0.00352867202257702,-0.0050944068566076,0.0087379874718943,0.605667447449546
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.00446167341736573,0.00868661900358328,-0.0125640998296575,0.021487446664389,0.607523764995994
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,39586,-0.00432515580194866,0.00844988958107649,-0.0208869393808586,0.0122366277769613,0.608759670680722
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00401256590355337,0.00784027553812334,-0.0193795059582751,0.0113543741511684,0.608809078989609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH22,Cadherin-22,39757,0.00142640646204984,0.00279711734893927,-0.00405594354187114,0.00690875646597081,0.610092453541825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.00134652407596212,0.00264197369737221,-0.00652479252281165,0.0038317443708874,0.610295396100799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17F,Interleukin-17F,41913,-0.00377979398914122,0.00742705858433348,-0.0183368288144348,0.0107772408361524,0.61081528728243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00279673818458482,0.00550239329288184,-0.0135814290386332,0.00798795266946358,0.611269463225498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFASC,Neurofascin,42296,-0.00146771420165496,0.0029468014475077,-0.00724344503877004,0.00430801663546013,0.618442509526581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSLP,Thymic stromal lymphopoietin,41900,-0.00301535617351576,0.00609568738195189,-0.0149629034421415,0.00893219109510994,0.620840963114286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTTG1,Securin,39757,0.00208139902441415,0.00422284616716261,-0.00619537946322457,0.0103581775120529,0.622099950416664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL33,Interleukin-33,41913,-0.00196118384222768,0.00399194963743605,-0.00978540513160234,0.00586303744714698,0.62323318741912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.00251092716360839,0.00511342011464126,-0.00751137626108848,0.0125332305883053,0.62340329665462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2A,Pancreatic alpha-amylase,41665,-0.00241225157291773,0.00495092683969985,-0.0121160681787294,0.00729156503289398,0.626101877888154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF3,Fibroblast growth factor 3,39657,0.00146470065793002,0.00300835666669554,-0.00443167840879324,0.00736107972465328,0.626354916953605
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC1,Syndecan-1,42145,0.00199203001338834,0.00409419286329816,-0.00603258799867605,0.0100166480254527,0.626585053805858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRP15,RRP15-like protein,39586,0.00448358064119719,0.00925680625369684,-0.0136597596160486,0.022626920898443,0.628143585517713
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBR1,T-box brain protein 1,39649,0.00235316280256017,0.00486464811818909,-0.00718154750909046,0.0118878731142108,0.628589045538438
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5L,CD5 antigen-like,39925,0.00234823232937071,0.0048799253947043,-0.00721642144424972,0.0119128861029911,0.630381876774956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.00170311542609443,0.00360998403948056,-0.00537245329128746,0.00877868414347632,0.63709212966853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2B,Alpha-amylase 2B,41300,-0.00239338571516827,0.00507785156944106,-0.0123459747912727,0.0075592033609362,0.6374072952643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GM2A,Ganglioside GM2 activator,39733,0.0018384244663867,0.00390842718050496,-0.00582209280740302,0.00949894174017641,0.638096696380515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00172910522822709,0.00368269666243645,-0.00894719068660253,0.00548898023014835,0.638704616606772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAPPA,Pappalysin-1,41913,-0.00224858799504364,0.00480064226065557,-0.0116578468259286,0.00716067083584127,0.639511127615342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00132848874782298,0.00284945455597633,-0.00691341967753659,0.00425644218189063,0.641062968869263
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00141384765270682,0.00305535317129261,-0.00457464456302669,0.00740233986844034,0.643555172655865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGA4,Pepsin A-4,39990,-0.00349575125336965,0.00760382357455067,-0.018399245459489,0.0114077429527497,0.645714517983659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,42100,-0.000805348799932989,0.00176111061238058,-0.00425712560019893,0.00264642800033295,0.647465678832405
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,39657,-0.000943158791019962,0.0020725863792205,-0.00500542809429214,0.00311911051225222,0.649072359085979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESR1,Estrogen receptor,39657,0.00261999536088733,0.00580480174195766,-0.00875741605334969,0.0139974067751243,0.651746402148699
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2,Interleukin-2,41913,-0.00145582300739222,0.0032363730305235,-0.00779911414721829,0.00488746813243384,0.652839161349574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPT1,Translationally-controlled tumor protein,41913,0.00291536650663193,0.00648364734681865,-0.00979258229313261,0.0156233153063965,0.652970764114384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3C,Protein FAM3C,42129,0.00138041490297918,0.00307419772742764,-0.004645012642779,0.00740584244873736,0.653415354709801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM3,Paralemmin-3,39575,-0.00345188715298222,0.00770020712717821,-0.0185442931222515,0.0116405188162871,0.653956392812536
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN1,Cerebellin-1,39586,0.00414578341127099,0.00940490158002293,-0.014287823685574,0.0225793905081159,0.659358553963808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00240603313303587,0.00546525385932815,-0.00830586443124729,0.013117930697319,0.659769183849259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHDC3L,KH domain-containing protein 3,39560,0.00299224278022869,0.00681861621857724,-0.0103722450081827,0.0163567305686401,0.660790244129509
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,42119,0.00216965963634018,0.0049484328428461,-0.00752926873563818,0.0118685880083185,0.661064293624179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR1,Toll-like receptor 1,39657,-0.001191228188987,0.00271818959047954,-0.00651887978632689,0.0041364234083529,0.661218534516466
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLMP,CXADR-like membrane protein,42262,0.000977560032922355,0.002238277484846,-0.0034094638373758,0.00536458390322051,0.662302047699637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MKI67,Proliferation marker protein Ki-67,39657,0.00179486008712016,0.00413368136416169,-0.00630715538663675,0.00989687556087707,0.664148938364026
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHD,SH2 domain-containing adapter protein D,39554,-0.00363557610298999,0.00837529058850347,-0.0200511456564568,0.0127799934504768,0.664236299735461
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,39657,0.00197952345337821,0.00458687573920767,-0.00701075299546884,0.0109697999022252,0.666067849680057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,39649,-0.00176611160286415,0.00412127352304448,-0.00984380770803133,0.00631158450230303,0.668269719071614
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.00284954496923164,0.00669828817204622,-0.0159781897864422,0.010279099847979,0.670543307912142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD8,Frizzled-8,39586,0.00185379160116873,0.00437134376928,-0.00671404218662007,0.0104216253889575,0.671517086181173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.00179044161444658,0.00423215171349962,-0.0100854589729058,0.00650457574401268,0.672261668688056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,39657,-0.00380219964468101,0.00900507248967249,-0.0214521417244391,0.0138477424350771,0.672866337441102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3B,Sodium channel subunit beta-3,39586,0.00198147340171685,0.0047289208563649,-0.00728721147675836,0.0112501582801921,0.675215737302829
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00234079799581179,0.00558677201893586,-0.0086092751613025,0.0132908711529261,0.675232104658878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSG,Basigin,42284,0.000881578546700521,0.00211176805774993,-0.00325748684648935,0.00502064393989039,0.676348576396361
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB6,Heat shock protein beta-6,42262,0.00167329954946094,0.00411350558336218,-0.00638917139392894,0.00973577049285081,0.684174565937847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL2,Fc receptor-like protein 2,42229,0.00205862096016323,0.00506197368118078,-0.0078628474549511,0.0119800893752776,0.684246877576607
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF75D,Zinc finger protein 75D,39757,-0.00252184156041609,0.00620656043788532,-0.0146867000186713,0.00964301689783913,0.684516241062152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSM,Oncostatin-M,42051,-0.00283240478586786,0.00697974986463052,-0.0165127145205437,0.010847904948808,0.684893666719164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,39919,0.00181225951298281,0.00447012117353796,-0.00694917798715161,0.0105736970131172,0.685179271776637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,39743,-0.00218546201566014,0.00543738377675517,-0.0128427342181003,0.00847181018678,0.687741309322725
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_E,,42119,0.00118876722643741,0.00296570846197212,-0.00462402135902793,0.00700155581190276,0.688546087178831
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA1,Apolipoprotein A-I,39979,0.00111669199795481,0.00278868395229271,-0.00434912854853891,0.00658251254444853,0.688842257136289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTF,Ciliary neurotrophic factor,39586,0.00139797719000282,0.00350745756447195,-0.0054766396363622,0.00827259401636783,0.690215751212688
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP73,Tumor protein p73,39649,0.00138455573906682,0.00347494881274763,-0.00542634393391854,0.00819545541205218,0.690314184492022
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD248,Endosialin,39966,0.00163477481159962,0.00410810986907187,-0.00641712053178125,0.00968667015498048,0.690683041440042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRXN3,Neurexin-3,39649,0.00143689665467057,0.00364664995380093,-0.00571053725477926,0.00858433056412039,0.693565042279664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.00308161358250314,0.00782160988307417,-0.0122487417883222,0.0184119689533285,0.693598148755005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.00201362476276425,0.00511926545183018,-0.0120473850483514,0.00802013552282289,0.694073920074133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY6D,Lymphocyte antigen 6D,42041,-0.00157038333351845,0.00401800837339632,-0.00944567974537523,0.00630491307833834,0.695924471214122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMI,N-myc-interactor,39875,-0.00287595110882436,0.00738650429496376,-0.0173534995269533,0.0116015973093046,0.697023038843846
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.00276093570222794,0.00710196657146139,-0.0111589187778364,0.0166807901822923,0.697463581398443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR1,Interferon gamma receptor 1,42185,-0.000849549227042255,0.0021873854291769,-0.00513682466822897,0.00343772621414446,0.69773670915145
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.0008919615945352,0.00231192457411765,-0.00363941057073539,0.00542333375980579,0.699644023774243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN15,Tetraspanin-15,39575,-0.00196920615000272,0.00510612695634311,-0.0119772149844352,0.00803880268442978,0.699759268638886
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00215521457900756,0.00570614968486233,-0.00902883880332261,0.0133392679613377,0.70566054174534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPGN,Epigen,39919,-0.00176027410522495,0.00469367886543118,-0.0109598846814701,0.00743933647102016,0.707644592577072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.00134775632973679,0.00361960952448177,-0.00574667833824749,0.00844219099772107,0.709639190060097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX2,Peroxiredoxin-2,39819,0.00225636068915113,0.00612386315808344,-0.00974641110069241,0.0142591324789947,0.712541835362781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF6,Fibroblast growth factor 6,39657,0.00145911784687134,0.00396836588894942,-0.00631887929546952,0.0092371149892122,0.713113428755808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00233201693179116,0.00635888458079166,-0.0101313968465605,0.0147954307101428,0.713824723661091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP1,Caspase-1,41839,0.00249595142886628,0.00696327493404703,-0.0111520674418659,0.0161439702995985,0.720015998826579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,42310,-0.00129946620467411,0.00362581491202982,-0.00840606343225255,0.00580713102290434,0.720054846348717
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPA33,Cell surface A33 antigen,42070,0.00482062792792402,0.0135334453994839,-0.0217049250550644,0.0313461809109125,0.721695558498216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENG,Endoglin,42310,-0.000620587989183483,0.00174836154390324,-0.00404737661523383,0.00280620063686687,0.722629484597439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.000973554682817622,0.00279110392146822,-0.00644411836889533,0.00449700900326009,0.727240241113471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00260793999963652,0.00758701707120484,-0.017478493459198,0.012262613459925,0.731050517661606
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNW1,Interferon omega-1,39575,0.00121847972527644,0.00358258120821365,-0.00580337944282231,0.0082403388933752,0.73377851227133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZPR1,Zinc finger protein ZPR1,39586,-0.00324621478894927,0.00978180902092964,-0.0224185604699714,0.0159261308920728,0.739999480844222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.0014145890947643,0.00428008053245832,-0.00697436874885401,0.00980354693838262,0.741024430859599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00160725109305446,0.00492692911094116,-0.0112640321504991,0.00804952996439021,0.744264737623005
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00118593810076892,0.00367654362877235,-0.00839196361316273,0.00602008741162488,0.747027809627738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00180140765245708,0.00560521549367079,-0.00918481471513766,0.0127876300200518,0.747928084811971
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00164548225547252,0.005147159310737,-0.00844294999357201,0.011733914504517,0.74921031578659
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN2,Contactin-2,42262,0.00142065142474667,0.00445109271475111,-0.00730349029616551,0.0101447931456588,0.749603138055599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHP1,Calcineurin B homologous protein 1,39586,0.00233706785111822,0.00749196158685198,-0.0123471768591117,0.0170213125613481,0.755089470472684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD2,Leiomodin-2,39586,-0.00192859517193883,0.00624170163616386,-0.01416233037882,0.0103051400349423,0.757338431803721
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300C,CMRF35-like molecule 6,42249,-0.00109107522390876,0.00356194251336784,-0.00807248255010973,0.00589033210229221,0.75936974745319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK1,Kallikrein-1,42016,-0.00396109919410829,0.0129341913919635,-0.0293121143223567,0.0213899159341401,0.75941887642668
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.000875943296370402,0.00286455972606603,-0.00649048035945981,0.00473859376671901,0.759772012509817
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL11,Interleukin-11,41913,0.00185897843780581,0.00616528375041414,-0.0102249777130059,0.0139429345886175,0.76301998018534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00190993424023383,0.00638220665191599,-0.0144190592779892,0.0105991907975215,0.764747927208161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA3,GDNF family receptor alpha-3,41989,0.000837387912576443,0.00281562187422469,-0.00468123096090395,0.00635600678605683,0.766159802018484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00161847513631062,0.00544594534900945,-0.0122925280203691,0.00905557774774791,0.766327826498227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00109702079380562,0.00372028072062284,-0.00619472941861515,0.00838877100622639,0.768094291101951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK11,Kallikrein-11,42062,-0.000954644249829269,0.00325936869635445,-0.00734300689468399,0.00543371839502546,0.769608928914906
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD59,CD59 glycoprotein,41638,0.000699650808761561,0.00238950151119694,-0.00398377215318444,0.00538307377070756,0.769678163074111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.000827085774648184,0.00284254345603365,-0.00474429939917778,0.00639847094847415,0.77108216831515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD2,Bromodomain-containing protein 2,39586,-0.00102888669812464,0.00355597610842864,-0.00799859987064477,0.00594082647439549,0.772326542127815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00200347402981156,0.00692789167127709,-0.0155821417055147,0.0115751936458915,0.77244177343547
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,39757,-0.00231347168602845,0.00801498734984013,-0.0180228468917151,0.0133959035196582,0.772859786832068
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRX,Cone-rod homeobox protein,41900,-0.00312416028695178,0.0108847853260662,-0.0244583395260415,0.0182100189521379,0.774100830337082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSND,Barttin,39560,0.00096065750220645,0.00340958666811949,-0.00572213236730775,0.00764344737172066,0.778139079373282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00195766609839988,0.00708473745843562,-0.0119284193201339,0.0158437515169337,0.782306223598468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP2,Guanylate-binding protein 2,41913,0.00169234331889832,0.00613758753992853,-0.0103373282593616,0.0137220148971582,0.782756439174136
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLFM4,Olfactomedin-4,39347,-0.00345106730234203,0.0125968394410136,-0.0281408726067287,0.0212387380020447,0.784118358964443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAP1,Antigen peptide transporter 1,39757,-0.00160060023925327,0.00592003010664673,-0.0132038592482809,0.0100026587697743,0.786880397607409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",41900,-0.00229488645580665,0.00849872033544114,-0.0189523783132713,0.014362605401658,0.787143445125589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCLRE1C,Protein artemis,39560,0.000834144380923846,0.00309347813282283,-0.0052290727594089,0.00689736152125659,0.787437590534109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX1B,Syntaxin-1B,39649,0.00106067744019456,0.00407166735294272,-0.00691979057157317,0.00904114545196229,0.794481436452923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.0012494479635522,0.00491134532494261,-0.0108756848004397,0.00837678887333531,0.79919104772448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP7,Dipeptidyl peptidase 2,42054,-0.00161143996741791,0.00636059813563147,-0.0140782123132556,0.0108553323784198,0.800003767041025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YAP1,Transcriptional coactivator YAP1,39929,-0.000704236791427349,0.00280119872919505,-0.00619458630064964,0.00478611271779494,0.801505168990557
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP2,Dipeptidase 2,42070,0.000754191898604844,0.00304418388509736,-0.00521240851618597,0.00672079231339566,0.804332803620909
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN1,Prorelaxin H1,39934,0.00111122146810579,0.00449681698573482,-0.00770253982393446,0.00992498276014604,0.804825329400986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLLT1,Protein ENL,39560,-0.00165085620885081,0.00674190674373615,-0.0148649934265737,0.0115632810088721,0.806565637184327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.00099697078824906,0.00410223552822915,-0.00704341084708007,0.00903735242357819,0.807985821293032
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTN,Neuroplastin,41843,-0.0019129948955615,0.00791401081922453,-0.0174244561012416,0.0135984663101186,0.808998895999591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACHE,Acetylcholinesterase,39736,-0.000841195104763965,0.00348100804430767,-0.00766397087160699,0.00598158066207906,0.809053707767269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000691221729554061,0.00289189510348568,-0.00635933613238599,0.00497689267327787,0.811094116879213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC9,Histone deacetylase 9,39586,-0.00161676762200616,0.00677243819964914,-0.0148907464933185,0.0116572112493061,0.811321300374282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.000682848957059293,0.0028716051884595,-0.00631119512643991,0.00494549721232133,0.81204483843686
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALCAM,CD166 antigen,42310,-0.000471392492624674,0.00199146218227985,-0.00437465836989318,0.00343187338464383,0.812887853213479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.00207014531226698,0.00877742993560422,-0.0151336173615173,0.0192739079860513,0.813554503349017
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3G,Semaphorin-3G,39736,-0.00108943496489898,0.00462655114918677,-0.0101574752173051,0.00797860528750709,0.813844773959458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM132A,Transmembrane protein 132A,39638,0.00149566069571582,0.00636746424119349,-0.0109845692170234,0.0139758906084551,0.814297612643065
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO1,Alpha-enolase,42119,-0.00184269725371278,0.00795874669427971,-0.017441840774501,0.0137564462670754,0.816905743534938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALLD,Palladin,39657,0.000876148889045862,0.00387248042141425,-0.00671391273692607,0.00846621051501779,0.82101112745192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,39541,0.00109593143090417,0.00491335110319044,-0.0085342367313491,0.0107260995931574,0.823499414935648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF12,Fibroblast growth factor 12,39657,0.00102132275848372,0.0046044979369854,-0.00800349319800767,0.0100461387149751,0.824466047854859
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.000711233772472566,0.00321012335195794,-0.00700307554231013,0.005580607997365,0.824660803153832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMH,Granzyme H,41900,0.00174124647083387,0.00796559307265681,-0.0138713159515735,0.0173538088932412,0.826968153540518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00133251476677314,0.00610276621887439,-0.0106289070222207,0.0132939365557669,0.827162879363779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.00113911349239697,0.00527093496433995,-0.0114701460225033,0.00919191903770933,0.828903597830301
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPEP,Glutamyl aminopeptidase,39575,0.000927203348682664,0.00430866393926202,-0.00751777797227089,0.00937218466963622,0.829619213027901
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.00109299367412807,0.00508300277878629,-0.00886969177229305,0.0110556791205492,0.829747918063963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.000604043947258918,0.00281964025312836,-0.00613053884339051,0.00492245094887267,0.830373015164908
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD10,Frizzled-10,39649,-0.001292810066602,0.00604867406861556,-0.0131482112410885,0.0105625911078845,0.830758083240383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00134820157682348,0.00645247759894664,-0.0139950576707589,0.0112986545171119,0.834496431293879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.0010580963531484,0.0050822646083271,-0.00890314227917272,0.0110193349854695,0.835081451697151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,39575,0.000801435599672224,0.00394640782338733,-0.00693352373416693,0.00853639493351138,0.839076446888593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1,Huntingtin-interacting protein 1,39575,0.000665959249285436,0.00334510931251206,-0.0058904550032382,0.00722237350180907,0.842200372406245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000600973546058512,0.00306990085853563,-0.00661797922878835,0.00541603213667133,0.844799032146853
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM1,Myomesin-1,39586,0.000946973539391699,0.00497087205238115,-0.00879593568327536,0.0106898827620588,0.848917330251739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,39929,0.000527419585313172,0.00278190501317205,-0.00492511424050405,0.00597995341113039,0.849634323569748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHB,Lutropin subunit beta,41843,0.00165252384657368,0.00894151359464583,-0.0158728427989322,0.0191778904920795,0.853377146724776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00115384396896167,0.00629937112228841,-0.013500611368647,0.0111929234307236,0.854668950200155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.00160102562511604,0.00887419655895793,-0.0157923996304415,0.0189944508806736,0.856831195505507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD4,Sushi domain-containing protein 4,39919,-0.000697692055269125,0.00390552431518196,-0.00835251971302577,0.00695713560248752,0.858221733275158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.000620697697170995,0.00351865369561873,-0.00627586354624171,0.0075172589405837,0.859980737945722
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNLZ,DNL-type zinc finger protein,39586,0.00150886442561197,0.00857388191480672,-0.0152959441274092,0.0183136729786331,0.860309903491165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.000616159424551361,0.00350927718042978,-0.00749434269819372,0.006262023849091,0.860627031905747
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.000809516199088017,0.00461326215047292,-0.00823247761583891,0.00985151001401494,0.860708393206562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,41839,0.000699700810579088,0.00402918519747042,-0.00719750217646292,0.0085969037976211,0.862136791375709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB116,Beta-defensin 116,39586,-0.00131986351024661,0.00762126021291015,-0.0162575335275505,0.0136178065070573,0.862511724810121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,39560,0.000749900058075782,0.00443360154749316,-0.00793995897501081,0.00943975909116237,0.8656895212866
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.00118715568576286,0.00702054302190773,-0.0125731086371763,0.014947420008702,0.865723082677052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD33,Myeloid cell surface antigen CD33,42181,0.00135734542633495,0.00803397819649567,-0.0143892518387966,0.0171039426914665,0.865838015303346
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSB,Lupus La protein,41839,0.000996493426096419,0.00595030992544865,-0.0106661140277829,0.0126591008799758,0.867003466646142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,39560,0.00145429822733979,0.0087068062748736,-0.0156110420714125,0.018519638526092,0.867349491425627
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REST,RE1-silencing transcription factor,39560,-0.00058032607564087,0.00347835286462438,-0.00739789769030466,0.00623724553902292,0.867499546107096
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00287944931957071,0.0174585673231868,-0.0313393426338755,0.0370982412730169,0.86900166936506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00067198738562422,0.00409935023882961,-0.00736273908248182,0.00870671385373026,0.869792936283627
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.000771977308724632,0.00473313458771174,-0.00850496648319038,0.0100489211006396,0.870442194171484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPO,Erythropoietin,42119,-0.00120196332419127,0.0073697524342914,-0.0156466780954024,0.0132427514470199,0.870446763275427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.000635751025189537,0.00393627013949369,-0.0070793384482181,0.00835084049859718,0.871693901583698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB2,Lysosome membrane protein 2,41777,-0.00049074357762939,0.00333620272798171,-0.00702970092447354,0.00604821376921476,0.883058142322284
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.000499719982354308,0.00340932914152207,-0.00618256513502895,0.00718200509973756,0.883470747575487
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCLN,Nicalin,41913,0.000747466545950117,0.00518255445470923,-0.00941034018527998,0.0109052732771802,0.885323058971391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.000622108554734674,0.00433589779675383,-0.00912046823637218,0.00787625112690283,0.88591482403795
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFD,Complement factor D,39979,0.000292011445482396,0.00205810750699431,-0.00374187926822646,0.00432590215919125,0.887174558931772
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL2,Podocalyxin-like protein 2,42181,0.000408063693964857,0.00288876596397652,-0.00525391759542911,0.00607004498335883,0.887667569145121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00068558259682409,0.00486914025460862,-0.00885793230220881,0.010229097495857,0.888029243909812
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP350,Centrosome-associated protein 350,39560,-0.00052066341523374,0.00371445132930406,-0.00780098802066969,0.00675966119020221,0.888526384247273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,41843,-0.000660616904509056,0.00486643664645128,-0.0101988327315536,0.00887759892253545,0.892021286358081
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARCL1,SPARC-like protein 1,42169,-0.000358890805334586,0.00276703329340521,-0.0057822760604088,0.00506449444973962,0.896803821548326
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,39586,0.00138815516446522,0.0110288550293593,-0.0202284006930789,0.0230047110220094,0.899840493826848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN7,Septin-7,39757,-0.000671208528829161,0.00539907535364796,-0.0112533962219792,0.00991097916432085,0.901064814737586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.000505522619383873,0.00414495687511033,-0.00761859285583238,0.00862963809460012,0.902931813504796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.000331960416195827,0.00279347898662094,-0.00580717922997286,0.00514325839758121,0.905408590890498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.000416058827532965,0.0035920891786534,-0.00745655361769364,0.00662443596262771,0.907792230928161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.000316168655702304,0.00273001720099376,-0.00566700236965007,0.00503466505824546,0.907803281524056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.000734681076727308,0.00652315535561829,-0.0135200655737391,0.0120507034202845,0.910328625579006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA4,Ephrin-A4,41992,0.000364478912274036,0.00327233825122437,-0.00604930406012572,0.00677826188467379,0.911315263932024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGB,Secretogranin-1,42210,-0.000475150386318801,0.00427513877968187,-0.00885442239449526,0.00790412162185766,0.911504842590679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAGLN3,Transgelin-3,39560,-0.000667665341888641,0.00609823452758912,-0.0126202050159633,0.011284874332186,0.91281980543261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.000726880344829158,0.00693492630662634,-0.0143193359058168,0.0128655752161585,0.916524977976738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.000428231938678237,0.00414279847291486,-0.00769165306823489,0.00854811694559137,0.917672946588185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.000577776485761088,0.00562495709309979,-0.0116026923882367,0.0104471394167145,0.918189772525071
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.000613906722339797,0.00604373296276118,-0.0112318098846721,0.0124596233293517,0.919093956533399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,42262,0.00057219701581281,0.00602368632715113,-0.0112342281854034,0.012378622217029,0.924323233127387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.000349510562633153,0.00374624296123103,-0.00699312564137967,0.00769214676664597,0.925669584790007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNL1,Thioredoxin-like protein 1,39570,0.000937202009812537,0.0103252365418445,-0.0193002616122028,0.0211746656318278,0.927678522271543
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBX2,Chromobox protein homolog 2,39575,0.000358522023998447,0.00400780238067339,-0.00749677064212141,0.0082138146901183,0.928721141809107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171A2,Protein FAM171A2,39934,-0.00141671273356095,0.0158478646598363,-0.0324785274668402,0.0296451019997183,0.9287699339278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.000323245401455356,0.00370018892674764,-0.00757561569788074,0.00692912489497002,0.930387623518156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKZF2,Zinc finger protein Helios,41843,0.000771776398829075,0.00898331715746201,-0.0168355252297965,0.0183790780274546,0.931537524470534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.000787946920157063,0.00930049971896096,-0.0190169263693205,0.0174410325290064,0.93248480905443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.000418253679118805,0.00504439767293563,-0.00946876575983504,0.0103052731180726,0.933921041522819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PITHD1,PITH domain-containing protein 1,39539,-0.000605012751259802,0.00784642010127296,-0.0159839961497548,0.0147739706472352,0.938539952526342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.000364900552825434,0.00504456655470128,-0.00952244989438907,0.0102522510000399,0.942336331139766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RUVBL1,RuvB-like 1,41843,-0.000711532786410507,0.010001800663566,-0.0203150620869999,0.0188919965141789,0.943287034666462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,39757,-0.000589914217769166,0.00874371026456228,-0.0177275863363112,0.0165477579007729,0.946210930288746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00049552152330169,0.00766206076766417,-0.0145221175813201,0.0155131606279235,0.948436223169528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.000205929150623361,0.00329123455636148,-0.00665674888109187,0.00624489057984514,0.950110878951185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP12,Macrophage metalloelastase,42146,-0.000327782628711511,0.00552953987159206,-0.011165680777032,0.0105101155196089,0.952731188824518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK12,Kallikrein-12,41843,0.000770193589672127,0.0134820655157631,-0.0256546548212235,0.0271950420005678,0.954444675862527
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC1A4,Neutral amino acid transporter A,39649,-0.000293162392821709,0.00515176144310151,-0.0103906148213007,0.00980429003565726,0.954621682624483
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORN4,MORN repeat-containing protein 4,39560,-0.000439503421512948,0.00795303719494409,-0.0160274563236034,0.0151484494805775,0.955930474315306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP15,Matrix metalloproteinase-15,39958,0.000256863366845004,0.00493285602247667,-0.00941153443720927,0.00992526117089928,0.958472289565211
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.000220351536971355,0.0043816120943321,-0.00836760816791956,0.00880831124186227,0.959891985909671
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.000173891025490883,0.00349207941331172,-0.00667058462460009,0.00701836667558186,0.960285988434444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBN2,Fibrillin-2,39649,-0.000297407828484947,0.00609201348866228,-0.012237754266263,0.0116429386092931,0.961064184460835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000193637157469198,0.0044705962064484,-0.00856873140716967,0.00895600572210807,0.965452420928215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAX,Integrin alpha-X,39757,-0.000219186888777937,0.00524046616502909,-0.0104905005722349,0.0100521267946791,0.96663828573042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,42070,-0.000100190489078859,0.002448224481455,-0.00489871047273066,0.00469832949457294,0.967357302290578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31,Interleukin-31,39657,-0.000222853311202125,0.00564656906444962,-0.0112901286775234,0.0108444220551191,0.968518751740327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.000631792220271881,0.0168459639280932,-0.0336498815193345,0.0323862970787908,0.970083755309662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSB,Cathepsin B,42153,0.000178878745224109,0.00513280289640814,-0.00988141493173585,0.0102391724221841,0.972199776150705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,39560,-0.000133453839400058,0.00407023128837653,-0.00811110716461806,0.00784419948581794,0.973844421861832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESPL1,Separin,39560,-0.000176930980098273,0.00542314174536946,-0.0108062888010224,0.0104524268408259,0.973974083204115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB2,Beta-crystallin B2,39929,-0.000216903036243251,0.00709879291225314,-0.0141305371442594,0.0136967310717729,0.975625033697995
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,39820,9.61728354780765e-05,0.00335596889552414,-0.00648152619974923,0.00667387187070539,0.977138462573808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.000125307931501177,0.00448718141104407,-0.0086695676341452,0.00892018349714755,0.977721785013997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,39894,9.82525924187681e-05,0.00387907732489473,-0.00750473896437491,0.00770124414921244,0.979793104743245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,39575,9.0362122851304e-05,0.00363073145226145,-0.00702587152358113,0.00720659576928374,0.980144646246673
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSTN,Osteocrin,39649,-9.88477257096163e-05,0.004102860049587,-0.00814045342290014,0.00794275797148091,0.980779344394435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.000154263777330106,0.00642555364236819,-0.0124398213617115,0.0127483489163718,0.980846770341049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00012402151566833,0.00523615496459773,-0.0103868852462799,0.0101388422149432,0.981103825860865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTH3,Cytohesin-3,39560,0.000166287565742451,0.00742752670338007,-0.0143916647728825,0.0147242399043674,0.982138849609612
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASA1,Ras GTPase-activating protein 1,41839,6.69904908211051e-05,0.003294538618954,-0.00639030520232873,0.00652428618397094,0.983777398932147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,39930,0.000104421163210419,0.0078876938161137,-0.0153554587163724,0.0155643010427933,0.989437754077542
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCP11,T-complex protein 11 homolog,39757,-5.84745643629672e-05,0.00586896516714079,-0.0115616462919589,0.011444697163233,0.992050705124977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100G,Protein S100-G,39934,2.79740654859071e-05,0.00496371629078406,-0.00970090986445085,0.00975685799542266,0.995503476998492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,2.87722724300018e-05,0.00758553454718227,-0.0148388754400473,0.0148964199849073,0.996973664235637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX2,Neuronal pentraxin-2,39966,1.27671019011515e-05,0.00347285119697316,-0.00679402124416624,0.00681955544796854,0.997066840497657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDSN,Corneodesmosin,42246,1.55946904790689e-05,0.00442790185363571,-0.00866309294264692,0.00869428232360505,0.997189976314643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,39757,1.90534779630807e-05,0.00545664165525143,-0.0106759641663297,0.0107140711222559,0.997214018197139
